data_2lv4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lv4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 70.530000000000001 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.349999999999994 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 65.319999999999993 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 73.209999999999994 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.239999999999995 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 74.510000000000005 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.540000000000006 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 75.010000000000005 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.420000000000002 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 72.349999999999994 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 74.209999999999994 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.409999999999997 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.239999999999995 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 m120 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.409999999999997 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.310000000000002 109.221 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.349999999999994 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.209999999999994 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 74.329999999999998 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.119999999999997 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.496 174.179 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.367 0.604 . . . . 75.349999999999994 111.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.409999999999997 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.952 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 73.150000000000006 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.219999999999999 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.129999999999995 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.010000000000005 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 63.439999999999998 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 63.149999999999999 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.319999999999993 109.483 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.9 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.010000000000005 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 74.209999999999994 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.010000000000005 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.319999999999993 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.540000000000006 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 72.409999999999997 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.130000000000003 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.420000000000002 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 71.420000000000002 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.350000000000001 111.645 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.329999999999998 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 74.140000000000001 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 72.430000000000007 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.409999999999997 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.200000000000003 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.768 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.109999999999999 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.129999999999995 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 73.120000000000005 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.340000000000003 108.951 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.952 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.140000000000001 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 74.5 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.299999999999997 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 54.219999999999999 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.648 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.209999999999994 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.409999999999997 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.409999999999997 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.349999999999994 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.505 HG12 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.319999999999993 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.239999999999995 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.400000000000006 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.019999999999996 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.962 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.120000000000005 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.319999999999993 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . 0.655 ' HD3' ' H ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 75.450000000000003 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 71.409999999999997 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 74.25 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 75.519999999999996 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.510000000000005 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.685 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . 0.75 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.219999999999999 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.530000000000001 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.109999999999999 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.409999999999997 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 75.310000000000002 108.624 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.839 ' HB3' HG21 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.200000000000003 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.466 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.329999999999998 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.559 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.409999999999997 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 73.439999999999998 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.835 ' HD3' HG22 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 75.209999999999994 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.768 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 74.019999999999996 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.649 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.803 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 73.420000000000002 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.530000000000001 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 62.219999999999999 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 65.030000000000001 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.582 ' HB3' HD11 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 73.120000000000005 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 75.019999999999996 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.030000000000001 113.351 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 64.209999999999994 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.299999999999997 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.140000000000001 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.230000000000004 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.430000000000007 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.420000000000002 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.655 ' HB ' HD13 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 71.549999999999997 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.962 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 74.150000000000006 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 61.32 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.469 ' HG2' HG21 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.430000000000007 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 64.310000000000002 110.258 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 73.140000000000001 108.621 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.509999999999998 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.200000000000003 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 74.329999999999998 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.671 ' HZ3' ' HB2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 73.409999999999997 110.501 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.200000000000003 110.45 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.655 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.446 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.519999999999996 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.310000000000002 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.530000000000001 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 73.340000000000003 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 70.530000000000001 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.349999999999994 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 65.319999999999993 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 73.209999999999994 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.239999999999995 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 74.510000000000005 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.319999999999993 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.540000000000006 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 75.010000000000005 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 72.349999999999994 108.658 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 74.209999999999994 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.409999999999997 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.239999999999995 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 0.1 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.409999999999997 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.310000000000002 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.349999999999994 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.209999999999994 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.119999999999997 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 111.257 -178.198 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.479 0.657 . . . . 75.349999999999994 111.364 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.409999999999997 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 73.150000000000006 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.219999999999999 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.556 ' HB2' ' HE2' ' A' ' 183' ' ' MET . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.129999999999995 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.010000000000005 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.515 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 63.149999999999999 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.319999999999993 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.775 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.010000000000005 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 74.209999999999994 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.564 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.010000000000005 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.319999999999993 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.540000000000006 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 72.409999999999997 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.130000000000003 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 1.023 HD22 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 71.420000000000002 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.350000000000001 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.329999999999998 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 74.140000000000001 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.230000000000004 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 1.023 ' HB2' HD22 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 72.430000000000007 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.140000000000001 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.409999999999997 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.200000000000003 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.819 HG21 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.109999999999999 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.129999999999995 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.579 HG12 HG22 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 73.120000000000005 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.340000000000003 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 74.5 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 54.219999999999999 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.624 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.209999999999994 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.855 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.409999999999997 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.409999999999997 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.349999999999994 111.354 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.473 HG11 HG12 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.319999999999993 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.239999999999995 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.400000000000006 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.019999999999996 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.615 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.120000000000005 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.429 HG13 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.319999999999993 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 75.450000000000003 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 71.409999999999997 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.209999999999994 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 74.25 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 75.519999999999996 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.510000000000005 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.209999999999994 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.219999999999999 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.530000000000001 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.109999999999999 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.701 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.409999999999997 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 75.310000000000002 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.427 ' HB3' HG21 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.200000000000003 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.409999999999997 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.329999999999998 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.855 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.409999999999997 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 73.439999999999998 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.699 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 75.209999999999994 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.819 ' HB2' HG21 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 74.019999999999996 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 74.400000000000006 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD11 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 73.420000000000002 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.424 HG11 ' HG1' ' A' ' 197' ' ' THR . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.530000000000001 111.836 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 62.219999999999999 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 65.030000000000001 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.48 ' HB3' HD11 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 73.120000000000005 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 75.019999999999996 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.030000000000001 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 64.209999999999994 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.120000000000005 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.299999999999997 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.594 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.140000000000001 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.230000000000004 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.749 HG22 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.430000000000007 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.420000000000002 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 71.549999999999997 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.67 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 74.150000000000006 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.574 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 61.32 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.503 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.430000000000007 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 64.310000000000002 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.416 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.200000000000003 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.406 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 74.329999999999998 111.81 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.503 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.409999999999997 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.574 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 73.409999999999997 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.200000000000003 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.527 HG21 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.420000000000002 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.749 ' HB ' HG22 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.519999999999996 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.239999999999995 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.310000000000002 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 73.340000000000003 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 70.530000000000001 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.349999999999994 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 65.319999999999993 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 73.209999999999994 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.239999999999995 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 74.510000000000005 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.319999999999993 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.540000000000006 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 75.010000000000005 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.420000000000002 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 72.349999999999994 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 74.209999999999994 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.409999999999997 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.239999999999995 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 19.0 m-80 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.409999999999997 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.310000000000002 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.209999999999994 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.542 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 74.329999999999998 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.119999999999997 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.319999999999993 111.225 -177.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.299 0.571 . . . . 75.349999999999994 111.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.409999999999997 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 73.150000000000006 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.796 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.219999999999999 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.96 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.129999999999995 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.010000000000005 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 63.439999999999998 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.96 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 63.149999999999999 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.319999999999993 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.675 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.010000000000005 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 74.209999999999994 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.010000000000005 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.319999999999993 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.540000000000006 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.487 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 72.409999999999997 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.130000000000003 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.420000000000002 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 71.420000000000002 110.231 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.350000000000001 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.329999999999998 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 74.140000000000001 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.230000000000004 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 72.430000000000007 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.140000000000001 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.409999999999997 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.129999999999995 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 73.120000000000005 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.340000000000003 108.51 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.752 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.140000000000001 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 74.5 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.299999999999997 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 54.219999999999999 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.209999999999994 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.65 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.409999999999997 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 213' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.409999999999997 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.668 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.349999999999994 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.319999999999993 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.239999999999995 109.329 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.400000000000006 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.72 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.019999999999996 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.530000000000001 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.120000000000005 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.608 HG13 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.319999999999993 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 75.450000000000003 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 71.409999999999997 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 48.0 t30 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.209999999999994 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.442 ' HD3' HD22 ' A' ' 223' ' ' ASN . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.209999999999994 110.276 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 74.25 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 75.519999999999996 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.510000000000005 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.209999999999994 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . 0.568 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.340000000000003 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.219999999999999 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.530000000000001 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.109999999999999 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.409999999999997 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 75.310000000000002 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.200000000000003 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.409999999999997 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.716 HG22 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.329999999999998 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.65 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.409999999999997 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.716 ' HE3' HG22 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 75.209999999999994 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.668 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 74.019999999999996 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 74.400000000000006 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.420000000000002 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.530000000000001 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.568 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 62.219999999999999 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 65.030000000000001 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.494 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 75.019999999999996 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.030000000000001 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 64.209999999999994 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.261 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.726 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.299999999999997 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.140000000000001 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.230000000000004 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.517 HG22 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.430000000000007 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.420000000000002 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 71.549999999999997 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 74.150000000000006 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.407 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 61.32 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.72 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.430000000000007 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.406 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 64.310000000000002 110.462 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 73.140000000000001 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 264' ' ' MET . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.509999999999998 111.125 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.200000000000003 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 74.329999999999998 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.409999999999997 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 73.409999999999997 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.575 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.200000000000003 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.679 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.420000000000002 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.669 HD13 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.519999999999996 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.310000000000002 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 73.340000000000003 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 70.530000000000001 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.349999999999994 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 65.319999999999993 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 73.209999999999994 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.239999999999995 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 74.510000000000005 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.319999999999993 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.540000000000006 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 75.010000000000005 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 72.349999999999994 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 74.209999999999994 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.409999999999997 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.239999999999995 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.310000000000002 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.349999999999994 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.209999999999994 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 74.329999999999998 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 109.982 -177.231 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.199 0.523 . . . . 75.349999999999994 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.409999999999997 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.8 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 73.150000000000006 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.727 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.219999999999999 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.52 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.129999999999995 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.010000000000005 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 63.439999999999998 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 63.149999999999999 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.319999999999993 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.779 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.010000000000005 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 74.209999999999994 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.010000000000005 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.319999999999993 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HZ1' ' HB2' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 72.409999999999997 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.130000000000003 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.553 HD23 ' HB1' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.420000000000002 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 71.420000000000002 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.581 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.350000000000001 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.329999999999998 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 74.140000000000001 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.230000000000004 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 72.430000000000007 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.140000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.409999999999997 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.200000000000003 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.109999999999999 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.129999999999995 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.568 HG11 HG22 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 73.120000000000005 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.340000000000003 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.140000000000001 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.727 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 74.5 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.299999999999997 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 54.219999999999999 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.209999999999994 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.409999999999997 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.586 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.409999999999997 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.349999999999994 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.319999999999993 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.239999999999995 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.486 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.019999999999996 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.671 ' HD2' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.802 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.120000000000005 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . 0.544 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 75.450000000000003 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 71.409999999999997 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.497 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.209999999999994 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 74.25 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 75.519999999999996 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.618 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.209999999999994 109.536 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.219999999999999 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.530000000000001 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.109999999999999 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.409999999999997 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 75.310000000000002 108.605 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.576 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.200000000000003 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.409999999999997 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.667 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.329999999999998 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.409999999999997 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.667 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 75.209999999999994 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.721 ' HB2' HG22 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 74.019999999999996 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 74.400000000000006 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.671 HE22 ' HD2' ' A' ' 217' ' ' LYS . 34.4 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 73.420000000000002 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.530000000000001 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 62.219999999999999 109.57 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.106 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.852 ' HH ' HG21 ' A' ' 256' ' ' ILE . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 73.120000000000005 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 75.019999999999996 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.581 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.030000000000001 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.591 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 64.209999999999994 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.120000000000005 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 1.035 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.299999999999997 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.618 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.140000000000001 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.230000000000004 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.852 HG21 ' HH ' ' A' ' 248' ' ' TYR . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.430000000000007 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.420000000000002 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.601 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 71.549999999999997 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.802 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 74.150000000000006 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 61.32 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.430000000000007 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 64.310000000000002 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 73.140000000000001 110.601 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.509999999999998 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.200000000000003 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.409999999999997 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.696 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 73.409999999999997 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.696 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.200000000000003 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.601 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.420000000000002 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG22 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.519999999999996 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.310000000000002 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.565 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.530000000000001 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 1.035 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 73.340000000000003 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 70.530000000000001 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.349999999999994 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 65.319999999999993 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 73.209999999999994 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.239999999999995 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 74.510000000000005 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.319999999999993 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.420000000000002 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 72.349999999999994 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 74.209999999999994 110.271 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.239999999999995 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 2.2 p30 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.409999999999997 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.310000000000002 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.349999999999994 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.209999999999994 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.119999999999997 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.319999999999993 110.601 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.412 0.625 . . . . 75.349999999999994 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.409999999999997 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 73.150000000000006 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.219999999999999 110.119 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.129999999999995 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.010000000000005 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 63.439999999999998 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.46 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 63.149999999999999 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.319999999999993 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.010000000000005 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 74.209999999999994 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.010000000000005 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.540000000000006 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 72.409999999999997 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.130000000000003 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 71.420000000000002 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.350000000000001 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.329999999999998 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.230000000000004 110.686 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 72.430000000000007 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.140000000000001 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.554 HG12 HD12 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.409999999999997 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.200000000000003 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.652 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.109999999999999 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.129999999999995 108.25 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.619 HG11 HG22 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 73.120000000000005 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.340000000000003 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.819 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.140000000000001 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 74.5 109.964 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.299999999999997 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 54.219999999999999 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.209999999999994 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.695 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.409999999999997 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.619 HG22 HG11 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.409999999999997 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.349999999999994 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.563 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.319999999999993 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.239999999999995 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.400000000000006 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.019999999999996 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.527 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.530000000000001 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.120000000000005 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.319999999999993 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . 0.606 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 75.450000000000003 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 71.409999999999997 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.464 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.209999999999994 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.209999999999994 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.449 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 74.25 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 75.519999999999996 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.606 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.510000000000005 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.209999999999994 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.340000000000003 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.219999999999999 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.530000000000001 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.109999999999999 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.409999999999997 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 75.310000000000002 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.406 ' HB2' ' HZ1' ' A' ' 234' ' ' LYS . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.200000000000003 109.171 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.409999999999997 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.329999999999998 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.695 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.409999999999997 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 73.439999999999998 113.695 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 75.209999999999994 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.652 ' HB2' HG22 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 74.019999999999996 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 74.400000000000006 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.677 ' HB2' HD11 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 73.420000000000002 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.530000000000001 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 62.219999999999999 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 65.030000000000001 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.705 ' HH ' HG21 ' A' ' 256' ' ' ILE . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 73.120000000000005 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 75.019999999999996 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.030000000000001 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 64.209999999999994 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.120000000000005 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.705 HG21 ' HH ' ' A' ' 248' ' ' TYR . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.430000000000007 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.420000000000002 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.667 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 71.549999999999997 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 74.150000000000006 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 61.32 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.430000000000007 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.456 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 64.310000000000002 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 73.140000000000001 109.526 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.509999999999998 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.200000000000003 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 74.329999999999998 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.409999999999997 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 73.409999999999997 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.200000000000003 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.667 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.517 ' HB ' HG22 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.519999999999996 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.239999999999995 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.310000000000002 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.43 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.530000000000001 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 73.340000000000003 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 70.530000000000001 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.349999999999994 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 65.319999999999993 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 73.209999999999994 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.239999999999995 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 74.510000000000005 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.540000000000006 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 75.010000000000005 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.420000000000002 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 72.349999999999994 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 74.209999999999994 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.409999999999997 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.239999999999995 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.422 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 3.2 p30 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.409999999999997 110.413 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.310000000000002 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.349999999999994 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.209999999999994 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 74.329999999999998 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.319999999999993 110.451 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.201 0.524 . . . . 75.349999999999994 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.409999999999997 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 73.150000000000006 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.219999999999999 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.129999999999995 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.010000000000005 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 63.439999999999998 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 63.149999999999999 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.319999999999993 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.010000000000005 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 74.209999999999994 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.604 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.010000000000005 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.319999999999993 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.604 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.540000000000006 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.754 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 72.409999999999997 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.645 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.130000000000003 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 71.420000000000002 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.350000000000001 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 191' ' ' SER . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.329999999999998 111.682 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 74.140000000000001 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.230000000000004 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 72.430000000000007 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.140000000000001 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.643 HD13 HD12 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.409999999999997 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.200000000000003 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.415 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.129999999999995 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.662 HG13 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 73.120000000000005 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.340000000000003 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.140000000000001 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 74.5 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 54.219999999999999 111.736 -175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.459 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.209999999999994 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.409999999999997 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 213' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.409999999999997 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.662 HG11 HG13 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.239999999999995 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.400000000000006 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.019999999999996 109.223 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.59 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.530000000000001 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.120000000000005 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.319999999999993 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 75.450000000000003 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.424 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 71.409999999999997 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.209999999999994 109.917 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.209999999999994 110.767 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 74.25 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 75.519999999999996 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.589 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.510000000000005 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.656 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.209999999999994 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.340000000000003 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.219999999999999 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.530000000000001 111.667 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.109999999999999 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 75.310000000000002 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.200000000000003 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.409999999999997 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.329999999999998 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.409999999999997 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 73.439999999999998 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.639 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 75.209999999999994 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 74.019999999999996 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 74.400000000000006 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 73.420000000000002 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.530000000000001 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 62.219999999999999 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 65.030000000000001 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 73.120000000000005 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 75.019999999999996 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.030000000000001 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 64.209999999999994 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 253' ' ' ASN . 0.2 OUTLIER -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.299999999999997 110.086 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.589 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.140000000000001 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.424 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.230000000000004 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.703 HD13 HG12 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.430000000000007 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.545 ' N ' HD11 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.474 ' HB ' HD13 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 71.549999999999997 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.64 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 74.150000000000006 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.59 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 61.32 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.585 ' HB2' ' HZ3' ' A' ' 261' ' ' LYS . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.430000000000007 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 64.310000000000002 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 73.140000000000001 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.509999999999998 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.200000000000003 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.409999999999997 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 73.409999999999997 110.915 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.200000000000003 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.515 HD11 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.420000000000002 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.643 HD12 HD13 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.519999999999996 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.754 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.310000000000002 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.645 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.530000000000001 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 73.340000000000003 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 70.530000000000001 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.349999999999994 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 65.319999999999993 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 73.209999999999994 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.239999999999995 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 74.510000000000005 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.319999999999993 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.540000000000006 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 75.010000000000005 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.420000000000002 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 72.349999999999994 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.409999999999997 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.239999999999995 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.409999999999997 110.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.310000000000002 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.209999999999994 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 74.329999999999998 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.119999999999997 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 110.273 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.603 0.716 . . . . 75.349999999999994 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.409999999999997 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 73.150000000000006 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.606 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.219999999999999 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.129999999999995 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.010000000000005 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 63.439999999999998 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 63.149999999999999 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.319999999999993 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.651 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.010000000000005 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 74.209999999999994 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.010000000000005 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.540000000000006 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 72.409999999999997 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.130000000000003 109.386 -168.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.420000000000002 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 71.420000000000002 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.350000000000001 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.329999999999998 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 74.140000000000001 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.230000000000004 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 72.430000000000007 109.967 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.409999999999997 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.200000000000003 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.109999999999999 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.129999999999995 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 73.120000000000005 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.340000000000003 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.719 ' OD2' ' HB2' ' A' ' 208' ' ' ASN . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.140000000000001 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.606 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 74.5 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.299999999999997 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 54.219999999999999 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.719 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.209999999999994 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.409999999999997 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.625 ' ND2' ' HG2' ' A' ' 212' ' ' GLU . 9.1 t30 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.409999999999997 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.625 ' HG2' ' ND2' ' A' ' 211' ' ' ASN . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.319999999999993 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.239999999999995 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.400000000000006 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.019999999999996 109.638 178.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.543 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.530000000000001 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.120000000000005 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.703 ' HB ' HD13 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 75.450000000000003 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 71.409999999999997 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.209999999999994 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.209999999999994 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 74.25 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 75.519999999999996 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.598 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.510000000000005 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.209999999999994 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.219999999999999 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.530000000000001 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.109999999999999 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.409999999999997 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 75.310000000000002 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.200000000000003 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.409999999999997 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.329999999999998 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.409999999999997 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 73.439999999999998 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.624 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 75.209999999999994 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' HB2' HG22 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 74.019999999999996 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 74.400000000000006 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.74 ' HB2' HD13 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 73.420000000000002 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.530000000000001 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.485 HG21 ' HH ' ' A' ' 248' ' ' TYR . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 62.219999999999999 109.222 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 65.030000000000001 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 73.120000000000005 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 75.019999999999996 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.030000000000001 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 64.209999999999994 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.120000000000005 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.299999999999997 111.226 -176.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.409 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.140000000000001 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.703 HD13 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.430000000000007 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.420000000000002 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.632 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 71.549999999999997 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 74.150000000000006 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 61.32 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.430000000000007 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 64.310000000000002 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 73.140000000000001 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.824 ' HA ' ' HE2' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.509999999999998 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.200000000000003 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.557 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.615 HG21 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.409999999999997 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.776 ' HA ' ' HE2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 73.409999999999997 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.744 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.200000000000003 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.420000000000002 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.438 HG21 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.519999999999996 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.239999999999995 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.310000000000002 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.530000000000001 111.147 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 73.340000000000003 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 70.530000000000001 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.349999999999994 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.602 ' H ' HD21 ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 65.319999999999993 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 73.209999999999994 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.239999999999995 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 74.510000000000005 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.319999999999993 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.540000000000006 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 75.010000000000005 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 72.349999999999994 108.233 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 74.209999999999994 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.409999999999997 110.165 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.310000000000002 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.349999999999994 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.209999999999994 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 74.329999999999998 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.319999999999993 110.908 179.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.413 HD21 ' N ' ' A' ' 175' ' ' THR . 2.6 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.153 0.502 . . . . 75.349999999999994 110.978 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.413 ' N ' HD21 ' A' ' 174' ' ' ASN . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.409999999999997 109.714 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 73.150000000000006 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.219999999999999 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.583 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.129999999999995 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.010000000000005 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 63.439999999999998 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 63.149999999999999 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.319999999999993 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.010000000000005 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 74.209999999999994 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.010000000000005 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.319999999999993 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.540000000000006 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 72.409999999999997 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.130000000000003 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 1.024 HD22 ' HB1' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 71.420000000000002 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.350000000000001 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.329999999999998 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 74.140000000000001 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.230000000000004 110.48 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 1.024 ' HB1' HD22 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 72.430000000000007 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.468 ' OG1' HG13 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.140000000000001 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.454 HG13 ' CD1' ' A' ' 185' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.409999999999997 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.200000000000003 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.109999999999999 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.129999999999995 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 73.120000000000005 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.340000000000003 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.140000000000001 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 74.5 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.299999999999997 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 54.219999999999999 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.209999999999994 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.409999999999997 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.579 HG13 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.409999999999997 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.349999999999994 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.579 HG13 HG13 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.319999999999993 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.239999999999995 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.400000000000006 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.0 t30 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.019999999999996 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.530000000000001 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.120000000000005 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.748 HG11 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.319999999999993 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . 0.402 ' CZ ' ' HD1' ' A' ' 228' ' ' TRP . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 75.450000000000003 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 71.409999999999997 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.658 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.209999999999994 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.618 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.499 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 74.25 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 75.519999999999996 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.510000000000005 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG22 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.340000000000003 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.219999999999999 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.530000000000001 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.409999999999997 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 75.310000000000002 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.200000000000003 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.442 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.329999999999998 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.409999999999997 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 73.439999999999998 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 75.209999999999994 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 74.019999999999996 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 74.400000000000006 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.641 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 73.420000000000002 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.468 HG13 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.530000000000001 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 62.219999999999999 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 65.030000000000001 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.829 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.899 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 75.019999999999996 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.030000000000001 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 64.209999999999994 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.120000000000005 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.299999999999997 110.467 -177.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.658 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.140000000000001 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.428 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.230000000000004 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.430000000000007 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.420000000000002 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.748 HG12 HG11 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 71.549999999999997 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.595 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 61.32 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.430000000000007 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 64.310000000000002 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 73.140000000000001 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.509999999999998 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.200000000000003 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 74.329999999999998 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 73.409999999999997 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.200000000000003 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.420000000000002 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.747 HG22 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.519999999999996 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.239999999999995 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.310000000000002 111.41 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.530000000000001 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 73.340000000000003 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 70.530000000000001 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.349999999999994 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 65.319999999999993 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 73.209999999999994 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.239999999999995 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 74.510000000000005 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.319999999999993 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.540000000000006 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 75.010000000000005 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.420000000000002 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 72.349999999999994 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 74.209999999999994 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.421 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.409999999999997 110.15 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.310000000000002 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.349999999999994 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.209999999999994 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 74.329999999999998 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.119999999999997 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.319999999999993 112.289 -174.653 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.409999999999997 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.808 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 73.150000000000006 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.219999999999999 109.805 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.129999999999995 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.010000000000005 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 63.439999999999998 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.551 HG21 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 63.149999999999999 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.319999999999993 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.551 ' HG3' HG21 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.010000000000005 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.319999999999993 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.540000000000006 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 72.409999999999997 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.130000000000003 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.597 HD13 ' HB3' ' A' ' 248' ' ' TYR . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.420000000000002 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 71.420000000000002 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.350000000000001 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.329999999999998 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 74.140000000000001 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.230000000000004 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.694 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 72.430000000000007 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.409999999999997 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.109999999999999 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.129999999999995 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 73.120000000000005 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.808 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.140000000000001 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.402 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 74.5 110.294 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.299999999999997 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 54.219999999999999 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.209999999999994 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.458 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.409999999999997 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.607 HG23 HG13 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.409999999999997 109.198 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.686 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.349999999999994 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.407 HG13 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.319999999999993 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.400000000000006 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.85 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.019999999999996 109.403 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.435 ' N ' HD21 ' A' ' 216' ' ' ASN . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.530000000000001 111.458 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.120000000000005 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.562 ' HB ' HD13 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.319999999999993 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 75.450000000000003 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 71.409999999999997 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.209999999999994 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.477 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.209999999999994 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 74.25 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.871 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 75.519999999999996 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.510000000000005 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.743 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.219999999999999 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.530000000000001 111.95 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.109999999999999 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.409999999999997 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 75.310000000000002 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.200000000000003 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.329999999999998 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.458 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.409999999999997 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 73.439999999999998 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 75.209999999999994 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.686 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 74.019999999999996 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 74.400000000000006 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.741 ' HB2' HD11 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 73.420000000000002 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.530000000000001 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 62.219999999999999 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 65.030000000000001 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.597 ' HB3' HD13 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 73.120000000000005 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.871 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 75.019999999999996 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.030000000000001 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 64.209999999999994 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.120000000000005 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 0.2 OUTLIER -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.299999999999997 111.177 -176.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.140000000000001 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.230000000000004 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.430000000000007 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.420000000000002 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.596 ' HB ' HD12 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 71.549999999999997 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.558 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 74.150000000000006 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 61.32 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.85 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.430000000000007 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 73.140000000000001 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.509999999999998 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.200000000000003 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . 0.499 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 74.329999999999998 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.629 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.409999999999997 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.498 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 73.409999999999997 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.200000000000003 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.596 HD12 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.420000000000002 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.519999999999996 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.239999999999995 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.310000000000002 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.530000000000001 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 73.340000000000003 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 70.530000000000001 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.349999999999994 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 65.319999999999993 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 73.209999999999994 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 74.510000000000005 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.319999999999993 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.540000000000006 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 75.010000000000005 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 72.349999999999994 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 74.209999999999994 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.409999999999997 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.239999999999995 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p30 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.409999999999997 109.543 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.310000000000002 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.349999999999994 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.209999999999994 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 74.329999999999998 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 109.193 169.513 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.14 0.495 . . . . 75.349999999999994 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.409999999999997 110.179 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 73.150000000000006 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.219999999999999 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.639 ' HB2' ' HE2' ' A' ' 183' ' ' MET . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.129999999999995 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.010000000000005 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 63.439999999999998 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.487 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 63.149999999999999 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.319999999999993 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.683 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.010000000000005 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 74.209999999999994 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.567 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.010000000000005 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.319999999999993 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.567 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.540000000000006 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.862 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 72.409999999999997 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.130000000000003 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.826 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.420000000000002 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 71.420000000000002 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.350000000000001 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.329999999999998 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 74.140000000000001 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.230000000000004 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 72.430000000000007 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.59 ' HG1' HG13 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.140000000000001 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.739 HD12 HD13 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.409999999999997 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.200000000000003 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.109999999999999 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.129999999999995 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 73.120000000000005 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.140000000000001 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 74.5 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.299999999999997 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 54.219999999999999 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 209' ' ' PRO . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.209999999999994 110.823 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.653 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.409999999999997 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.409999999999997 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.712 ' HB2' ' HH ' ' A' ' 242' ' ' TYR . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.349999999999994 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 109.993 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.400000000000006 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.019999999999996 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.530000000000001 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.120000000000005 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.319999999999993 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 75.450000000000003 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 71.409999999999997 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.209999999999994 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.209999999999994 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 74.25 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 75.519999999999996 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.510000000000005 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.340000000000003 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.219999999999999 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.530000000000001 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.109999999999999 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.409999999999997 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 75.310000000000002 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.200000000000003 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.409999999999997 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.985 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.329999999999998 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.653 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.409999999999997 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 73.439999999999998 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.985 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 75.209999999999994 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.712 ' HH ' ' HB2' ' A' ' 212' ' ' GLU . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 74.019999999999996 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 74.400000000000006 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.765 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 73.420000000000002 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.59 HG13 ' HG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.530000000000001 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.409 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 62.219999999999999 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 65.030000000000001 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.826 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 75.019999999999996 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.030000000000001 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 249' ' ' ARG . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 64.209999999999994 112.068 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.299999999999997 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.140000000000001 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.430000000000007 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.564 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 71.549999999999997 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.654 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 74.150000000000006 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 61.32 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.430000000000007 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.517 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 64.310000000000002 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.441 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 73.140000000000001 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.509999999999998 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.200000000000003 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 74.329999999999998 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.409999999999997 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 73.409999999999997 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.200000000000003 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.239999999999995 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.310000000000002 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.530000000000001 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 173.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 70.530000000000001 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.349999999999994 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.591 ' H ' HD21 ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 65.319999999999993 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 73.209999999999994 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.239999999999995 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 74.510000000000005 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.540000000000006 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 75.010000000000005 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.420000000000002 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 72.349999999999994 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 74.209999999999994 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.409999999999997 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.239999999999995 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 m120 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.409999999999997 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.310000000000002 109.221 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.349999999999994 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.209999999999994 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 74.329999999999998 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.119999999999997 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -51.49 135.49 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.496 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.24 103.37 13.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.394 -0.366 . . . . 71.340000000000003 111.783 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -79.75 101.46 8.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.557 -0.535 . . . . 74.219999999999999 109.557 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.59 39.58 1.62 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.483 -0.865 . . . . 73.299999999999997 113.027 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -119.83 152.8 36.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.867 0.365 . . . . 70.109999999999999 110.74 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 p -112.53 161.61 25.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 74.340000000000003 111.423 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.96 -178.23 3.4 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.723 2.282 . . . . 72.420000000000002 111.3 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.3 m -76.1 150.05 82.88 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.837 0.351 . . . . 73.439999999999998 110.841 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 16.9 Cg_exo -68.53 143.83 58.6 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.767 2.311 . . . . 72.400000000000006 111.464 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.8 m -58.71 140.82 54.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 54.43 110.26 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 162' ' ' SER . 19.7 m -105.92 -154.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 120.899 0.381 . . . . 70.019999999999996 111.017 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.426 ' H ' ' HB ' ' A' ' 161' ' ' VAL . 9.2 t -125.96 -166.88 1.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.813 -0.631 . . . . 73.129999999999995 109.926 -175.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.69 177.74 11.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.504 -0.316 . . . . 74.409999999999997 110.521 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -69.21 164.58 22.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.294 0.568 . . . . 74.319999999999993 112.442 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -116.14 151.11 36.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.531 -0.759 . . . . 75.0 110.92 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -110.43 -174.31 2.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 74.120000000000005 110.79 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 167' ' ' ILE . 5.5 mt 63.88 24.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.82 1.295 . . . . 71.0 110.39 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.07 -24.41 16.9 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.39 -1.277 . . . . 73.109999999999999 109.961 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.8 m -142.24 -50.2 0.38 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.706 -1.134 . . . . 71.030000000000001 108.776 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.11 47.57 1.35 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.724 -1.126 . . . . 73.299999999999997 110.52 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 6.3 t -50.92 155.22 1.24 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.117 -0.947 . . . . 75.109999999999999 112.362 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.3 tt -102.7 153.73 5.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 73.040000000000006 110.236 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -85.47 68.88 10.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.601 0.715 . . . . 72.200000000000003 110.165 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -78.78 -162.06 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.05 -0.977 . . . . 75.349999999999994 111.452 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.409999999999997 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.952 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 73.150000000000006 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.219999999999999 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.129999999999995 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.010000000000005 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 63.439999999999998 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 63.149999999999999 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.319999999999993 109.483 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.9 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.010000000000005 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 74.209999999999994 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.010000000000005 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.319999999999993 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.540000000000006 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 72.409999999999997 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.130000000000003 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.420000000000002 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 71.420000000000002 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.350000000000001 111.645 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.329999999999998 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 74.140000000000001 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 72.430000000000007 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.409999999999997 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.200000000000003 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.768 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.109999999999999 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.129999999999995 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 73.120000000000005 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.340000000000003 108.951 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.952 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.140000000000001 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 74.5 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.299999999999997 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 54.219999999999999 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.648 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.209999999999994 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.409999999999997 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.409999999999997 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.349999999999994 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.505 HG12 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.319999999999993 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.239999999999995 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.400000000000006 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.019999999999996 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.962 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.120000000000005 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.319999999999993 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.655 ' HD3' ' H ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 75.450000000000003 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 71.409999999999997 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 74.25 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 75.519999999999996 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.510000000000005 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.685 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . 0.75 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.219999999999999 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.530000000000001 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.109999999999999 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.409999999999997 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 75.310000000000002 108.624 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.839 ' HB3' HG21 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.200000000000003 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.466 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.329999999999998 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.559 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.409999999999997 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 73.439999999999998 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.835 ' HD3' HG22 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 75.209999999999994 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.768 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 74.019999999999996 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.649 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.803 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 73.420000000000002 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.530000000000001 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 62.219999999999999 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 65.030000000000001 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.582 ' HB3' HD11 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 73.120000000000005 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 75.019999999999996 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.030000000000001 113.351 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 64.209999999999994 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.299999999999997 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.140000000000001 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.230000000000004 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.430000000000007 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.420000000000002 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.655 ' HB ' HD13 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 71.549999999999997 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.962 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 74.150000000000006 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 61.32 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.469 ' HG2' HG21 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.430000000000007 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 64.310000000000002 110.258 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 73.140000000000001 108.621 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.509999999999998 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.200000000000003 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 74.329999999999998 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.671 ' HZ3' ' HB2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 73.409999999999997 110.501 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.200000000000003 110.45 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.655 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.446 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.519999999999996 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.310000000000002 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.530000000000001 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 73.340000000000003 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 70.530000000000001 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.349999999999994 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 65.319999999999993 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 73.209999999999994 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.239999999999995 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 74.510000000000005 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.319999999999993 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.540000000000006 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 75.010000000000005 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 72.349999999999994 108.658 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 74.209999999999994 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.409999999999997 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.239999999999995 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 0.1 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.409999999999997 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.310000000000002 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.349999999999994 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.209999999999994 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.119999999999997 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p -155.06 162.73 40.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 111.257 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.66 124.31 45.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.569 . . . . 71.340000000000003 110.021 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 p -97.45 146.61 25.05 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 110.671 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.7 139.46 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.781 -0.724 . . . . 73.299999999999997 112.251 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -144.11 138.53 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.588 0.233 . . . . 70.109999999999999 110.639 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.0 p -101.71 144.32 28.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.9 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.87 147.98 93.98 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.696 2.264 . . . . 72.420000000000002 112.404 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.94 134.95 20.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.243 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -84.9 178.76 4.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.934 2.423 . . . . 72.400000000000006 112.144 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -140.5 -162.29 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.541 -0.3 . . . . 54.43 110.39 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.77 145.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.129 -0.693 . . . . 70.019999999999996 109.129 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.4 t -87.72 172.5 9.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.902 -0.59 . . . . 73.129999999999995 110.753 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -80.62 151.46 29.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 74.409999999999997 110.719 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.01 144.32 48.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 -174.95 4.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.282 -0.417 . . . . 75.0 110.172 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.503 ' HB3' HD12 ' A' ' 167' ' ' ILE . 2.9 t80 -101.15 164.88 11.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.567 -0.531 . . . . 74.120000000000005 109.567 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.805 HG21 ' HA ' ' A' ' 171' ' ' THR . 4.2 mp 60.82 45.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.298 1.047 . . . . 71.0 110.638 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.55 -33.79 11.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.16 -0.927 . . . . 73.109999999999999 109.421 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.3 m -137.87 -31.43 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 71.030000000000001 110.331 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.48 -52.21 65.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.572 . . . . 73.299999999999997 111.001 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.805 ' HA ' HG21 ' A' ' 167' ' ' ILE . 34.1 p 41.64 75.32 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.862 -1.063 . . . . 75.109999999999999 111.885 -172.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.41 HG21 ' OD1' ' A' ' 174' ' ' ASN . 7.9 tp -100.62 133.9 42.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.83 -1.077 . . . . 73.040000000000006 110.837 -172.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.2 m -86.19 58.43 5.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.401 0.619 . . . . 72.200000000000003 109.978 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.41 ' OD1' HG21 ' A' ' 172' ' ' ILE . 2.7 p-10 -82.83 -170.78 3.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.307 -0.86 . . . . 75.349999999999994 111.364 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.409999999999997 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 73.150000000000006 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.219999999999999 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.556 ' HB2' ' HE2' ' A' ' 183' ' ' MET . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.129999999999995 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.010000000000005 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.515 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 63.149999999999999 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.319999999999993 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.775 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.010000000000005 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 74.209999999999994 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.564 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.010000000000005 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.319999999999993 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.540000000000006 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 72.409999999999997 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.130000000000003 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 1.023 HD22 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 71.420000000000002 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.350000000000001 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.329999999999998 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 74.140000000000001 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.230000000000004 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 1.023 ' HB2' HD22 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 72.430000000000007 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.140000000000001 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.409999999999997 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.200000000000003 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.819 HG21 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.109999999999999 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.129999999999995 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.579 HG12 HG22 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 73.120000000000005 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.340000000000003 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.5 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 74.5 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 54.219999999999999 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.624 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.209999999999994 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.855 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.409999999999997 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.409999999999997 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.349999999999994 111.354 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.473 HG11 HG12 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.319999999999993 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.239999999999995 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.400000000000006 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.019999999999996 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.615 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.120000000000005 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.429 HG13 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.319999999999993 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 75.450000000000003 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 71.409999999999997 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.209999999999994 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 74.25 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 75.519999999999996 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.510000000000005 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.209999999999994 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.219999999999999 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.530000000000001 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.109999999999999 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.701 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.409999999999997 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 75.310000000000002 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.427 ' HB3' HG21 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.200000000000003 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.409999999999997 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.329999999999998 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.855 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.409999999999997 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 73.439999999999998 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.699 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 75.209999999999994 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.819 ' HB2' HG21 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 74.019999999999996 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 74.400000000000006 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD11 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 73.420000000000002 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.424 HG11 ' HG1' ' A' ' 197' ' ' THR . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.530000000000001 111.836 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 62.219999999999999 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 65.030000000000001 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.48 ' HB3' HD11 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 73.120000000000005 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 75.019999999999996 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.030000000000001 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 64.209999999999994 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.120000000000005 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.299999999999997 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.594 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.140000000000001 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.230000000000004 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.749 HG22 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.430000000000007 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.420000000000002 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 71.549999999999997 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.67 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 74.150000000000006 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.574 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 61.32 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.503 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.430000000000007 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 64.310000000000002 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.416 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.200000000000003 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.406 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 74.329999999999998 111.81 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.503 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.409999999999997 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.574 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 73.409999999999997 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.200000000000003 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.527 HG21 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.420000000000002 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.749 ' HB ' HG22 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.519999999999996 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.239999999999995 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.310000000000002 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 73.340000000000003 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 70.530000000000001 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.349999999999994 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 65.319999999999993 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 73.209999999999994 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.239999999999995 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 74.510000000000005 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.319999999999993 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.540000000000006 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 75.010000000000005 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.420000000000002 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 72.349999999999994 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 74.209999999999994 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.409999999999997 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.239999999999995 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 19.0 m-80 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.409999999999997 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.310000000000002 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.209999999999994 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.542 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 74.329999999999998 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.119999999999997 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 153.88 32.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.319999999999993 111.225 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.09 127.89 3.05 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.346 -0.388 . . . . 71.340000000000003 110.256 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -156.94 103.41 2.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.692 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.45 124.19 5.9 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.582 -0.607 . . . . 73.299999999999997 111.582 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -84.45 127.71 34.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.862 0.363 . . . . 70.109999999999999 110.893 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.7 p -75.97 126.91 86.34 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.708 -0.678 . . . . 74.340000000000003 111.172 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.67 139.51 7.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.656 2.238 . . . . 72.420000000000002 112.384 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.53 136.62 20.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.116 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.53 177.66 8.53 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.766 2.311 . . . . 72.400000000000006 112.396 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -87.16 156.55 19.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.109 -0.496 . . . . 54.43 110.7 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.28 176.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 109.316 -0.624 . . . . 70.019999999999996 109.316 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 t -92.38 178.57 5.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.44 -0.8 . . . . 73.129999999999995 110.33 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.11 150.3 51.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.359 -0.837 . . . . 74.409999999999997 109.694 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -97.62 -172.03 2.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 74.319999999999993 110.014 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.669 ' HB2' ' HG2' ' A' ' 168' ' ' GLU . 11.8 mm100 -69.55 151.91 45.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.099 0.476 . . . . 75.0 110.897 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.538 ' HB3' HD12 ' A' ' 167' ' ' ILE . 7.9 m-85 -102.63 152.71 20.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.816 -0.629 . . . . 74.120000000000005 109.823 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.955 HG21 ' HA ' ' A' ' 171' ' ' THR . 3.8 mp 56.76 37.78 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.37 1.081 . . . . 71.0 110.794 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.669 ' HG2' ' HB2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -107.4 -16.95 14.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.458 -0.792 . . . . 73.109999999999999 109.331 173.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -139.81 -39.12 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.808 -1.087 . . . . 71.030000000000001 109.257 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.19 33.32 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.392 -0.822 . . . . 73.299999999999997 110.675 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.955 ' HA ' HG21 ' A' ' 167' ' ' ILE . 9.1 t -49.5 143.73 6.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 75.109999999999999 112.604 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.19 148.13 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.109 -0.95 . . . . 73.040000000000006 110.146 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -81.92 55.42 2.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 72.200000000000003 110.238 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.22 -173.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 75.349999999999994 111.073 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.409999999999997 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 73.150000000000006 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.796 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.219999999999999 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.96 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.129999999999995 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.010000000000005 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 63.439999999999998 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.96 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 63.149999999999999 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.319999999999993 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.675 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.010000000000005 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 74.209999999999994 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.010000000000005 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.319999999999993 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.540000000000006 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.487 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 72.409999999999997 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.130000000000003 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.420000000000002 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 71.420000000000002 110.231 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.350000000000001 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.329999999999998 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 74.140000000000001 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.230000000000004 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 72.430000000000007 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.140000000000001 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.409999999999997 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.129999999999995 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 73.120000000000005 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.340000000000003 108.51 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.752 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.140000000000001 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 74.5 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.299999999999997 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 54.219999999999999 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.209999999999994 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.65 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.409999999999997 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 213' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.409999999999997 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.668 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.349999999999994 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.319999999999993 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.239999999999995 109.329 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.400000000000006 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.72 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.019999999999996 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.530000000000001 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.120000000000005 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.608 HG13 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.319999999999993 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 75.450000000000003 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 71.409999999999997 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 48.0 t30 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.209999999999994 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.442 ' HD3' HD22 ' A' ' 223' ' ' ASN . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.209999999999994 110.276 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 74.25 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 75.519999999999996 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.510000000000005 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.209999999999994 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . 0.568 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.340000000000003 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.219999999999999 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.530000000000001 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.109999999999999 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.409999999999997 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 75.310000000000002 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.200000000000003 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.409999999999997 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.716 HG22 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.329999999999998 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.65 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.409999999999997 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.716 ' HE3' HG22 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 75.209999999999994 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.668 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 74.019999999999996 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 74.400000000000006 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.420000000000002 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.530000000000001 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.568 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 62.219999999999999 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 65.030000000000001 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.494 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 75.019999999999996 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.030000000000001 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 64.209999999999994 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.261 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.726 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.299999999999997 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.140000000000001 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.230000000000004 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.517 HG22 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.430000000000007 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.420000000000002 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.679 ' HB ' HD13 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 71.549999999999997 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 74.150000000000006 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.407 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 61.32 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.72 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.430000000000007 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.406 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 64.310000000000002 110.462 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 73.140000000000001 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 264' ' ' MET . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.509999999999998 111.125 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.200000000000003 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 74.329999999999998 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.409999999999997 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 73.409999999999997 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.575 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.200000000000003 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.679 HD13 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.420000000000002 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.669 HD13 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.519999999999996 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.310000000000002 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 73.340000000000003 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 70.530000000000001 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.349999999999994 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 65.319999999999993 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 73.209999999999994 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.239999999999995 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 74.510000000000005 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.319999999999993 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.540000000000006 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 75.010000000000005 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 72.349999999999994 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 74.209999999999994 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.409999999999997 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.239999999999995 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.310000000000002 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.349999999999994 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.209999999999994 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 74.329999999999998 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t -150.15 179.26 8.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 109.982 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.23 -177.32 3.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.017 0.437 . . . . 71.340000000000003 111.286 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 m -99.22 -171.35 2.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.921 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.01 153.76 25.52 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.729 -0.949 . . . . 73.299999999999997 110.729 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -115.49 159.74 20.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.959 0.409 . . . . 70.109999999999999 111.522 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.7 p -88.4 128.81 51.73 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 74.340000000000003 111.267 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.53 115.54 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.419 2.079 . . . . 72.420000000000002 112.297 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.2 m -81.43 145.08 54.53 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 73.439999999999998 110.503 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 8.2 Cg_exo -72.04 155.86 56.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.867 2.378 . . . . 72.400000000000006 112.388 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -82.62 178.84 8.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.525 . . . . 54.43 110.412 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.27 112.86 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.756 0.789 . . . . 70.019999999999996 111.554 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.1 m -111.6 148.56 33.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.066 -0.97 . . . . 73.129999999999995 109.428 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.566 ' HG3' ' H ' ' A' ' 164' ' ' PHE . 12.1 pt-20 -80.4 -60.75 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 111.46 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' H ' ' HG3' ' A' ' 163' ' ' GLU . 94.7 m-85 -138.1 153.59 49.27 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.308 -0.256 . . . . 74.319999999999993 110.308 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -137.46 -166.37 1.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.654 -0.498 . . . . 75.0 109.654 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.83 -168.98 2.42 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.85 -0.426 . . . . 74.120000000000005 109.85 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.871 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 4.2 mt 65.16 36.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.208 1.004 . . . . 71.0 109.857 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 170' ' ' GLU . 2.2 pt-20 -114.11 86.85 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.003 -0.999 . . . . 73.109999999999999 109.853 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 39.9 m 80.73 -39.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.191 -0.913 . . . . 71.030000000000001 108.901 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 168' ' ' GLU . 7.3 pt-20 -106.85 71.67 0.86 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.432 1.111 . . . . 73.299999999999997 109.057 169.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.871 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 29.8 p -55.37 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.215 -1.811 . . . . 75.109999999999999 113.582 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.76 151.61 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.365 -0.834 . . . . 73.040000000000006 110.615 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.2 m -83.43 62.4 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 110.416 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.7 -173.22 4.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 75.349999999999994 110.799 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.409999999999997 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.8 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 73.150000000000006 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.727 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.219999999999999 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.52 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.129999999999995 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.010000000000005 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 63.439999999999998 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 63.149999999999999 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.319999999999993 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.779 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.010000000000005 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 74.209999999999994 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.010000000000005 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.319999999999993 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.619 ' HZ1' ' HB2' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 72.409999999999997 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.130000000000003 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.553 HD23 ' HB1' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.420000000000002 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 71.420000000000002 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.581 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.350000000000001 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.329999999999998 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 74.140000000000001 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.230000000000004 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 72.430000000000007 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.140000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.409999999999997 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.200000000000003 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.109999999999999 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.129999999999995 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.568 HG11 HG22 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 73.120000000000005 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.340000000000003 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.140000000000001 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.727 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 74.5 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.299999999999997 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 54.219999999999999 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.209999999999994 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.409999999999997 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.586 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.409999999999997 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.349999999999994 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.319999999999993 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.239999999999995 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.486 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.019999999999996 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.671 ' HD2' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.802 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.120000000000005 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.544 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 75.450000000000003 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 71.409999999999997 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.497 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.209999999999994 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 74.25 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 75.519999999999996 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.618 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.209999999999994 109.536 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.219999999999999 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.530000000000001 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.109999999999999 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.409999999999997 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 75.310000000000002 108.605 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.576 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.200000000000003 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.409999999999997 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.667 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.329999999999998 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.409999999999997 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.667 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 75.209999999999994 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.721 ' HB2' HG22 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 74.019999999999996 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 74.400000000000006 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.671 HE22 ' HD2' ' A' ' 217' ' ' LYS . 34.4 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 73.420000000000002 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.530000000000001 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 62.219999999999999 109.57 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.106 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.852 ' HH ' HG21 ' A' ' 256' ' ' ILE . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 73.120000000000005 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 75.019999999999996 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.581 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.030000000000001 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.591 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 64.209999999999994 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.120000000000005 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 1.035 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.299999999999997 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.618 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.140000000000001 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.230000000000004 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.852 HG21 ' HH ' ' A' ' 248' ' ' TYR . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.430000000000007 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.420000000000002 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.601 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 71.549999999999997 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.802 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 74.150000000000006 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 61.32 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.430000000000007 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 64.310000000000002 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 73.140000000000001 110.601 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.509999999999998 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.200000000000003 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.409999999999997 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.696 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 73.409999999999997 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.696 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.200000000000003 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.601 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.420000000000002 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG22 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.519999999999996 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.310000000000002 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.565 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.530000000000001 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 1.035 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 73.340000000000003 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 70.530000000000001 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.349999999999994 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 65.319999999999993 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 73.209999999999994 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.239999999999995 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 74.510000000000005 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.319999999999993 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.420000000000002 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 72.349999999999994 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 74.209999999999994 110.271 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.239999999999995 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 2.2 p30 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.409999999999997 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.310000000000002 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.349999999999994 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.209999999999994 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.119999999999997 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -120.23 -177.65 3.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.319999999999993 110.601 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.18 -163.21 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 71.340000000000003 110.145 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 t -78.78 175.46 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.206 -0.294 . . . . 74.219999999999999 110.206 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.7 -149.52 9.45 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.94 -0.647 . . . . 73.299999999999997 112.292 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.75 176.08 7.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 70.109999999999999 110.434 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.2 t -121.99 139.77 30.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.8 0.334 . . . . 74.340000000000003 110.908 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.0 Cg_exo -76.86 173.16 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.952 2.435 . . . . 72.420000000000002 111.264 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.4 t -112.17 107.52 55.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.461 -0.336 . . . . 73.439999999999998 110.624 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.28 115.42 2.52 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.984 2.456 . . . . 72.400000000000006 112.09 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 m -81.56 176.89 9.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.509 -0.768 . . . . 54.43 110.876 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.813 HG21 ' H ' ' A' ' 162' ' ' SER . 9.4 p -141.67 -170.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.354 -0.98 . . . . 70.019999999999996 108.354 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.813 ' H ' HG21 ' A' ' 161' ' ' VAL . 8.5 t -81.38 -167.31 1.42 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.941 0.4 . . . . 73.129999999999995 110.098 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.35 -54.03 2.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.995 -0.548 . . . . 74.409999999999997 111.577 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -142.68 160.06 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.855 -0.424 . . . . 74.319999999999993 109.855 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.48 165.77 22.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.552 -0.536 . . . . 75.0 109.552 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -93.76 176.58 6.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.247 0.546 . . . . 74.120000000000005 111.121 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.778 HG21 HG21 ' A' ' 171' ' ' THR . 2.5 mp 58.65 67.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.841 -1.072 . . . . 71.0 111.231 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 -31.72 2.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.463 -1.244 . . . . 73.109999999999999 108.887 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.4 m -148.49 -36.36 0.19 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.729 -1.578 . . . . 71.030000000000001 107.387 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.03 68.7 5.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.836 -1.075 . . . . 73.299999999999997 109.074 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.778 HG21 HG21 ' A' ' 167' ' ' ILE . 30.0 m -75.91 151.09 37.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.532 -1.213 . . . . 75.109999999999999 110.603 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.1 tt -58.89 142.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.843 -0.429 . . . . 73.040000000000006 109.843 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.3 m -84.78 68.55 10.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.687 0.756 . . . . 72.200000000000003 110.356 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.86 -164.59 1.09 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.821 -1.081 . . . . 75.349999999999994 110.919 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.409999999999997 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 73.150000000000006 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.219999999999999 110.119 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.129999999999995 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.010000000000005 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 63.439999999999998 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.46 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 63.149999999999999 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.319999999999993 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.010000000000005 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 74.209999999999994 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.010000000000005 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.540000000000006 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 72.409999999999997 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.130000000000003 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 71.420000000000002 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.350000000000001 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.329999999999998 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.230000000000004 110.686 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.553 ' HB1' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 72.430000000000007 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.140000000000001 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.554 HG12 HD12 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.409999999999997 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.200000000000003 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.652 HG22 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.109999999999999 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.129999999999995 108.25 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.619 HG11 HG22 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 73.120000000000005 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.340000000000003 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.819 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.140000000000001 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 74.5 109.964 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.299999999999997 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 54.219999999999999 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.209999999999994 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.695 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.409999999999997 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.619 HG22 HG11 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.409999999999997 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.349999999999994 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.563 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.319999999999993 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.239999999999995 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.400000000000006 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.019999999999996 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.527 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.530000000000001 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.120000000000005 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.625 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.319999999999993 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.606 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 75.450000000000003 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 71.409999999999997 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.464 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.209999999999994 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.209999999999994 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.449 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 74.25 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 75.519999999999996 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.606 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.510000000000005 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.209999999999994 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.340000000000003 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.219999999999999 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.530000000000001 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.109999999999999 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.409999999999997 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 75.310000000000002 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.406 ' HB2' ' HZ1' ' A' ' 234' ' ' LYS . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.200000000000003 109.171 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.409999999999997 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.329999999999998 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.695 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.409999999999997 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 73.439999999999998 113.695 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 75.209999999999994 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.652 ' HB2' HG22 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 74.019999999999996 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 74.400000000000006 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.677 ' HB2' HD11 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 73.420000000000002 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.530000000000001 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 62.219999999999999 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 65.030000000000001 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.705 ' HH ' HG21 ' A' ' 256' ' ' ILE . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 73.120000000000005 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 75.019999999999996 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.030000000000001 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 64.209999999999994 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.120000000000005 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.807 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.705 HG21 ' HH ' ' A' ' 248' ' ' TYR . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.430000000000007 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.420000000000002 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.667 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 71.549999999999997 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 74.150000000000006 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 61.32 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.430000000000007 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.456 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 64.310000000000002 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 73.140000000000001 109.526 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.509999999999998 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.200000000000003 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 74.329999999999998 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.409999999999997 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 73.409999999999997 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.200000000000003 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.667 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.517 ' HB ' HG22 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.519999999999996 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.239999999999995 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.310000000000002 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.43 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.530000000000001 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 73.340000000000003 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 70.530000000000001 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.349999999999994 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 65.319999999999993 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 73.209999999999994 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.239999999999995 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 74.510000000000005 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.540000000000006 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 75.010000000000005 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.420000000000002 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 72.349999999999994 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 74.209999999999994 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.409999999999997 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.239999999999995 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.422 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 3.2 p30 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.409999999999997 110.413 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.310000000000002 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.349999999999994 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.209999999999994 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 74.329999999999998 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m -96.32 11.01 36.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.319999999999993 110.451 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 160.37 28.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 71.340000000000003 110.98 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.4 t -162.48 156.35 20.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.258 -0.645 . . . . 74.219999999999999 109.258 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.73 -161.35 37.35 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.021 -0.609 . . . . 73.299999999999997 111.842 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -139.04 -173.34 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.4 . . . . 70.109999999999999 111.493 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 2.4 p -76.99 144.0 71.46 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 74.340000000000003 111.853 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.0 Cg_exo -79.5 178.56 7.24 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.516 2.81 . . . . 72.420000000000002 112.11 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.0 139.4 34.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.125 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.37 165.91 30.71 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.665 2.243 . . . . 72.400000000000006 111.936 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.9 m -116.53 135.35 53.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.588 -0.278 . . . . 54.43 110.405 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -163.29 137.26 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.289 -0.414 . . . . 70.019999999999996 110.023 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -134.99 151.4 50.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.329 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 112.63 18.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.941 -0.572 . . . . 74.409999999999997 110.423 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -97.28 151.18 20.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.535 -0.543 . . . . 74.319999999999993 109.535 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -69.25 123.25 20.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 75.0 111.007 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.404 ' CD2' HG13 ' A' ' 167' ' ' ILE . 13.4 t80 -155.94 148.11 23.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 74.120000000000005 109.753 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.822 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 8.8 mt 67.38 27.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 122.511 1.148 . . . . 71.0 110.737 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 170' ' ' GLU . 5.5 pt-20 -125.78 95.34 4.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.076 -0.966 . . . . 73.109999999999999 109.091 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m 80.88 -24.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.077 -1.419 . . . . 71.030000000000001 109.424 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 168' ' ' GLU . 8.2 pt-20 -123.99 57.8 1.19 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.172 -0.922 . . . . 73.299999999999997 110.464 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.822 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 8.9 t -65.86 164.05 15.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 75.109999999999999 110.801 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.11 127.97 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.371 0.605 . . . . 73.040000000000006 110.999 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -85.31 64.75 8.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.517 0.675 . . . . 72.200000000000003 109.806 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.3 -167.8 1.98 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.061 -0.972 . . . . 75.349999999999994 110.92 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.409999999999997 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 73.150000000000006 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.219999999999999 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.129999999999995 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.010000000000005 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 63.439999999999998 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 63.149999999999999 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.319999999999993 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.010000000000005 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 74.209999999999994 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.604 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.010000000000005 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.319999999999993 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.604 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.540000000000006 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.754 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 72.409999999999997 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.645 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.130000000000003 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 71.420000000000002 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.350000000000001 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 191' ' ' SER . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.329999999999998 111.682 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 74.140000000000001 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.230000000000004 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 72.430000000000007 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.140000000000001 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.643 HD13 HD12 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.409999999999997 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.200000000000003 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.415 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.129999999999995 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.662 HG13 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 73.120000000000005 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.340000000000003 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.140000000000001 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 74.5 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 54.219999999999999 111.736 -175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.459 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.209999999999994 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.466 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.409999999999997 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 213' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.409999999999997 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.662 HG11 HG13 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.239999999999995 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.400000000000006 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.019999999999996 109.223 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.59 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.530000000000001 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.120000000000005 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.319999999999993 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 75.450000000000003 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.424 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 71.409999999999997 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.209999999999994 109.917 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.209999999999994 110.767 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 74.25 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 75.519999999999996 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.589 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.510000000000005 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.656 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.209999999999994 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.340000000000003 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.219999999999999 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.530000000000001 111.667 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.109999999999999 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 75.310000000000002 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.200000000000003 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.409999999999997 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.329999999999998 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.466 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.409999999999997 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 73.439999999999998 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.639 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 75.209999999999994 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 74.019999999999996 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 74.400000000000006 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 73.420000000000002 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.530000000000001 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 62.219999999999999 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 65.030000000000001 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 73.120000000000005 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 75.019999999999996 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.030000000000001 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 64.209999999999994 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 253' ' ' ASN . 0.2 OUTLIER -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.299999999999997 110.086 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.589 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.140000000000001 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.424 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.230000000000004 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.703 HD13 HG12 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.430000000000007 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.545 ' N ' HD11 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.474 ' HB ' HD13 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 71.549999999999997 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.64 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 74.150000000000006 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.59 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 61.32 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.585 ' HB2' ' HZ3' ' A' ' 261' ' ' LYS . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.430000000000007 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 64.310000000000002 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 73.140000000000001 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.509999999999998 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.200000000000003 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.409999999999997 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 73.409999999999997 110.915 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.200000000000003 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.515 HD11 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.420000000000002 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.643 HD12 HD13 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.519999999999996 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.754 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.310000000000002 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.645 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.530000000000001 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 73.340000000000003 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 70.530000000000001 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.349999999999994 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 65.319999999999993 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 73.209999999999994 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.239999999999995 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 74.510000000000005 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.319999999999993 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.540000000000006 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 75.010000000000005 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.420000000000002 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 72.349999999999994 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.409999999999997 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.239999999999995 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.409999999999997 110.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.310000000000002 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.209999999999994 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 74.329999999999998 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.119999999999997 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m -62.84 137.69 58.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 110.273 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.86 -162.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 71.340000000000003 111.331 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.7 m -76.42 174.03 10.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 110.612 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.33 -160.79 16.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.67 -0.776 . . . . 73.299999999999997 112.13 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.27 -173.04 2.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.178 -0.304 . . . . 70.109999999999999 110.178 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.7 t -127.97 140.52 38.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.579 -0.282 . . . . 74.340000000000003 110.627 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 165.45 25.98 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.678 2.252 . . . . 72.420000000000002 112.194 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.77 161.25 72.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 73.439999999999998 111.121 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.25 179.61 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.958 2.439 . . . . 72.400000000000006 113.071 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -69.0 179.03 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 54.43 112.198 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.34 117.15 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.408 -0.814 . . . . 70.019999999999996 108.991 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.0 m -68.03 158.22 33.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 73.129999999999995 111.935 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.94 126.58 32.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.594 -0.73 . . . . 74.409999999999997 111.061 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -99.38 178.84 4.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.35 -0.386 . . . . 74.319999999999993 110.031 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.49 128.51 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.994 0.425 . . . . 75.0 110.326 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -102.17 179.7 4.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.602 0.715 . . . . 74.120000000000005 112.696 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 2.6 mt 59.33 30.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 114.188 -1.369 . . . . 71.0 112.277 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.03 -8.27 5.99 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.075 -0.966 . . . . 73.109999999999999 108.872 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 m -137.27 -68.29 0.48 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.57 -1.196 . . . . 71.030000000000001 108.132 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.38 70.67 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.955 0.883 . . . . 73.299999999999997 110.014 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 9.0 t -64.7 179.0 0.69 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.364 -1.289 . . . . 75.109999999999999 111.263 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.6 tt -103.6 138.68 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 110.878 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -83.43 63.72 7.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.491 0.662 . . . . 72.200000000000003 109.459 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -81.03 -165.13 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.006 -0.997 . . . . 75.349999999999994 111.654 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.409999999999997 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 73.150000000000006 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.606 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.219999999999999 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.129999999999995 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.010000000000005 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 63.439999999999998 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 63.149999999999999 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.319999999999993 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.651 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.010000000000005 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 74.209999999999994 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.010000000000005 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.540000000000006 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 72.409999999999997 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.130000000000003 109.386 -168.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.420000000000002 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 71.420000000000002 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.350000000000001 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.329999999999998 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 74.140000000000001 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.230000000000004 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 72.430000000000007 109.967 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.409999999999997 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.200000000000003 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.109999999999999 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.129999999999995 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 73.120000000000005 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.340000000000003 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.719 ' OD2' ' HB2' ' A' ' 208' ' ' ASN . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.140000000000001 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.606 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 74.5 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.299999999999997 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 54.219999999999999 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.719 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.209999999999994 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.409999999999997 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.625 ' ND2' ' HG2' ' A' ' 212' ' ' GLU . 9.1 t30 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.409999999999997 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.625 ' HG2' ' ND2' ' A' ' 211' ' ' ASN . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.319999999999993 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.239999999999995 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.400000000000006 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.019999999999996 109.638 178.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.543 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.530000000000001 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.120000000000005 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.703 ' HB ' HD13 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 75.450000000000003 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 71.409999999999997 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.209999999999994 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.209999999999994 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 74.25 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 75.519999999999996 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.598 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.510000000000005 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.209999999999994 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.219999999999999 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.530000000000001 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.109999999999999 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.409999999999997 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 75.310000000000002 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.200000000000003 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.409999999999997 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.329999999999998 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.409999999999997 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 73.439999999999998 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.624 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 75.209999999999994 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' HB2' HG22 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 74.019999999999996 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 74.400000000000006 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.74 ' HB2' HD13 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 73.420000000000002 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.530000000000001 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.485 HG21 ' HH ' ' A' ' 248' ' ' TYR . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 62.219999999999999 109.222 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 65.030000000000001 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 73.120000000000005 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 75.019999999999996 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.030000000000001 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 64.209999999999994 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.120000000000005 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.299999999999997 111.226 -176.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.409 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.140000000000001 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.703 HD13 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.430000000000007 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.420000000000002 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.632 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 71.549999999999997 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 74.150000000000006 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 61.32 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.430000000000007 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 64.310000000000002 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 73.140000000000001 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.824 ' HA ' ' HE2' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.509999999999998 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.200000000000003 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.557 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.615 HG21 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.409999999999997 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.776 ' HA ' ' HE2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 73.409999999999997 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.744 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.200000000000003 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.420000000000002 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.438 HG21 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.519999999999996 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.239999999999995 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.310000000000002 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.530000000000001 111.147 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 73.340000000000003 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 70.530000000000001 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.349999999999994 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.602 ' H ' HD21 ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 65.319999999999993 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 73.209999999999994 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.239999999999995 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 74.510000000000005 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.319999999999993 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.540000000000006 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 75.010000000000005 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 72.349999999999994 108.233 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 74.209999999999994 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.409999999999997 110.165 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.310000000000002 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.349999999999994 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.209999999999994 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 74.329999999999998 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -67.34 107.91 2.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.319999999999993 110.908 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.05 152.3 45.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 71.340000000000003 111.324 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -83.58 179.58 7.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.793 -0.639 . . . . 74.219999999999999 109.69 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.69 -160.87 34.04 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.673 -0.775 . . . . 73.299999999999997 112.162 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -102.53 154.67 18.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 70.109999999999999 110.976 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.8 p -90.98 158.36 41.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 74.340000000000003 110.976 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.25 136.17 58.47 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.431 2.088 . . . . 72.420000000000002 112.114 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.596 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 27.5 m -83.74 162.98 51.13 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.755 -0.657 . . . . 73.439999999999998 110.779 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD2' ' HB ' ' A' ' 158' ' ' VAL . 38.3 Cg_endo -67.2 -168.38 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 113.075 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 t -125.31 -167.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 54.43 110.301 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.69 138.13 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.355 -0.609 . . . . 70.019999999999996 109.355 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.1 p -69.9 163.62 25.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.282 -0.872 . . . . 73.129999999999995 112.009 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.34 159.72 30.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.804 -0.634 . . . . 74.409999999999997 111.375 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -86.71 -78.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 74.319999999999993 111.322 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -146.25 175.05 10.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.215 0.531 . . . . 75.0 112.002 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.644 ' CD2' HG13 ' A' ' 167' ' ' ILE . 42.9 t80 -148.27 160.73 42.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.77 -1.196 . . . . 74.120000000000005 107.77 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.823 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 7.9 mt 67.18 36.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 122.558 1.171 . . . . 71.0 109.741 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -15.85 7.37 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.605 -1.18 . . . . 73.109999999999999 109.821 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.1 m -149.03 -44.28 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.078 -1.419 . . . . 71.030000000000001 107.508 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -119.78 88.49 2.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.241 -1.345 . . . . 73.299999999999997 108.517 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.823 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 24.3 p -50.88 161.87 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.492 -1.231 . . . . 75.109999999999999 112.144 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.94 160.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 109.977 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 58.72 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.198 0.523 . . . . 72.200000000000003 111.383 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.413 HD21 ' N ' ' A' ' 175' ' ' THR . 2.6 p-10 -96.74 -167.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 110.978 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.413 ' N ' HD21 ' A' ' 174' ' ' ASN . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.409999999999997 109.714 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 73.150000000000006 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.219999999999999 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.583 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.129999999999995 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.010000000000005 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 63.439999999999998 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 63.149999999999999 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.319999999999993 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.010000000000005 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 74.209999999999994 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.010000000000005 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.319999999999993 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.540000000000006 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 72.409999999999997 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.130000000000003 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 1.024 HD22 ' HB1' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 71.420000000000002 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.350000000000001 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.329999999999998 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 74.140000000000001 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.230000000000004 110.48 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 1.024 ' HB1' HD22 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 72.430000000000007 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.468 ' OG1' HG13 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.140000000000001 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.454 HG13 ' CD1' ' A' ' 185' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.409999999999997 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.200000000000003 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.109999999999999 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.129999999999995 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 73.120000000000005 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.340000000000003 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.140000000000001 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 74.5 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.299999999999997 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 54.219999999999999 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.209999999999994 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.409999999999997 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.579 HG13 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.409999999999997 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.349999999999994 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.579 HG13 HG13 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.319999999999993 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.239999999999995 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.400000000000006 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.0 t30 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.019999999999996 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.530000000000001 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.120000000000005 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.748 HG11 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.319999999999993 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.402 ' CZ ' ' HD1' ' A' ' 228' ' ' TRP . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 75.450000000000003 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 71.409999999999997 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.658 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.209999999999994 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.618 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.499 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 74.25 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 75.519999999999996 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.510000000000005 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG22 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.340000000000003 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.219999999999999 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.530000000000001 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.409999999999997 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 75.310000000000002 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.634 ' HB3' HG23 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.200000000000003 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.442 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.329999999999998 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.409999999999997 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 73.439999999999998 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 75.209999999999994 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 74.019999999999996 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 74.400000000000006 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.641 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 73.420000000000002 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.468 HG13 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.530000000000001 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 62.219999999999999 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 65.030000000000001 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.829 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.899 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 75.019999999999996 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.030000000000001 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 64.209999999999994 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.120000000000005 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.299999999999997 110.467 -177.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.658 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.140000000000001 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.428 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.230000000000004 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.430000000000007 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.420000000000002 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.748 HG12 HG11 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 71.549999999999997 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.595 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 61.32 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.430000000000007 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 64.310000000000002 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 73.140000000000001 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.509999999999998 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.200000000000003 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 74.329999999999998 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 73.409999999999997 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.599 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.200000000000003 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.420000000000002 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.747 HG22 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.519999999999996 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.239999999999995 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.310000000000002 111.41 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.530000000000001 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 73.340000000000003 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 70.530000000000001 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.349999999999994 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 65.319999999999993 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 73.209999999999994 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.239999999999995 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 74.510000000000005 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.319999999999993 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.540000000000006 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 75.010000000000005 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.420000000000002 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 72.349999999999994 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 74.209999999999994 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.421 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.409999999999997 110.15 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.310000000000002 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.349999999999994 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.209999999999994 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 74.329999999999998 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.119999999999997 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m -75.18 82.68 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.319999999999993 112.289 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 68.89 148.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.699 1.0 . . . . 71.340000000000003 113.699 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -130.25 126.86 38.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.961 -1.018 . . . . 74.219999999999999 108.867 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.51 -106.89 0.9 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.667 -0.778 . . . . 73.299999999999997 112.745 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -123.8 122.28 37.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.048 0.451 . . . . 70.109999999999999 110.624 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.4 p -74.18 148.97 86.85 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.462 -0.79 . . . . 74.340000000000003 111.034 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.1 140.49 95.33 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.582 2.188 . . . . 72.420000000000002 111.834 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.42 135.04 65.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.183 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.61 137.06 24.51 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.605 2.203 . . . . 72.400000000000006 112.122 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -74.13 139.74 44.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.068 -0.514 . . . . 54.43 110.417 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.24 73.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.324 -0.621 . . . . 70.019999999999996 109.324 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -104.74 134.61 47.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.634 -0.712 . . . . 73.129999999999995 110.158 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -67.11 -62.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 74.409999999999997 111.336 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -136.04 165.34 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 74.319999999999993 110.801 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -131.22 166.64 20.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.582 -0.736 . . . . 75.0 109.102 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -123.7 -172.23 2.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 74.120000000000005 110.418 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 171' ' ' THR . 2.2 mp 55.44 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.305 -0.861 . . . . 71.0 111.166 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.34 -18.59 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.763 -0.653 . . . . 73.109999999999999 109.399 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m -135.81 -66.54 0.55 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.932 -1.031 . . . . 71.030000000000001 108.794 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.64 58.15 3.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.387 -0.824 . . . . 73.299999999999997 110.319 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 167' ' ' ILE . 5.2 t -57.46 148.75 22.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 75.109999999999999 111.485 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.96 126.67 39.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.567 0.699 . . . . 73.040000000000006 110.982 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.4 m -88.64 62.12 6.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.328 0.585 . . . . 72.200000000000003 111.488 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.91 -166.3 1.36 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.902 -0.59 . . . . 75.349999999999994 110.302 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.409999999999997 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.808 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 73.150000000000006 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.219999999999999 109.805 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.129999999999995 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.010000000000005 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 63.439999999999998 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.551 HG21 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 63.149999999999999 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.319999999999993 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.551 ' HG3' HG21 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.010000000000005 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.319999999999993 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.694 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.540000000000006 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 72.409999999999997 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.130000000000003 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.597 HD13 ' HB3' ' A' ' 248' ' ' TYR . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.420000000000002 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 71.420000000000002 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.350000000000001 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.329999999999998 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 74.140000000000001 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.230000000000004 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.694 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 72.430000000000007 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.409999999999997 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.109999999999999 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.129999999999995 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 73.120000000000005 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.808 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.140000000000001 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.402 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 74.5 110.294 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.299999999999997 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 54.219999999999999 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.209999999999994 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.458 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.409999999999997 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.607 HG23 HG13 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 167' ' ' ILE . 2.3 t-20 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.409999999999997 109.198 169.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.686 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.349999999999994 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.407 HG13 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.319999999999993 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.400000000000006 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.85 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.019999999999996 109.403 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.435 ' N ' HD21 ' A' ' 216' ' ' ASN . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.530000000000001 111.458 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.120000000000005 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.562 ' HB ' HD13 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.319999999999993 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 75.450000000000003 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 71.409999999999997 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.209999999999994 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.477 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.209999999999994 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 74.25 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.871 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 75.519999999999996 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.510000000000005 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.743 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.219999999999999 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.530000000000001 111.95 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.109999999999999 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.409999999999997 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 75.310000000000002 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.200000000000003 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.329999999999998 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.458 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.409999999999997 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 73.439999999999998 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 75.209999999999994 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.686 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 74.019999999999996 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 74.400000000000006 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.741 ' HB2' HD11 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 73.420000000000002 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.530000000000001 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 62.219999999999999 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 65.030000000000001 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.597 ' HB3' HD13 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 73.120000000000005 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.871 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 75.019999999999996 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.030000000000001 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 64.209999999999994 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.120000000000005 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 0.2 OUTLIER -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.299999999999997 111.177 -176.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.140000000000001 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.230000000000004 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.430000000000007 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.420000000000002 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.596 ' HB ' HD12 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 71.549999999999997 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.558 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 74.150000000000006 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 61.32 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.85 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.430000000000007 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 73.140000000000001 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.509999999999998 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.200000000000003 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . 0.499 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 74.329999999999998 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.629 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.409999999999997 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.498 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 73.409999999999997 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.200000000000003 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.596 HD12 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.420000000000002 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.519999999999996 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.239999999999995 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.310000000000002 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.530000000000001 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 73.340000000000003 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 70.530000000000001 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.349999999999994 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 65.319999999999993 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 73.209999999999994 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 74.510000000000005 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.319999999999993 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.540000000000006 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 75.010000000000005 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 72.349999999999994 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 74.209999999999994 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.409999999999997 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.239999999999995 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p30 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.409999999999997 109.543 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.310000000000002 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.349999999999994 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.209999999999994 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 74.329999999999998 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m -83.06 136.51 34.46 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 109.193 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.4 110.95 13.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.17 0.509 . . . . 71.340000000000003 110.815 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -105.91 144.26 32.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 110.356 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.77 108.03 2.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.799 -0.715 . . . . 73.299999999999997 112.226 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -111.58 118.08 34.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 70.109999999999999 110.074 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 15.2 p -67.87 134.88 92.07 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.66 -0.7 . . . . 74.340000000000003 111.716 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 154.87 67.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.71 2.274 . . . . 72.420000000000002 112.225 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.73 156.24 35.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.063 -0.517 . . . . 73.439999999999998 111.028 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.1 167.62 24.65 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.874 2.382 . . . . 72.400000000000006 112.114 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.5 t -111.66 155.27 23.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.135 -0.484 . . . . 54.43 110.0 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.6 122.63 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 70.019999999999996 110.511 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.2 m -112.05 133.93 53.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.315 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 106.85 11.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 74.409999999999997 111.312 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.32 -179.37 3.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.999 -0.546 . . . . 74.319999999999993 110.036 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.472 ' HG3' ' CG ' ' A' ' 168' ' ' GLU . 14.5 tt0 -95.73 113.13 24.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 75.0 111.685 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -163.04 145.47 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 74.120000000000005 109.858 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 1.007 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 10.2 mt 65.79 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.921 1.343 . . . . 71.0 110.287 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.472 ' CG ' ' HG3' ' A' ' 165' ' ' GLN . 6.3 pt-20 -130.07 91.96 3.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.315 -1.312 . . . . 73.109999999999999 108.435 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.2 m 88.09 -22.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.328 -1.306 . . . . 71.030000000000001 108.847 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.09 71.39 1.42 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.111 -0.949 . . . . 73.299999999999997 110.609 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 1.007 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 14.6 t -64.47 157.57 26.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 75.109999999999999 110.828 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.8 tt -86.6 137.57 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 73.040000000000006 110.894 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.9 t -85.41 62.67 7.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.516 0.674 . . . . 72.200000000000003 109.684 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.67 -172.98 4.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.395 -0.821 . . . . 75.349999999999994 111.187 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.409999999999997 110.179 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 73.150000000000006 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.219999999999999 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.639 ' HB2' ' HE2' ' A' ' 183' ' ' MET . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.129999999999995 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.010000000000005 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 63.439999999999998 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.487 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 63.149999999999999 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.319999999999993 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.683 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.010000000000005 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 74.209999999999994 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.567 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.010000000000005 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.319999999999993 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.567 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.540000000000006 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.862 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 72.409999999999997 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.130000000000003 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.826 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.420000000000002 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 71.420000000000002 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.350000000000001 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.329999999999998 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 74.140000000000001 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.230000000000004 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 72.430000000000007 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.59 ' HG1' HG13 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.140000000000001 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.739 HD12 HD13 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.409999999999997 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.200000000000003 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.109999999999999 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.129999999999995 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 73.120000000000005 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.140000000000001 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 74.5 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.299999999999997 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 54.219999999999999 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 209' ' ' PRO . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.209999999999994 110.823 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.653 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.409999999999997 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.409999999999997 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.712 ' HB2' ' HH ' ' A' ' 242' ' ' TYR . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.349999999999994 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 109.993 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.400000000000006 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.019999999999996 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.530000000000001 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.120000000000005 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.319999999999993 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 75.450000000000003 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 71.409999999999997 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.209999999999994 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.209999999999994 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 74.25 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 75.519999999999996 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.510000000000005 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.340000000000003 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.219999999999999 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.530000000000001 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.109999999999999 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.409999999999997 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 75.310000000000002 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.488 ' HB3' HG23 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.200000000000003 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.409999999999997 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.985 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.329999999999998 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.653 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.409999999999997 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 73.439999999999998 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.985 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 75.209999999999994 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.712 ' HH ' ' HB2' ' A' ' 212' ' ' GLU . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 74.019999999999996 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 74.400000000000006 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.765 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 73.420000000000002 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.59 HG13 ' HG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.530000000000001 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.409 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 62.219999999999999 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 65.030000000000001 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.826 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.818 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 75.019999999999996 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.030000000000001 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 249' ' ' ARG . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 64.209999999999994 112.068 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.299999999999997 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.140000000000001 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.804 HD12 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.430000000000007 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.564 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 71.549999999999997 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.654 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 74.150000000000006 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 61.32 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.430000000000007 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.517 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 64.310000000000002 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.441 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 73.140000000000001 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.509999999999998 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.200000000000003 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 74.329999999999998 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.409999999999997 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 73.409999999999997 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.200000000000003 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.239999999999995 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.310000000000002 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.530000000000001 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 173.737 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 63.44 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.13 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 55.1 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 62.31 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.24 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 71.41 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.32 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.33 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 72.1 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.42 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 71.41 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 72.32 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.41 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.24 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.41 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.31 109.221 -176.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.35 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.21 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 72.44 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.12 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.496 174.179 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.367 0.604 . . . . 75.35 111.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.41 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.942 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 71.5 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.22 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.13 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.01 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 61.24 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.915 HG22 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 42.34 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 201' ' ' ILE . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.32 109.483 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.915 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.01 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 70.53 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.01 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.32 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.54 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 63.23 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.462 HG13 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.05 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.42 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 35.02 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.419 ' HB3' ' H ' ' A' ' 250' ' ' GLY . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.35 111.645 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.33 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 71.3 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.23 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 45.4 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.14 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.13 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.2 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.776 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.11 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.13 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 HG21 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 70.23 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.413 ' N ' ' OG1' ' A' ' 181' ' ' THR . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.34 108.951 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.942 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.14 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 61.53 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.3 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 43.43 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.659 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.21 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.41 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.41 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.35 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.24 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.4 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.02 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.53 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.959 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.12 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.723 HG13 HD11 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.32 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 64.34 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 64.12 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.21 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 52.43 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 73.22 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.24 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.21 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TYR . . . . . 0.776 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.34 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.22 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.53 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.11 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.41 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 74.42 108.624 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.2 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.465 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.41 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.33 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.15 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 55.53 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 63.4 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.776 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 72.41 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.795 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 71.12 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.53 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 51.24 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 43.33 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.605 ' HB3' HD12 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 64.4 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 74.44 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 192' ' ' PRO . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.03 113.351 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 51.44 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.12 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.3 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.14 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.23 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.723 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.43 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.42 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 62.15 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.959 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 70.45 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 53.35 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.43 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 53.21 110.258 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.505 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 71.51 108.621 173.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.51 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.15 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 73.25 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 60.0 110.501 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.2 110.45 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.42 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.52 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.24 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.31 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.53 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 64.31 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 63.44 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.13 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 55.1 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 62.31 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.24 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 71.41 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.32 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.33 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 72.1 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.42 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 71.41 108.658 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 72.32 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.41 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.24 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 0.9 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.41 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.31 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.35 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.21 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.12 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.32 111.257 -178.198 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.479 0.657 . . . . 75.35 111.364 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.41 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 71.5 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.22 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.13 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.01 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 61.24 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 42.34 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.32 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.801 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.01 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 70.53 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.01 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.32 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.54 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 63.23 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.05 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.03 HD21 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.42 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 35.02 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.35 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.33 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 71.3 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.23 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 1.03 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 45.4 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.14 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.13 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.2 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.11 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.13 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.584 HG12 HG21 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 70.23 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.34 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.14 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 61.53 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 43.43 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.21 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.41 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.41 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 210' ' ' VAL . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.35 111.354 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.495 HG13 HG11 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.32 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.24 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.4 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.02 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.401 ' HE3' ' OE1' ' A' ' 244' ' ' GLN . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.53 111.615 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.12 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.32 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 64.34 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 64.12 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.21 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.21 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 52.43 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 73.22 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.24 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.21 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.34 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.22 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.53 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.11 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.706 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.41 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 74.42 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.2 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.41 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.33 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.15 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 55.53 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.702 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 63.4 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.84 ' HB2' HG23 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 72.24 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 72.41 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD12 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 71.12 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.53 111.836 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 51.24 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 43.33 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 64.4 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 74.44 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.03 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 51.44 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.12 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.3 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.14 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.23 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.43 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.42 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.488 ' HB ' HD11 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 62.15 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.692 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 70.45 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.602 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 53.35 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.43 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 53.21 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 71.51 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.51 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.15 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 73.25 111.81 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.41 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 60.0 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.2 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.545 HG23 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.42 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.776 ' HB ' HG23 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.52 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.24 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.31 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.53 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 64.31 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 63.44 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.13 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 55.1 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 62.31 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.24 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 71.41 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.32 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.33 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 72.1 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.42 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 71.41 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 72.32 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.41 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.24 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 12.2 m120 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.41 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.31 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.21 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.555 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 72.44 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.12 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.32 111.225 -177.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.299 0.571 . . . . 75.35 111.073 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.41 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 71.5 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.22 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.951 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.13 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.01 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 61.24 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.951 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 42.34 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.32 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.01 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 70.53 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.01 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.32 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.54 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 63.23 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.05 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.531 HD13 ' HG3' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.42 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 194' ' ' GLU . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 35.02 110.231 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.35 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.33 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.531 ' HG3' HD13 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 71.3 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.23 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 45.4 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.14 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.13 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.2 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.11 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.13 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 70.23 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.413 ' H ' ' HG1' ' A' ' 181' ' ' THR . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.34 108.51 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.14 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 61.53 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.3 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 43.43 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.21 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.41 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG12 ' A' ' 202' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.41 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.681 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.35 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.32 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 263' ' ' ALA . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.24 109.329 175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.4 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.757 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.02 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.53 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.12 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.32 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ARG . . . . . 0.607 ' O ' ' HD2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 64.34 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 64.12 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 1.4 t-20 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.21 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.21 110.276 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 52.43 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 73.22 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.24 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.21 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TYR . . . . . 0.58 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.34 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.22 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.53 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.11 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.41 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 74.42 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.682 ' HB3' HG22 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.2 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.41 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.33 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.15 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 55.53 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.724 ' HE3' HG21 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 63.4 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 72.24 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 72.41 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.682 ' HB2' HD12 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 71.12 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.53 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.58 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 51.24 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 43.33 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.531 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 64.4 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 74.44 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.03 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 51.44 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 254' ' ' GLU . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.261 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.742 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.3 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.14 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.23 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.527 HG23 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.43 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.42 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 62.15 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 70.45 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 53.35 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.757 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.43 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 53.21 110.462 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 214' ' ' HIS . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 71.51 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.51 111.125 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.15 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 73.25 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.41 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.592 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 60.0 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.592 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.2 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.42 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.52 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.24 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.31 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.53 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 64.31 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 63.44 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.13 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 55.1 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 62.31 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.24 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 71.41 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.32 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.33 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 72.1 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.42 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 71.41 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 72.32 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.41 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.24 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.41 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.31 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.35 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.21 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 72.44 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.12 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.32 109.982 -177.231 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 11.6 p30 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.199 0.523 . . . . 75.35 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.41 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 71.5 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.74 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.22 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.13 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.01 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 61.24 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 42.34 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.32 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.808 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.01 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 70.53 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.01 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.32 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 63.23 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.573 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.05 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.42 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 35.02 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.657 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.35 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.33 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 71.3 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.23 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 45.4 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.14 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.62 HG12 HD13 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.2 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.11 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.13 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.593 HG12 HG21 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 70.23 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.34 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.14 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.74 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 61.53 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.3 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 43.43 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.21 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.41 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.41 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.35 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.32 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.24 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.4 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.02 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.422 ' CE ' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.53 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.12 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.32 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 64.34 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 64.12 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.21 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.21 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 52.43 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 73.22 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.637 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.24 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.21 109.536 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.22 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.53 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.11 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.41 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 242' ' ' TYR . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 74.42 108.605 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.589 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.2 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.41 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.33 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.15 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 55.53 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.673 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 63.4 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.745 ' HB2' HG23 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 72.24 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 72.41 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.632 HE21 HD11 ' A' ' 246' ' ' ILE . 28.9 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 71.12 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.53 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.632 HD11 HE21 ' A' ' 244' ' ' GLN . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 51.24 109.57 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 43.33 111.106 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 64.4 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 74.44 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.657 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.03 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.606 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 51.44 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.12 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.3 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.637 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.14 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.23 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.43 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.42 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 62.15 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.811 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 70.45 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 53.35 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.43 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 53.21 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 71.51 110.601 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.51 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.15 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.25 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.41 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 60.0 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.707 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.2 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.64 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.42 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.52 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.24 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.31 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.573 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.53 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 64.31 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 63.44 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.13 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 55.1 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 62.31 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.24 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 71.41 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.32 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.33 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 72.1 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.42 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 71.41 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 72.32 110.271 178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.24 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 3.2 p-10 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.41 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.31 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.35 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.21 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 72.44 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.12 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.32 110.601 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.412 0.625 . . . . 75.35 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.41 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.829 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 71.5 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.22 110.119 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.13 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.01 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 61.24 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 42.34 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.32 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.01 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 70.53 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.01 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.32 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.54 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 63.23 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.05 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.42 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 35.02 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.35 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.33 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 71.3 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.402 ' C ' HD21 ' A' ' 190' ' ' LEU . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.23 110.686 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 45.4 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.14 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.565 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.13 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.2 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.13 108.25 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 70.23 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.34 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.14 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 61.53 109.964 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.3 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 43.43 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.21 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.708 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.41 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.41 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.35 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.566 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.32 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.24 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.4 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.02 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.545 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.53 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.12 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.32 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ARG . . . . . 0.62 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 64.34 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 64.12 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.21 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.21 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.457 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 52.43 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 73.22 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.62 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.24 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.21 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.22 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.53 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.11 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.41 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 74.42 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.2 109.171 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.41 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.33 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.708 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.15 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 55.53 113.695 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 63.4 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 72.24 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 72.41 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.692 ' HB2' HD12 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 71.12 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.53 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 51.24 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 43.33 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.686 ' HB2' HD12 ' A' ' 190' ' ' LEU . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 64.4 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 74.44 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLY . . . . . 0.534 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.03 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 51.44 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.12 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.3 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.14 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.23 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.524 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.43 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.42 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.684 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 62.15 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 70.45 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 53.35 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.43 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 53.21 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 71.51 109.526 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.51 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.15 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 73.25 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.41 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 60.0 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.2 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.52 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.24 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.31 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.53 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 64.31 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 63.44 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.13 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 55.1 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 62.31 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.24 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 71.41 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.32 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.33 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 72.1 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.42 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 72.32 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.872 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.41 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.24 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.41 110.413 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.31 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.35 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.21 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 72.44 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.12 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.32 110.451 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.201 0.524 . . . . 75.35 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.41 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 71.5 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.22 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.13 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.01 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 61.24 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 42.34 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.32 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.01 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 70.53 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.01 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.32 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.54 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.786 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 63.23 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.655 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.05 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 35.02 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.35 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.33 111.682 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 71.3 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.23 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 45.4 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.14 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.13 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.2 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.11 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.13 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 70.23 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.34 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.14 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 61.53 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.4 ' O ' ' HE2' ' A' ' 203' ' ' LYS . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 43.43 111.736 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.21 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.41 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 202' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.41 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.32 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.24 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.4 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.02 109.223 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.597 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.53 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.12 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.32 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 64.34 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 64.12 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.4 HD21 ' HD3' ' A' ' 225' ' ' LYS . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.21 109.917 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 223' ' ' ASN . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.21 110.767 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 52.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 73.22 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.604 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.24 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.21 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.34 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.22 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 233' ' ' LEU . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.53 111.667 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.11 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.41 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.457 ' HG2' ' CE1' ' A' ' 242' ' ' TYR . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 74.42 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.2 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.41 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.33 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.15 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 55.53 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 63.4 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 72.41 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 71.12 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.53 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 51.24 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 43.33 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 64.4 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 74.44 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.03 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 51.44 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.12 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.3 110.086 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.14 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.43 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.23 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.43 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.557 ' N ' HD13 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.42 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.479 ' HB ' HD11 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 62.15 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 70.45 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.597 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 53.35 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.43 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 53.21 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 71.51 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.51 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.15 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.41 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 260' ' ' PHE . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 60.0 110.915 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.2 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.42 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.52 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.786 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.24 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.31 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.655 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.53 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 64.31 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 63.44 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.13 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 55.1 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 62.31 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.24 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 71.41 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.32 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.33 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 72.1 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.42 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 71.41 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.41 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.24 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.41 110.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.31 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.35 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.21 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 72.44 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.12 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.32 110.273 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.603 0.716 . . . . 75.35 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.41 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 71.5 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.22 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.13 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.01 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 61.24 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.656 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 42.34 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.32 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.01 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 70.53 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.01 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.32 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.54 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 63.23 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.4 HG22 HH11 ' A' ' 275' ' ' ARG . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.05 109.386 -168.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.541 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.42 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 35.02 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.35 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.33 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 71.3 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.23 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.452 ' H ' HD21 ' A' ' 190' ' ' LEU . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 45.4 109.967 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.14 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.53 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.13 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.2 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.11 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.13 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 70.23 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.34 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.14 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 61.53 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.3 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 43.43 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASN . . . . . 0.727 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.21 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.41 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.468 ' OD1' ' HG2' ' A' ' 212' ' ' GLU . 23.3 t-20 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.41 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 210' ' ' VAL . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.32 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.24 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.4 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 29.9 t-20 -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.02 109.638 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.54 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.53 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.12 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.32 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 64.34 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 64.12 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.21 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.21 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 52.43 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 73.22 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.61 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.24 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.21 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.34 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.22 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.53 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.769 HD12 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.11 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.41 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 74.42 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.2 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.41 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.33 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.15 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 55.53 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 63.4 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.611 ' HB2' HG23 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 72.24 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 72.41 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.769 ' HB2' HD12 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 71.12 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.53 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 51.24 109.222 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 43.33 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 64.4 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 74.44 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.03 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 51.44 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.12 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 18.9 p30 -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.3 111.226 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.14 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.23 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.42 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.648 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 62.15 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 70.45 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.54 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 53.35 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.43 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 53.21 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 71.51 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.434 ' CE ' ' HA ' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.51 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.15 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.41 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.794 ' HE2' ' HA ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 60.0 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.761 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.2 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.591 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.42 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.455 HG22 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.52 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.24 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.31 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 189' ' ' VAL . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.53 111.147 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 64.31 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 63.44 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.13 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 55.1 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 62.31 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.24 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 71.41 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.32 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 72.1 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.42 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 141' ' ' LEU . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 71.41 108.233 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 72.32 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.41 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.24 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.41 110.165 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.31 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.35 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.21 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 72.44 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.12 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.32 110.908 179.677 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.153 0.502 . . . . 75.35 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.41 109.714 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 71.5 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.22 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.13 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.01 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 61.24 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 42.34 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.32 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.598 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.01 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 70.53 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.463 HD13 HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.01 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.32 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.54 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 63.23 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.05 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.963 HD21 ' HB2' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.42 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 35.02 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.35 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.33 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 71.3 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 190' ' ' LEU . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.23 110.48 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.963 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 45.4 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.14 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 198' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.13 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.2 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.11 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.13 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 70.23 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.34 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.14 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 61.53 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.3 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 43.43 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.21 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.41 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.41 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.35 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.591 HG13 HG11 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.32 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.24 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.4 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 7.9 t-20 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.02 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.53 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.12 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.762 HG12 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.32 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 64.34 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.21 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.21 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.507 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 52.43 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.916 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 73.22 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.24 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.21 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG23 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.34 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.22 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.53 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.41 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 74.42 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.642 ' HB3' HG22 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.2 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.411 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.41 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.33 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.15 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 55.53 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 63.4 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.678 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 72.24 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 72.41 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.68 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 71.12 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.53 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 51.24 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 43.33 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.837 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 64.4 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.916 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 74.44 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.03 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 51.44 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.12 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 27.0 t-20 -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.3 110.467 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.14 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.23 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.42 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.762 HG12 HG12 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 62.15 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 70.45 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 53.35 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.43 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 53.21 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.51 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.15 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 73.25 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.41 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.606 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 60.0 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.606 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.2 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.42 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.52 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.24 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.31 111.41 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.53 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 64.31 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 63.44 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.13 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 55.1 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 62.31 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.24 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 71.41 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.32 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 72.1 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.42 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 71.41 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 72.32 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.41 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.24 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.15 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.31 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.35 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.21 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 72.44 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.12 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.32 112.289 -174.653 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.851 0.358 . . . . 75.35 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.41 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 71.5 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.22 109.805 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.13 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.01 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 61.24 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.571 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 42.34 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.32 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.01 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 70.53 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.01 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.32 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.54 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 63.23 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.05 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.42 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 35.02 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.35 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.33 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 71.3 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.23 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.721 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 45.4 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.13 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.11 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.13 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 70.23 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.34 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.852 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.14 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 61.53 110.294 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.3 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 43.43 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.21 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.41 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.41 109.198 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.688 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.35 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.32 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.24 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.4 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 28.3 t-20 -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.02 109.403 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.53 111.458 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.12 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.32 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 64.34 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 64.12 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.21 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.743 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.504 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 52.43 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 73.22 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TRP . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.24 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.791 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.21 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.34 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.22 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.53 111.95 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.11 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.41 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 74.42 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.2 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.41 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.33 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.15 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 55.53 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 63.4 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.688 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 72.24 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 72.41 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.752 ' HB2' HD12 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 71.12 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.53 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 51.24 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 43.33 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.611 ' HB3' HD12 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 64.4 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.882 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 74.44 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.03 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 51.44 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.12 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 40.5 t-20 -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.3 111.177 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.14 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.23 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.43 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.42 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 62.15 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 70.45 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 53.35 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.43 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.63 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 53.21 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 71.51 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.51 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.15 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 73.25 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.41 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 60.0 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.2 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.61 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.42 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.52 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.24 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.31 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.53 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 64.31 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 63.44 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.13 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 55.1 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 62.31 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.24 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 71.41 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.32 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.33 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.476 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 72.1 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.42 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 71.41 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 72.32 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.41 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.24 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.41 109.543 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.31 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.35 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.21 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 72.44 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.12 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.32 109.193 169.513 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.14 0.495 . . . . 75.35 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.41 110.179 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 71.5 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.22 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 181' ' ' THR . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.13 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.01 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 61.24 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 42.34 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.32 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.705 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.01 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 70.53 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.01 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.32 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.54 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 63.23 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.05 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.836 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.42 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 35.02 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.35 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.33 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 71.3 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.23 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 45.4 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.455 ' OG1' HG12 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.14 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.13 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.2 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.11 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.13 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 70.23 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.34 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.14 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.651 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 61.53 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.3 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 43.43 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.21 110.823 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.666 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.41 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG12 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.41 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 210' ' ' VAL . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.35 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 210' ' ' VAL . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.32 109.993 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.24 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.4 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.02 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.12 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.827 ' HB ' HD11 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 64.34 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 64.12 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.21 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.21 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 52.43 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.24 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.21 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.34 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.22 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.53 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.11 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.41 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 74.42 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.2 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.41 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.999 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.33 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.666 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.15 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 55.53 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.999 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 63.4 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 72.24 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 72.41 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.766 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 71.12 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' OG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.53 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 51.24 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 43.33 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.836 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 64.4 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.847 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 74.44 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.03 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 51.44 112.068 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' SER . . . . . 0.548 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.3 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.14 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.43 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.42 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 62.15 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.662 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 70.45 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 53.35 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.43 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 53.21 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 71.51 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.51 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.15 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 73.25 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.41 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 60.0 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.2 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.42 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.52 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.24 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.31 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.53 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 64.31 108.568 173.737 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 63.44 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.13 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 55.1 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 62.31 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.24 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 71.41 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.32 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.33 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 72.1 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.42 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 71.41 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 72.32 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.41 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.24 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.41 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.31 109.221 -176.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.35 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.21 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 72.44 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.12 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -51.49 135.49 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.496 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.24 103.37 13.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.394 -0.366 . . . . 71.34 111.783 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -79.75 101.46 8.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.557 -0.535 . . . . 74.22 109.557 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.59 39.58 1.62 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.483 -0.865 . . . . 54.32 113.027 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -119.83 152.8 36.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.867 0.365 . . . . 61.14 110.74 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 p -112.53 161.61 25.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 74.34 111.423 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.96 -178.23 3.4 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.723 2.282 . . . . 72.42 111.3 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.3 m -76.1 150.05 82.88 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.837 0.351 . . . . 73.44 110.841 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 16.9 Cg_exo -68.53 143.83 58.6 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.767 2.311 . . . . 72.4 111.464 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.8 m -58.71 140.82 54.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 54.43 110.26 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.92 -154.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 120.899 0.381 . . . . 51.42 111.017 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.2 t -125.96 -166.88 1.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.813 -0.631 . . . . 45.24 109.926 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.69 177.74 11.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.504 -0.316 . . . . 74.41 110.521 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -69.21 164.58 22.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.294 0.568 . . . . 71.2 112.442 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -116.14 151.11 36.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.531 -0.759 . . . . 74.42 110.92 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -110.43 -174.31 2.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 74.12 110.79 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 5.5 mt 63.88 24.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.82 1.295 . . . . 70.04 110.39 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.07 -24.41 16.9 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.39 -1.277 . . . . 54.11 109.961 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.8 m -142.24 -50.2 0.38 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.706 -1.134 . . . . 71.03 108.776 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 170' ' ' GLU . 8.0 pt-20 -92.11 47.57 1.35 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.724 -1.126 . . . . 73.3 110.52 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 6.3 t -50.92 155.22 1.24 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.117 -0.947 . . . . 75.11 112.362 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.3 tt -102.7 153.73 5.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 73.04 110.236 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -85.47 68.88 10.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.601 0.715 . . . . 72.2 110.165 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.78 -162.06 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.05 -0.977 . . . . 75.35 111.452 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.41 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.942 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 71.5 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.22 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.13 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.01 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 61.24 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.915 HG22 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 42.34 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 201' ' ' ILE . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.32 109.483 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.915 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.01 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 70.53 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.01 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.32 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.54 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 63.23 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.462 HG13 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.05 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.42 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 35.02 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.419 ' HB3' ' H ' ' A' ' 250' ' ' GLY . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.35 111.645 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.33 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 71.3 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.23 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 45.4 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.14 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.13 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.2 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.776 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.11 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.13 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 HG21 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 70.23 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.413 ' N ' ' OG1' ' A' ' 181' ' ' THR . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.34 108.951 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.942 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.14 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 61.53 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.3 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 43.43 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.659 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.21 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.41 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.41 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.35 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.24 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.4 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.02 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.53 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.959 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.12 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.723 HG13 HD11 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.32 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 64.34 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 64.12 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.21 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 52.43 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 73.22 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.24 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.21 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TYR . . . . . 0.776 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.34 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.22 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.53 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.11 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.41 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 74.42 108.624 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.2 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.465 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.41 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.33 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.15 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 55.53 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 63.4 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.776 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 72.41 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.795 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 71.12 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.53 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 51.24 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 43.33 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.605 ' HB3' HD12 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 64.4 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 74.44 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 192' ' ' PRO . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.03 113.351 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 51.44 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.12 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.3 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.14 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.23 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.723 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.43 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.42 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 62.15 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.959 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 70.45 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 53.35 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.43 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 53.21 110.258 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.505 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 71.51 108.621 173.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.51 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.15 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 73.25 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 60.0 110.501 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.2 110.45 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.42 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.52 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.24 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.31 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.53 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 64.31 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 63.44 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.13 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 55.1 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 62.31 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.24 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 71.41 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.32 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.33 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 72.1 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.42 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 71.41 108.658 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 72.32 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.41 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.24 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 0.9 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.41 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.31 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.35 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.21 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.12 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p -155.06 162.73 40.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.32 111.257 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.66 124.31 45.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.569 . . . . 71.34 110.021 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 p -97.45 146.61 25.05 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.31 -0.404 . . . . 74.22 110.671 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.7 139.46 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.781 -0.724 . . . . 54.32 112.251 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -144.11 138.53 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.588 0.233 . . . . 61.14 110.639 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.0 p -101.71 144.32 28.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.9 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 31.3 Cg_exo -62.87 147.98 93.98 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.696 2.264 . . . . 72.42 112.404 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.94 134.95 20.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 73.44 111.243 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -84.9 178.76 4.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.934 2.423 . . . . 72.4 112.144 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -140.5 -162.29 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.541 -0.3 . . . . 54.43 110.39 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.77 145.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.129 -0.693 . . . . 51.42 109.129 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.4 t -87.72 172.5 9.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.902 -0.59 . . . . 45.24 110.753 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -80.62 151.46 29.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 74.41 110.719 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.01 144.32 48.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.157 -0.474 . . . . 71.2 110.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 -174.95 4.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.282 -0.417 . . . . 74.42 110.172 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.493 ' HB3' HD12 ' A' ' 167' ' ' ILE . 2.9 t80 -101.15 164.88 11.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.567 -0.531 . . . . 74.12 109.567 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.827 HG23 ' HA ' ' A' ' 171' ' ' THR . 4.2 mp 60.82 45.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.298 1.047 . . . . 70.04 110.638 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.55 -33.79 11.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.16 -0.927 . . . . 54.11 109.421 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.3 m -137.87 -31.43 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 71.03 110.331 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.48 -52.21 65.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.572 . . . . 73.3 111.001 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.827 ' HA ' HG23 ' A' ' 167' ' ' ILE . 34.1 p 41.64 75.32 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.862 -1.063 . . . . 75.11 111.885 -172.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 174' ' ' ASN . 7.9 tp -100.62 133.9 42.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.83 -1.077 . . . . 73.04 110.837 -172.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.2 m -86.19 58.43 5.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.401 0.619 . . . . 72.2 109.978 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 172' ' ' ILE . 2.7 p-10 -82.83 -170.78 3.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.307 -0.86 . . . . 75.35 111.364 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.41 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 71.5 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.22 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.13 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.01 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 61.24 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 42.34 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.32 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.801 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.01 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 70.53 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.01 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.32 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.54 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 63.23 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.05 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.03 HD21 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.42 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 35.02 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.35 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.33 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 71.3 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.23 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 1.03 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 45.4 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.14 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.13 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.2 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.11 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.13 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.584 HG12 HG21 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 70.23 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.34 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.14 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 61.53 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.3 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 43.43 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.21 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.41 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.41 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 210' ' ' VAL . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.35 111.354 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.495 HG13 HG11 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.32 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.24 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.4 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.02 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.401 ' HE3' ' OE1' ' A' ' 244' ' ' GLN . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.53 111.615 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.12 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.32 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 64.34 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 64.12 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.21 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.21 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 52.43 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 73.22 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.24 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.21 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.34 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.22 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.53 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.11 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.706 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.41 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 74.42 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.2 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.41 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.33 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.15 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 55.53 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.702 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 63.4 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.84 ' HB2' HG23 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 72.24 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 72.41 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD12 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 71.12 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.53 111.836 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 51.24 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 43.33 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 64.4 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 74.44 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.03 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 51.44 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.12 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.3 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.14 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.23 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.43 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.42 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.488 ' HB ' HD11 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 62.15 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.692 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 70.45 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.602 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 53.35 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.43 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 53.21 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 71.51 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.51 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.15 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 73.25 111.81 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.41 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 60.0 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.2 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.545 HG23 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.42 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.776 ' HB ' HG23 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.52 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.24 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.31 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.53 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 64.31 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 63.44 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.13 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 55.1 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 62.31 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.24 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 71.41 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.32 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.33 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 72.1 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.42 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 71.41 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 72.32 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.41 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.24 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 12.2 m120 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.41 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.31 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.35 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.21 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.555 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 72.44 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.12 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 153.88 32.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.32 111.225 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.09 127.89 3.05 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.346 -0.388 . . . . 71.34 110.256 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -156.94 103.41 2.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 74.22 110.692 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.45 124.19 5.9 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.582 -0.607 . . . . 54.32 111.582 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -84.45 127.71 34.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.862 0.363 . . . . 61.14 110.893 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.7 p -75.97 126.91 86.34 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.708 -0.678 . . . . 74.34 111.172 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.67 139.51 7.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.656 2.238 . . . . 72.42 112.384 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.53 136.62 20.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.116 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.53 177.66 8.53 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.766 2.311 . . . . 72.4 112.396 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -87.16 156.55 19.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.109 -0.496 . . . . 54.43 110.7 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.28 176.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 109.316 -0.624 . . . . 51.42 109.316 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 t -92.38 178.57 5.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.44 -0.8 . . . . 45.24 110.33 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.11 150.3 51.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.359 -0.837 . . . . 74.41 109.694 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -97.62 -172.03 2.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 71.2 110.014 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.701 ' HB2' ' HG2' ' A' ' 168' ' ' GLU . 11.8 mm100 -69.55 151.91 45.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.099 0.476 . . . . 74.42 110.897 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.571 ' HB3' HD12 ' A' ' 167' ' ' ILE . 7.9 m-85 -102.63 152.71 20.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.816 -0.629 . . . . 74.12 109.823 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.987 HG23 ' HA ' ' A' ' 171' ' ' THR . 3.8 mp 56.76 37.78 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.37 1.081 . . . . 70.04 110.794 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -107.4 -16.95 14.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.458 -0.792 . . . . 54.11 109.331 173.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -139.81 -39.12 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.808 -1.087 . . . . 71.03 109.257 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.19 33.32 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.392 -0.822 . . . . 73.3 110.675 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.987 ' HA ' HG23 ' A' ' 167' ' ' ILE . 9.1 t -49.5 143.73 6.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 75.11 112.604 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.19 148.13 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.109 -0.95 . . . . 73.04 110.146 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -81.92 55.42 2.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 72.2 110.238 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.22 -173.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 75.35 111.073 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.41 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 71.5 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.22 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.951 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.13 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.01 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 61.24 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.951 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 42.34 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.32 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.01 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 70.53 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.01 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.32 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.54 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 63.23 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.05 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.531 HD13 ' HG3' ' A' ' 194' ' ' GLU . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.42 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 194' ' ' GLU . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 35.02 110.231 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.35 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.33 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.531 ' HG3' HD13 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 71.3 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.23 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 45.4 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.14 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.13 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.2 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.11 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.13 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 70.23 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.413 ' H ' ' HG1' ' A' ' 181' ' ' THR . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.34 108.51 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.14 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 61.53 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.3 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 43.43 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.21 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.41 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG12 ' A' ' 202' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.41 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.681 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.35 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.32 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 263' ' ' ALA . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.24 109.329 175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.4 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.757 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.02 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.53 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.12 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.32 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.607 ' O ' ' HD2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 64.34 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 64.12 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 1.4 t-20 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.21 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.21 110.276 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 52.43 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 73.22 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.24 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.21 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TYR . . . . . 0.58 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.34 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.22 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.53 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.11 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.41 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 74.42 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.682 ' HB3' HG22 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.2 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.41 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.33 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.15 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 55.53 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.724 ' HE3' HG21 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 63.4 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 72.24 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 72.41 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.682 ' HB2' HD12 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 71.12 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.53 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.58 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 51.24 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 43.33 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.531 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 64.4 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 74.44 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.03 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 51.44 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 254' ' ' GLU . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.261 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.742 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.3 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.14 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.23 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.527 HG23 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.43 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.42 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 62.15 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 70.45 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 53.35 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.757 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.43 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 53.21 110.462 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 214' ' ' HIS . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 71.51 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.51 111.125 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.15 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 73.25 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.41 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.592 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 60.0 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.592 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.2 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.42 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.52 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.24 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.31 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.53 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 64.31 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 63.44 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.13 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 55.1 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 62.31 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.24 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 71.41 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.32 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.33 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 72.1 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.42 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 71.41 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 72.32 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.41 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.24 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.41 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.31 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.35 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.21 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 72.44 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.12 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t -150.15 179.26 8.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.32 109.982 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.23 -177.32 3.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.017 0.437 . . . . 71.34 111.286 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 m -99.22 -171.35 2.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.921 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.01 153.76 25.52 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.729 -0.949 . . . . 54.32 110.729 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -115.49 159.74 20.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.959 0.409 . . . . 61.14 111.522 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.7 p -88.4 128.81 51.73 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 74.34 111.267 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.53 115.54 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.419 2.079 . . . . 72.42 112.297 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.2 m -81.43 145.08 54.53 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 73.44 110.503 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 8.2 Cg_exo -72.04 155.86 56.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.867 2.378 . . . . 72.4 112.388 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -82.62 178.84 8.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.525 . . . . 54.43 110.412 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.27 112.86 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.756 0.789 . . . . 51.42 111.554 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.1 m -111.6 148.56 33.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.066 -0.97 . . . . 45.24 109.428 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG3' ' H ' ' A' ' 164' ' ' PHE . 12.1 pt-20 -80.4 -60.75 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.888 -0.325 . . . . 74.41 111.46 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.589 ' H ' ' HG3' ' A' ' 163' ' ' GLU . 94.7 m-85 -138.1 153.59 49.27 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.308 -0.256 . . . . 71.2 110.308 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -137.46 -166.37 1.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.654 -0.498 . . . . 74.42 109.654 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.83 -168.98 2.42 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.85 -0.426 . . . . 74.12 109.85 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.905 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 4.2 mt 65.16 36.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.208 1.004 . . . . 70.04 109.857 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' A' ' 169' ' ' THR . 2.2 pt-20 -114.11 86.85 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.003 -0.999 . . . . 54.11 109.853 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 39.9 m 80.73 -39.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.191 -0.913 . . . . 71.03 108.901 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.85 71.67 0.86 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.432 1.111 . . . . 73.3 109.057 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 29.8 p -55.37 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.215 -1.811 . . . . 75.11 113.582 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.76 151.61 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.365 -0.834 . . . . 73.04 110.615 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.2 m -83.43 62.4 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.163 0.506 . . . . 72.2 110.416 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -80.7 -173.22 4.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 75.35 110.799 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.41 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 71.5 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.74 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.22 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.13 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.01 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 61.24 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 42.34 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.32 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.808 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.01 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 70.53 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.01 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.32 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 63.23 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.573 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.05 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.42 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 35.02 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.657 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.35 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.33 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 71.3 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.23 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 45.4 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.14 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.62 HG12 HD13 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.2 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.11 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.13 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.593 HG12 HG21 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 70.23 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.34 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.14 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.74 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 61.53 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.3 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 43.43 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.21 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.41 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.41 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.35 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.32 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.24 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.4 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.02 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.422 ' CE ' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.53 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.12 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.32 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 64.34 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 64.12 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.21 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.21 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 52.43 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 73.22 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.637 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.24 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.21 109.536 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.22 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.53 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.11 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.41 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 242' ' ' TYR . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 74.42 108.605 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.589 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.2 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.41 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.33 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.15 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 55.53 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.673 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 63.4 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.745 ' HB2' HG23 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 72.24 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 72.41 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.632 HE21 HD11 ' A' ' 246' ' ' ILE . 28.9 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 71.12 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.53 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.632 HD11 HE21 ' A' ' 244' ' ' GLN . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 51.24 109.57 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 43.33 111.106 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 64.4 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 74.44 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.657 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.03 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.606 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 51.44 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.12 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.3 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.637 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.14 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.23 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.43 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.42 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 62.15 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.811 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 70.45 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 53.35 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.43 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 53.21 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 71.51 110.601 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.51 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.15 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.25 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.41 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 60.0 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.707 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.2 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.64 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.42 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.52 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.24 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.31 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.573 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.53 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 64.31 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 63.44 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.13 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 55.1 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 62.31 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.24 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 71.41 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.32 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.33 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 72.1 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.42 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 71.41 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 72.32 110.271 178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.24 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 3.2 p-10 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.41 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.31 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.35 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.21 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 72.44 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.12 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -120.23 -177.65 3.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.32 110.601 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.18 -163.21 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.145 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 t -78.78 175.46 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.206 -0.294 . . . . 74.22 110.206 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.7 -149.52 9.45 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.94 -0.647 . . . . 54.32 112.292 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.75 176.08 7.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 61.14 110.434 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.2 t -121.99 139.77 30.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.8 0.334 . . . . 74.34 110.908 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.0 Cg_exo -76.86 173.16 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.952 2.435 . . . . 72.42 111.264 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.4 t -112.17 107.52 55.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.461 -0.336 . . . . 73.44 110.624 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.28 115.42 2.52 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.984 2.456 . . . . 72.4 112.09 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 m -81.56 176.89 9.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.509 -0.768 . . . . 54.43 110.876 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 162' ' ' SER . 9.4 p -141.67 -170.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.354 -0.98 . . . . 51.42 108.354 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.801 ' H ' HG22 ' A' ' 161' ' ' VAL . 8.5 t -81.38 -167.31 1.42 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.941 0.4 . . . . 45.24 110.098 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.35 -54.03 2.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.995 -0.548 . . . . 74.41 111.577 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -142.68 160.06 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.855 -0.424 . . . . 71.2 109.855 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.48 165.77 22.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.552 -0.536 . . . . 74.42 109.552 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -93.76 176.58 6.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.247 0.546 . . . . 74.12 111.121 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.807 HG23 HG23 ' A' ' 171' ' ' THR . 2.5 mp 58.65 67.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.841 -1.072 . . . . 70.04 111.231 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 -31.72 2.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.463 -1.244 . . . . 54.11 108.887 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.4 m -148.49 -36.36 0.19 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.729 -1.578 . . . . 71.03 107.387 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.03 68.7 5.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.836 -1.075 . . . . 73.3 109.074 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.807 HG23 HG23 ' A' ' 167' ' ' ILE . 30.0 m -75.91 151.09 37.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.532 -1.213 . . . . 75.11 110.603 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.1 tt -58.89 142.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.843 -0.429 . . . . 73.04 109.843 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.3 m -84.78 68.55 10.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.687 0.756 . . . . 72.2 110.356 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.86 -164.59 1.09 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.821 -1.081 . . . . 75.35 110.919 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.41 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.829 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 71.5 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.22 110.119 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.13 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.01 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 61.24 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 42.34 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.32 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.01 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 70.53 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.01 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.32 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.54 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 63.23 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.05 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.42 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 35.02 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.35 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.33 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 71.3 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.402 ' C ' HD21 ' A' ' 190' ' ' LEU . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.23 110.686 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 45.4 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.14 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.565 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.13 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.2 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.13 108.25 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 70.23 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.34 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.14 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 61.53 109.964 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.3 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 43.43 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.21 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.708 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.41 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.41 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.35 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.566 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.32 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.24 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.4 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.02 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.545 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.53 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.12 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.32 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.62 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 64.34 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 64.12 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.21 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.21 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.457 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 52.43 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 73.22 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.62 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.24 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.21 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.34 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.22 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.53 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.11 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.41 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 74.42 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.2 109.171 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.41 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.33 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.708 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.15 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 55.53 113.695 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 63.4 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 72.24 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 72.41 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.692 ' HB2' HD12 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 71.12 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.53 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 51.24 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 43.33 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.686 ' HB2' HD12 ' A' ' 190' ' ' LEU . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 64.4 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 74.44 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.534 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.03 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 51.44 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.12 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.3 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.14 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.23 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.524 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.43 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.42 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.684 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 62.15 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 70.45 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 53.35 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.43 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 53.21 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 71.51 109.526 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.51 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.15 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 73.25 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.41 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 60.0 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.2 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.42 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.52 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.24 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.31 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.53 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 64.31 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 63.44 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.13 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 55.1 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 62.31 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.24 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 71.41 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.32 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.33 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 72.1 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.42 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 72.32 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.872 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.41 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.24 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.41 110.413 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.31 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.35 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.21 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 72.44 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.12 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m -96.32 11.01 36.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.32 110.451 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 160.37 28.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 71.34 110.98 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.4 t -162.48 156.35 20.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.258 -0.645 . . . . 74.22 109.258 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.73 -161.35 37.35 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.021 -0.609 . . . . 54.32 111.842 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -139.04 -173.34 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.4 . . . . 61.14 111.493 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 2.4 p -76.99 144.0 71.46 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 74.34 111.853 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.0 Cg_exo -79.5 178.56 7.24 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.516 2.81 . . . . 72.42 112.11 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.0 139.4 34.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.82 0.343 . . . . 73.44 111.125 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.37 165.91 30.71 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.665 2.243 . . . . 72.4 111.936 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.9 m -116.53 135.35 53.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.588 -0.278 . . . . 54.43 110.405 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -163.29 137.26 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.289 -0.414 . . . . 51.42 110.023 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -134.99 151.4 50.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.156 -0.475 . . . . 45.24 110.329 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 112.63 18.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.941 -0.572 . . . . 74.41 110.423 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -97.28 151.18 20.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.535 -0.543 . . . . 71.2 109.535 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -69.25 123.25 20.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 74.42 111.007 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 167' ' ' ILE . 13.4 t80 -155.94 148.11 23.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 74.12 109.753 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.847 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 8.8 mt 67.38 27.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 122.511 1.148 . . . . 70.04 110.737 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 170' ' ' GLU . 5.5 pt-20 -125.78 95.34 4.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.076 -0.966 . . . . 54.11 109.091 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m 80.88 -24.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.077 -1.419 . . . . 71.03 109.424 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 168' ' ' GLU . 8.2 pt-20 -123.99 57.8 1.19 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.172 -0.922 . . . . 73.3 110.464 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 8.9 t -65.86 164.05 15.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 75.11 110.801 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.11 127.97 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.371 0.605 . . . . 73.04 110.999 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -85.31 64.75 8.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.517 0.675 . . . . 72.2 109.806 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.3 -167.8 1.98 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.061 -0.972 . . . . 75.35 110.92 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.41 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 71.5 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.22 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.13 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.01 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 61.24 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 42.34 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.32 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.01 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 70.53 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.01 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.32 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.54 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.786 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 63.23 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.655 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.05 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.42 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 35.02 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.35 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.33 111.682 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 71.3 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.23 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 45.4 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.14 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.13 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.2 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.11 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.13 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 70.23 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.34 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.14 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 61.53 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.4 ' O ' ' HE2' ' A' ' 203' ' ' LYS . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 43.43 111.736 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.21 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.41 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 202' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.41 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.32 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.24 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.4 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.02 109.223 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.597 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.53 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.12 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.32 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 64.34 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 64.12 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.4 HD21 ' HD3' ' A' ' 225' ' ' LYS . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.21 109.917 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 223' ' ' ASN . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.21 110.767 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 52.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 73.22 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.604 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.24 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.21 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.34 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.22 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 233' ' ' LEU . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.53 111.667 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.11 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.41 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.457 ' HG2' ' CE1' ' A' ' 242' ' ' TYR . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 74.42 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.2 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.41 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.33 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.15 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 55.53 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 63.4 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 72.41 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 71.12 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.53 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 51.24 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 43.33 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 64.4 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 74.44 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.03 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 51.44 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.12 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.3 110.086 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.14 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.43 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.23 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.43 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.557 ' N ' HD13 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.42 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.479 ' HB ' HD11 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 62.15 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 70.45 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.597 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 53.35 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.43 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 53.21 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 71.51 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.51 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.15 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.41 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 260' ' ' PHE . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 60.0 110.915 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.2 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.42 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.52 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.786 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.24 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.31 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.655 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.53 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 64.31 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 63.44 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.13 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 55.1 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 62.31 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.24 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 71.41 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.32 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.33 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 72.1 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.42 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 71.41 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.41 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.24 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.41 110.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.31 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.35 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.21 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 72.44 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.12 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m -62.84 137.69 58.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.32 110.273 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.86 -162.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 71.34 111.331 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.7 m -76.42 174.03 10.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 74.22 110.612 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.33 -160.79 16.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.67 -0.776 . . . . 54.32 112.13 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.27 -173.04 2.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.178 -0.304 . . . . 61.14 110.178 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.7 t -127.97 140.52 38.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.579 -0.282 . . . . 74.34 110.627 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 165.45 25.98 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.678 2.252 . . . . 72.42 112.194 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.77 161.25 72.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 73.44 111.121 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.25 179.61 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.958 2.439 . . . . 72.4 113.071 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -69.0 179.03 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 54.43 112.198 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.34 117.15 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.408 -0.814 . . . . 51.42 108.991 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.0 m -68.03 158.22 33.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 45.24 111.935 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.94 126.58 32.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.594 -0.73 . . . . 74.41 111.061 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -99.38 178.84 4.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.35 -0.386 . . . . 71.2 110.031 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -75.49 128.51 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.994 0.425 . . . . 74.42 110.326 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -102.17 179.7 4.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.602 0.715 . . . . 74.12 112.696 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 2.6 mt 59.33 30.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 114.188 -1.369 . . . . 70.04 112.277 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.03 -8.27 5.99 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.075 -0.966 . . . . 54.11 108.872 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 m -137.27 -68.29 0.48 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.57 -1.196 . . . . 71.03 108.132 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.38 70.67 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.955 0.883 . . . . 73.3 110.014 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 9.0 t -64.7 179.0 0.69 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.364 -1.289 . . . . 75.11 111.263 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.6 tt -103.6 138.68 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.121 -0.49 . . . . 73.04 110.878 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -83.43 63.72 7.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.491 0.662 . . . . 72.2 109.459 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -81.03 -165.13 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.006 -0.997 . . . . 75.35 111.654 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.41 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 71.5 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.22 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.13 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.01 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 61.24 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.656 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 42.34 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.32 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.01 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 70.53 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.01 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.32 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.54 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 63.23 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.4 HG22 HH11 ' A' ' 275' ' ' ARG . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.05 109.386 -168.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.541 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.42 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 35.02 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.35 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.33 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 71.3 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.23 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' H ' HD21 ' A' ' 190' ' ' LEU . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 45.4 109.967 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.14 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.53 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.13 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.2 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.11 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.13 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 70.23 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.34 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.14 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 61.53 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.3 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 43.43 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.727 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.21 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.41 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.468 ' OD1' ' HG2' ' A' ' 212' ' ' GLU . 23.3 t-20 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.41 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 210' ' ' VAL . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.32 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.24 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.4 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 29.9 t-20 -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.02 109.638 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.54 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.53 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.12 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.32 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 64.34 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 64.12 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.21 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.21 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 52.43 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 73.22 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.61 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.24 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.21 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.34 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.22 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.53 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.769 HD12 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.11 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.41 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 74.42 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.2 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.41 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.33 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.15 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 55.53 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 63.4 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.611 ' HB2' HG23 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 72.24 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 72.41 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.769 ' HB2' HD12 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 71.12 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.53 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 51.24 109.222 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 43.33 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 64.4 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 74.44 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.03 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 51.44 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.12 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 18.9 p30 -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.3 111.226 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.14 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.23 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.42 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.648 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 62.15 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 70.45 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.54 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 53.35 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.43 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 53.21 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 71.51 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.434 ' CE ' ' HA ' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.51 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.15 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.41 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.794 ' HE2' ' HA ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 60.0 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.761 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.2 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.591 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.42 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.455 HG22 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.52 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.24 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.31 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 189' ' ' VAL . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.53 111.147 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 64.31 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 63.44 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.13 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 55.1 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 62.31 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.24 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 71.41 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.32 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 72.1 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.42 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 141' ' ' LEU . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 71.41 108.233 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 72.32 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.41 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.24 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.41 110.165 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.31 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.35 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.21 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 72.44 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.12 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -67.34 107.91 2.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.32 110.908 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.05 152.3 45.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 71.34 111.324 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -83.58 179.58 7.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.793 -0.639 . . . . 74.22 109.69 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.69 -160.87 34.04 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.673 -0.775 . . . . 54.32 112.162 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -102.53 154.67 18.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 61.14 110.976 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.8 p -90.98 158.36 41.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.976 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.25 136.17 58.47 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.431 2.088 . . . . 72.42 112.114 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.607 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 27.5 m -83.74 162.98 51.13 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.755 -0.657 . . . . 73.44 110.779 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 158' ' ' VAL . 38.3 Cg_endo -67.2 -168.38 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 72.4 113.075 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 t -125.31 -167.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 54.43 110.301 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.69 138.13 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.355 -0.609 . . . . 51.42 109.355 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.1 p -69.9 163.62 25.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.282 -0.872 . . . . 45.24 112.009 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.34 159.72 30.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.804 -0.634 . . . . 74.41 111.375 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -86.71 -78.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 71.2 111.322 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -146.25 175.05 10.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.215 0.531 . . . . 74.42 112.002 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.651 ' CD2' HG13 ' A' ' 167' ' ' ILE . 42.9 t80 -148.27 160.73 42.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.77 -1.196 . . . . 74.12 107.77 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 7.9 mt 67.18 36.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 122.558 1.171 . . . . 70.04 109.741 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -15.85 7.37 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.605 -1.18 . . . . 54.11 109.821 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.1 m -149.03 -44.28 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.078 -1.419 . . . . 71.03 107.508 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -119.78 88.49 2.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.241 -1.345 . . . . 73.3 108.517 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 24.3 p -50.88 161.87 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.492 -1.231 . . . . 75.11 112.144 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.94 160.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 73.04 109.977 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 58.72 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.198 0.523 . . . . 72.2 111.383 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 175' ' ' THR . 2.6 p-10 -96.74 -167.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.873 -0.603 . . . . 75.35 110.978 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.406 ' N ' HD22 ' A' ' 174' ' ' ASN . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.41 109.714 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 71.5 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.22 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.13 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.01 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 61.24 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 42.34 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.32 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.598 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.01 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 70.53 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.463 HD13 HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.01 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.32 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.54 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 63.23 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.05 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.963 HD21 ' HB2' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.42 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 35.02 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.35 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.33 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 71.3 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 190' ' ' LEU . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.23 110.48 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.963 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 45.4 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.14 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 198' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.13 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.2 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.11 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.13 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 70.23 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.34 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.14 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 61.53 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.3 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 43.43 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.21 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.41 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.41 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.35 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.591 HG13 HG11 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.32 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.24 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.4 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 7.9 t-20 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.02 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.53 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.12 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.762 HG12 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.32 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 64.34 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.21 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.21 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.507 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 52.43 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.916 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 73.22 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.24 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.21 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG23 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.34 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.22 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.53 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.41 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 74.42 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.642 ' HB3' HG22 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.2 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.411 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.41 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.33 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.15 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 55.53 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 63.4 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.678 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 72.24 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 72.41 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.68 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 71.12 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.53 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 51.24 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 43.33 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.837 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 64.4 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.916 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 74.44 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.03 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 51.44 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.12 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 27.0 t-20 -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.3 110.467 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.14 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.23 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.42 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.762 HG12 HG12 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 62.15 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 70.45 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 53.35 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.43 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 53.21 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.51 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.15 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 73.25 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.41 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.606 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 60.0 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.606 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.2 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.42 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.52 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.24 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.31 111.41 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.53 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 64.31 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 63.44 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.13 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 55.1 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 62.31 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.24 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 71.41 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.32 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 72.1 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.42 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 71.41 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 72.32 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.41 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.24 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.15 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.31 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.35 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.21 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 72.44 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.12 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m -75.18 82.68 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.32 112.289 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 68.89 148.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.699 1.0 . . . . 71.34 113.699 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -130.25 126.86 38.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.961 -1.018 . . . . 74.22 108.867 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.51 -106.89 0.9 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.667 -0.778 . . . . 54.32 112.745 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -123.8 122.28 37.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.048 0.451 . . . . 61.14 110.624 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.4 p -74.18 148.97 86.85 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.462 -0.79 . . . . 74.34 111.034 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.1 140.49 95.33 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.582 2.188 . . . . 72.42 111.834 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.42 135.04 65.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.183 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.61 137.06 24.51 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.605 2.203 . . . . 72.4 112.122 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -74.13 139.74 44.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.068 -0.514 . . . . 54.43 110.417 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.24 73.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.324 -0.621 . . . . 51.42 109.324 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -104.74 134.61 47.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.634 -0.712 . . . . 45.24 110.158 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -67.11 -62.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 74.41 111.336 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -136.04 165.34 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 71.2 110.801 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -131.22 166.64 20.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.582 -0.736 . . . . 74.42 109.102 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -123.7 -172.23 2.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 74.12 110.418 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 171' ' ' THR . 2.2 mp 55.44 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.305 -0.861 . . . . 70.04 111.166 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.34 -18.59 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.763 -0.653 . . . . 54.11 109.399 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m -135.81 -66.54 0.55 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.932 -1.031 . . . . 71.03 108.794 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.64 58.15 3.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.387 -0.824 . . . . 73.3 110.319 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.466 ' HA ' HG23 ' A' ' 167' ' ' ILE . 5.2 t -57.46 148.75 22.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 75.11 111.485 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.96 126.67 39.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.567 0.699 . . . . 73.04 110.982 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.4 m -88.64 62.12 6.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.328 0.585 . . . . 72.2 111.488 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.91 -166.3 1.36 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.902 -0.59 . . . . 75.35 110.302 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.41 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 71.5 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.22 109.805 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.13 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.01 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 61.24 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.571 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 42.34 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.32 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.01 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 70.53 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.01 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.32 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.54 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 63.23 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.05 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.42 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 35.02 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.35 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.33 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 71.3 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.23 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.721 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 45.4 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.13 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.11 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.13 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 70.23 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.34 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.852 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.14 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 61.53 110.294 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.3 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 43.43 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.21 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.41 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 167' ' ' ILE . 2.3 t-20 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.41 109.198 169.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.688 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.35 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.32 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.24 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.4 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 28.3 t-20 -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.02 109.403 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.53 111.458 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.12 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.32 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 64.34 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 64.12 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.21 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.743 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.504 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 52.43 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 73.22 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TRP . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.24 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.791 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.21 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.34 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.22 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.53 111.95 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.11 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.41 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 74.42 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.2 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.41 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.33 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.15 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 55.53 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 63.4 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.688 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 72.24 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 72.41 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.752 ' HB2' HD12 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 71.12 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.53 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 51.24 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 43.33 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.611 ' HB3' HD12 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 64.4 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.882 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 74.44 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.03 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 51.44 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.12 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 40.5 t-20 -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.3 111.177 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.14 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.23 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.43 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.42 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 62.15 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 70.45 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 53.35 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.43 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.63 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 53.21 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 71.51 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.51 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.15 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 73.25 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.41 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 60.0 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.2 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.61 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.42 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.52 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.24 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.31 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.53 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 64.31 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 63.44 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.13 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 55.1 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 62.31 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.24 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 71.41 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.32 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.33 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.476 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 72.1 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.42 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 71.41 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 72.32 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.41 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.24 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.41 109.543 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.31 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.35 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.21 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 72.44 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.12 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m -83.06 136.51 34.46 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.32 109.193 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.4 110.95 13.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.17 0.509 . . . . 71.34 110.815 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -105.91 144.26 32.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.869 -0.605 . . . . 74.22 110.356 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.77 108.03 2.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.799 -0.715 . . . . 54.32 112.226 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -111.58 118.08 34.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 61.14 110.074 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 15.2 p -67.87 134.88 92.07 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.66 -0.7 . . . . 74.34 111.716 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 154.87 67.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.71 2.274 . . . . 72.42 112.225 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.73 156.24 35.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.063 -0.517 . . . . 73.44 111.028 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.1 167.62 24.65 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.874 2.382 . . . . 72.4 112.114 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.5 t -111.66 155.27 23.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.135 -0.484 . . . . 54.43 110.0 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.6 122.63 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 51.42 110.511 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.2 m -112.05 133.93 53.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.118 -0.492 . . . . 45.24 110.315 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 106.85 11.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 74.41 111.312 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.32 -179.37 3.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.999 -0.546 . . . . 71.2 110.036 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 168' ' ' GLU . 14.5 tt0 -95.73 113.13 24.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 74.42 111.685 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -163.04 145.47 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 74.12 109.858 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 1.033 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 10.2 mt 65.79 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.921 1.343 . . . . 70.04 110.287 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 165' ' ' GLN . 6.3 pt-20 -130.07 91.96 3.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.315 -1.312 . . . . 54.11 108.435 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.2 m 88.09 -22.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.328 -1.306 . . . . 71.03 108.847 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.09 71.39 1.42 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.111 -0.949 . . . . 73.3 110.609 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 1.033 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 14.6 t -64.47 157.57 26.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 75.11 110.828 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.8 tt -86.6 137.57 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 73.04 110.894 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.9 t -85.41 62.67 7.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.516 0.674 . . . . 72.2 109.684 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.67 -172.98 4.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.395 -0.821 . . . . 75.35 111.187 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.41 110.179 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 71.5 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.22 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 181' ' ' THR . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.13 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.01 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 61.24 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 42.34 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.32 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.705 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.01 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 70.53 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.01 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.32 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.54 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 63.23 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.05 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.836 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.42 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 35.02 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.35 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.33 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 71.3 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.23 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 45.4 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.455 ' OG1' HG12 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.14 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.13 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.2 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.11 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.13 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 70.23 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.34 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.14 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.651 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 61.53 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.3 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 43.43 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.21 110.823 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.666 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.41 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG12 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.41 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 210' ' ' VAL . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.35 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 210' ' ' VAL . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.32 109.993 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.24 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.4 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.02 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.12 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.827 ' HB ' HD11 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 64.34 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 64.12 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.21 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.21 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 52.43 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.24 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.21 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.34 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.22 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.53 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.11 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.41 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 74.42 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.2 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.41 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.999 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.33 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.666 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.15 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 55.53 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.999 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 63.4 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 72.24 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 72.41 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.766 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 71.12 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' OG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.53 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 51.24 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 43.33 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.836 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 64.4 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.847 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 74.44 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.03 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 51.44 112.068 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.548 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.3 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.14 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.43 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.42 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 62.15 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.662 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 70.45 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 53.35 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.43 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 53.21 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 71.51 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.51 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.15 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 73.25 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.41 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 60.0 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.2 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.42 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.52 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.24 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.31 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.53 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 64.31 108.568 173.737 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 63.439999999999998 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.129999999999995 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 55.100000000000001 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 62.310000000000002 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.239999999999995 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 71.409999999999997 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.329999999999998 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 72.099999999999994 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.420000000000002 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 71.409999999999997 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 72.319999999999993 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.409999999999997 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.239999999999995 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 m120 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.409999999999997 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.310000000000002 109.221 -176.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.349999999999994 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.209999999999994 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 72.439999999999998 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.119999999999997 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.496 174.179 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.367 0.604 . . . . 75.349999999999994 111.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.409999999999997 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.942 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 71.5 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.219999999999999 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.129999999999995 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.010000000000005 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 61.240000000000002 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.915 HG22 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 42.340000000000003 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 201' ' ' ILE . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.319999999999993 109.483 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.915 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.010000000000005 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 70.530000000000001 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.010000000000005 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.319999999999993 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.540000000000006 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 63.229999999999997 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.462 HG13 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.049999999999997 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.420000000000002 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 35.020000000000003 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.419 ' HB3' ' H ' ' A' ' 250' ' ' GLY . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.350000000000001 111.645 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.329999999999998 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 71.299999999999997 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 45.399999999999999 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.129999999999995 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.200000000000003 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.776 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.109999999999999 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.129999999999995 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 HG21 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 70.230000000000004 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.413 ' N ' ' OG1' ' A' ' 181' ' ' THR . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.340000000000003 108.951 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.942 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.140000000000001 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 61.530000000000001 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.299999999999997 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 43.43 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.659 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.209999999999994 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.409999999999997 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.409999999999997 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.349999999999994 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.319999999999993 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.239999999999995 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.400000000000006 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.019999999999996 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.959 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.120000000000005 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.723 HG13 HD11 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.319999999999993 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . 0.719 ' HD3' ' H ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 64.340000000000003 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 64.120000000000005 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 52.43 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 73.219999999999999 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.239999999999995 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . 0.776 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.219999999999999 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.530000000000001 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.109999999999999 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.409999999999997 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 74.420000000000002 108.624 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.200000000000003 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.465 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.329999999999998 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.150000000000006 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 55.530000000000001 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 63.399999999999999 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.776 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 72.239999999999995 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.795 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 71.120000000000005 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.530000000000001 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 51.240000000000002 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 43.329999999999998 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.605 ' HB3' HD12 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 64.400000000000006 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 74.439999999999998 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 192' ' ' PRO . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.030000000000001 113.351 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 51.439999999999998 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.299999999999997 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.140000000000001 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.230000000000004 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.723 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.430000000000007 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.420000000000002 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 62.149999999999999 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.959 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 70.450000000000003 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 53.350000000000001 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.430000000000007 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 53.210000000000001 110.258 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.505 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 71.510000000000005 108.621 173.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.509999999999998 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.149999999999999 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 73.25 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 60.0 110.501 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.200000000000003 110.45 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.519999999999996 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.310000000000002 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.530000000000001 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 64.310000000000002 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 63.439999999999998 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.129999999999995 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 55.100000000000001 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 62.310000000000002 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.239999999999995 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 71.409999999999997 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.319999999999993 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.329999999999998 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 72.099999999999994 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 72.319999999999993 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.409999999999997 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.239999999999995 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.499 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.409999999999997 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.310000000000002 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.349999999999994 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.209999999999994 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.119999999999997 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 111.257 -178.198 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.479 0.657 . . . . 75.349999999999994 111.364 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.409999999999997 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 71.5 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.219999999999999 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.129999999999995 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.010000000000005 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 42.340000000000003 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.319999999999993 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.801 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.010000000000005 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 70.530000000000001 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.010000000000005 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.319999999999993 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.540000000000006 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 63.229999999999997 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.049999999999997 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.03 HD21 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 35.020000000000003 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.350000000000001 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.329999999999998 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 71.299999999999997 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.230000000000004 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 1.03 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 45.399999999999999 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.140000000000001 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.129999999999995 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.200000000000003 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.109999999999999 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.129999999999995 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.584 HG12 HG21 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 70.230000000000004 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.340000000000003 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 61.530000000000001 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 43.43 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.209999999999994 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.409999999999997 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.409999999999997 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 210' ' ' VAL . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.349999999999994 111.354 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.495 HG13 HG11 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.319999999999993 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.239999999999995 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.400000000000006 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.019999999999996 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.401 ' HE3' ' OE1' ' A' ' 244' ' ' GLN . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.615 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.120000000000005 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.319999999999993 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 64.340000000000003 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 64.120000000000005 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.209999999999994 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 52.43 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 73.219999999999999 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.239999999999995 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.209999999999994 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.219999999999999 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.530000000000001 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.109999999999999 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.706 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.409999999999997 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 74.420000000000002 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.200000000000003 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.409999999999997 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.329999999999998 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.150000000000006 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 55.530000000000001 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.702 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 63.399999999999999 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.84 ' HB2' HG23 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 72.239999999999995 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 72.409999999999997 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD12 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 71.120000000000005 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.530000000000001 111.836 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 51.240000000000002 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 43.329999999999998 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 64.400000000000006 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 74.439999999999998 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.030000000000001 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 51.439999999999998 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.120000000000005 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.299999999999997 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.140000000000001 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.230000000000004 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.430000000000007 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.420000000000002 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.488 ' HB ' HD11 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 62.149999999999999 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.692 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 70.450000000000003 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.602 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 53.350000000000001 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.430000000000007 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 53.210000000000001 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 71.510000000000005 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.149999999999999 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 73.25 111.81 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.409999999999997 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 60.0 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.200000000000003 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.545 HG23 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.420000000000002 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.776 ' HB ' HG23 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.519999999999996 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.239999999999995 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.310000000000002 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 64.310000000000002 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 63.439999999999998 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.129999999999995 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 55.100000000000001 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.239999999999995 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 71.409999999999997 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.319999999999993 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.329999999999998 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 72.099999999999994 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.420000000000002 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 72.319999999999993 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.409999999999997 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.239999999999995 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 19.0 m-80 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.409999999999997 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.310000000000002 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.209999999999994 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.555 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 72.439999999999998 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.119999999999997 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.319999999999993 111.225 -177.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 121.299 0.571 . . . . 75.349999999999994 111.073 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.409999999999997 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 71.5 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.219999999999999 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.951 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.129999999999995 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.010000000000005 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 61.240000000000002 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.951 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 42.340000000000003 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.319999999999993 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.010000000000005 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 70.530000000000001 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.010000000000005 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.319999999999993 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.540000000000006 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 63.229999999999997 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.049999999999997 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.420000000000002 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 194' ' ' GLU . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 35.020000000000003 110.231 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.350000000000001 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.329999999999998 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.531 ' HG3' HD13 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 71.299999999999997 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.230000000000004 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 45.399999999999999 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.140000000000001 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.129999999999995 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.129999999999995 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 70.230000000000004 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.413 ' H ' ' HG1' ' A' ' 181' ' ' THR . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.340000000000003 108.51 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.140000000000001 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 61.530000000000001 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.299999999999997 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 43.43 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.209999999999994 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.409999999999997 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG12 ' A' ' 202' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.409999999999997 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.681 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.349999999999994 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.319999999999993 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 263' ' ' ALA . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.239999999999995 109.329 175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.400000000000006 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.757 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.019999999999996 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.530000000000001 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.120000000000005 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.319999999999993 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 64.340000000000003 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 64.120000000000005 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.508 HD21 ' HD3' ' A' ' 225' ' ' LYS . 48.0 t30 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.209999999999994 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 223' ' ' ASN . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.209999999999994 110.276 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 52.43 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 73.219999999999999 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.239999999999995 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.209999999999994 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . 0.58 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.340000000000003 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.219999999999999 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.530000000000001 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.109999999999999 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.409999999999997 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 74.420000000000002 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.682 ' HB3' HG22 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.200000000000003 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.409999999999997 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.329999999999998 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.150000000000006 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 55.530000000000001 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.724 ' HE3' HG21 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 63.399999999999999 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 72.239999999999995 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 72.409999999999997 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.682 ' HB2' HD12 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 71.120000000000005 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.530000000000001 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.58 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 51.240000000000002 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 43.329999999999998 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.531 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 64.400000000000006 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 74.439999999999998 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.030000000000001 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 51.439999999999998 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 254' ' ' GLU . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.261 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.742 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.299999999999997 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.140000000000001 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.230000000000004 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.527 HG23 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.430000000000007 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.420000000000002 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 62.149999999999999 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 70.450000000000003 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 53.350000000000001 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.757 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.430000000000007 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 53.210000000000001 110.462 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 214' ' ' HIS . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 71.510000000000005 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.509999999999998 111.125 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.149999999999999 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 73.25 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.409999999999997 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.592 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 60.0 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.592 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.200000000000003 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.420000000000002 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.519999999999996 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.310000000000002 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 64.310000000000002 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 63.439999999999998 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.129999999999995 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 55.100000000000001 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 62.310000000000002 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.239999999999995 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 71.409999999999997 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.319999999999993 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.329999999999998 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 72.099999999999994 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 71.409999999999997 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 72.319999999999993 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.409999999999997 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.239999999999995 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.310000000000002 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.349999999999994 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.209999999999994 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 72.439999999999998 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 109.982 -177.231 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.199 0.523 . . . . 75.349999999999994 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.409999999999997 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 71.5 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.74 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.219999999999999 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.129999999999995 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.010000000000005 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 61.240000000000002 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 42.340000000000003 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.319999999999993 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.808 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.010000000000005 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 70.530000000000001 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.010000000000005 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.319999999999993 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 63.229999999999997 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.573 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.049999999999997 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.420000000000002 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 35.020000000000003 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.657 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.350000000000001 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.329999999999998 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 71.299999999999997 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.230000000000004 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 45.399999999999999 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.140000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.62 HG12 HD13 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.129999999999995 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.200000000000003 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.109999999999999 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.129999999999995 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.593 HG12 HG21 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 70.230000000000004 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.340000000000003 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.140000000000001 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.74 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 61.530000000000001 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.299999999999997 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 43.43 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.209999999999994 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.409999999999997 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.409999999999997 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.349999999999994 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.319999999999993 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.239999999999995 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.019999999999996 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.705 ' HD2' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.120000000000005 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 64.340000000000003 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 64.120000000000005 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.209999999999994 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 52.43 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 73.219999999999999 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.637 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.239999999999995 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.209999999999994 109.536 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.219999999999999 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.530000000000001 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.109999999999999 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.409999999999997 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 242' ' ' TYR . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 74.420000000000002 108.605 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.589 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.200000000000003 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.409999999999997 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.329999999999998 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.150000000000006 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 55.530000000000001 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.673 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 63.399999999999999 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.745 ' HB2' HG23 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 72.409999999999997 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.705 HE22 ' HD2' ' A' ' 217' ' ' LYS . 34.4 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 71.120000000000005 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.530000000000001 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 51.240000000000002 109.57 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 43.329999999999998 111.106 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 64.400000000000006 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 74.439999999999998 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.657 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.030000000000001 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.606 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 51.439999999999998 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.120000000000005 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.299999999999997 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.637 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.140000000000001 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.230000000000004 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.430000000000007 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.420000000000002 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 62.149999999999999 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.811 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 70.450000000000003 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 53.350000000000001 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.430000000000007 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 53.210000000000001 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 71.510000000000005 110.601 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.509999999999998 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.149999999999999 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.25 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.409999999999997 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 60.0 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.707 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.200000000000003 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.64 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.420000000000002 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.519999999999996 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.310000000000002 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.573 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.530000000000001 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 64.310000000000002 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 63.439999999999998 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.129999999999995 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 55.100000000000001 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 62.310000000000002 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.239999999999995 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 71.409999999999997 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.319999999999993 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.329999999999998 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 72.099999999999994 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.420000000000002 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 71.409999999999997 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 72.319999999999993 110.271 178.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.239999999999995 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 2.2 p30 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.409999999999997 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.310000000000002 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.349999999999994 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.209999999999994 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 72.439999999999998 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.119999999999997 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.319999999999993 110.601 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.412 0.625 . . . . 75.349999999999994 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.409999999999997 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.829 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 71.5 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.219999999999999 110.119 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.129999999999995 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.010000000000005 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 61.240000000000002 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 42.340000000000003 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.319999999999993 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.010000000000005 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 70.530000000000001 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.010000000000005 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.540000000000006 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 63.229999999999997 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.049999999999997 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 35.020000000000003 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.350000000000001 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.329999999999998 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 71.299999999999997 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.402 ' C ' HD21 ' A' ' 190' ' ' LEU . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.230000000000004 110.686 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 45.399999999999999 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.140000000000001 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.565 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.129999999999995 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.200000000000003 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.109999999999999 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.129999999999995 108.25 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 70.230000000000004 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.340000000000003 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.140000000000001 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 61.530000000000001 109.964 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.299999999999997 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 43.43 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.209999999999994 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.708 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.409999999999997 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.409999999999997 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.349999999999994 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.566 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.319999999999993 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.239999999999995 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.400000000000006 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.019999999999996 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.545 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.530000000000001 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.120000000000005 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.319999999999993 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . 0.62 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 64.340000000000003 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 64.120000000000005 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.209999999999994 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.209999999999994 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.457 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 52.43 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 73.219999999999999 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.62 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.239999999999995 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.209999999999994 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.340000000000003 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.219999999999999 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.530000000000001 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.109999999999999 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.409999999999997 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 74.420000000000002 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.200000000000003 109.171 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.409999999999997 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.329999999999998 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.708 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.150000000000006 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 55.530000000000001 113.695 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 63.399999999999999 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 72.239999999999995 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 72.409999999999997 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.692 ' HB2' HD12 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 71.120000000000005 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.530000000000001 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 51.240000000000002 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 43.329999999999998 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.686 ' HB2' HD12 ' A' ' 190' ' ' LEU . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 64.400000000000006 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 74.439999999999998 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . 0.534 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.030000000000001 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 51.439999999999998 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.120000000000005 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.524 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.430000000000007 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.420000000000002 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.684 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 62.149999999999999 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 70.450000000000003 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 53.350000000000001 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.430000000000007 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 53.210000000000001 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 71.510000000000005 109.526 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.509999999999998 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.149999999999999 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 73.25 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.409999999999997 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 60.0 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.200000000000003 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.519999999999996 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.239999999999995 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.310000000000002 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.530000000000001 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 64.310000000000002 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 63.439999999999998 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.129999999999995 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 55.100000000000001 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 62.310000000000002 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.239999999999995 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 71.409999999999997 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 72.099999999999994 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.420000000000002 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 72.319999999999993 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.872 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.409999999999997 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.239999999999995 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.501 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 3.2 p30 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.409999999999997 110.413 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.310000000000002 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.349999999999994 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.209999999999994 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 72.439999999999998 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.319999999999993 110.451 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.201 0.524 . . . . 75.349999999999994 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.409999999999997 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 71.5 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.219999999999999 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.129999999999995 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.010000000000005 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 61.240000000000002 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 42.340000000000003 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.319999999999993 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.010000000000005 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 70.530000000000001 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.010000000000005 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.319999999999993 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.540000000000006 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.786 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 63.229999999999997 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.655 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.049999999999997 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 35.020000000000003 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.350000000000001 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.329999999999998 111.682 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 71.299999999999997 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.230000000000004 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 45.399999999999999 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.140000000000001 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.129999999999995 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.200000000000003 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.129999999999995 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 70.230000000000004 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.340000000000003 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.140000000000001 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 61.530000000000001 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.4 ' O ' ' HE2' ' A' ' 203' ' ' LYS . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 43.43 111.736 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.209999999999994 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.409999999999997 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 202' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.409999999999997 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.239999999999995 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.400000000000006 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.019999999999996 109.223 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.597 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.530000000000001 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.120000000000005 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.319999999999993 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 64.340000000000003 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 64.120000000000005 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.4 HD21 ' HD3' ' A' ' 225' ' ' LYS . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.209999999999994 109.917 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 223' ' ' ASN . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.209999999999994 110.767 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 52.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 73.219999999999999 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.604 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.239999999999995 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.209999999999994 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.340000000000003 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.219999999999999 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 233' ' ' LEU . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.530000000000001 111.667 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.109999999999999 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.457 ' HG2' ' CE1' ' A' ' 242' ' ' TYR . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 74.420000000000002 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.200000000000003 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.409999999999997 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.329999999999998 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.150000000000006 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 55.530000000000001 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 63.399999999999999 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 72.239999999999995 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 72.409999999999997 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 71.120000000000005 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.530000000000001 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 51.240000000000002 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 43.329999999999998 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 64.400000000000006 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 74.439999999999998 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.030000000000001 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 51.439999999999998 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.476 HD22 ' C ' ' A' ' 253' ' ' ASN . 0.2 OUTLIER -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.299999999999997 110.086 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.140000000000001 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.43 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.230000000000004 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.430000000000007 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.557 ' N ' HD13 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.479 ' HB ' HD11 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 62.149999999999999 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 70.450000000000003 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.597 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 53.350000000000001 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.430000000000007 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 53.210000000000001 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 71.510000000000005 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.509999999999998 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.149999999999999 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.409999999999997 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 260' ' ' PHE . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 60.0 110.915 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.200000000000003 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.420000000000002 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.519999999999996 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.786 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.310000000000002 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.655 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.530000000000001 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 64.310000000000002 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 63.439999999999998 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.129999999999995 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 55.100000000000001 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 62.310000000000002 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.239999999999995 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 71.409999999999997 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.319999999999993 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.329999999999998 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 72.099999999999994 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.420000000000002 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.409999999999997 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.239999999999995 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 6.7 m-80 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.409999999999997 110.803 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.310000000000002 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.209999999999994 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 72.439999999999998 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.119999999999997 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 110.273 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.603 0.716 . . . . 75.349999999999994 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.409999999999997 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 71.5 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.219999999999999 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.129999999999995 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.010000000000005 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 61.240000000000002 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.656 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 42.340000000000003 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.319999999999993 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.010000000000005 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 70.530000000000001 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.010000000000005 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.540000000000006 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 63.229999999999997 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.4 HG22 HH11 ' A' ' 275' ' ' ARG . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.049999999999997 109.386 -168.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.541 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.420000000000002 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 35.020000000000003 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.350000000000001 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.329999999999998 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 71.299999999999997 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.230000000000004 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.452 ' H ' HD21 ' A' ' 190' ' ' LEU . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 45.399999999999999 109.967 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.53 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.129999999999995 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.200000000000003 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.109999999999999 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.129999999999995 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 70.230000000000004 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.340000000000003 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.140000000000001 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 61.530000000000001 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.299999999999997 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 43.43 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . 0.727 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.209999999999994 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.409999999999997 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.618 ' ND2' ' HG2' ' A' ' 212' ' ' GLU . 9.1 t30 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.409999999999997 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.618 ' HG2' ' ND2' ' A' ' 211' ' ' ASN . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.319999999999993 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.239999999999995 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.400000000000006 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.019999999999996 109.638 178.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.54 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.530000000000001 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.120000000000005 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 64.340000000000003 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 64.120000000000005 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.209999999999994 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.209999999999994 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 52.43 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 73.219999999999999 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.61 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.239999999999995 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.209999999999994 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.219999999999999 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.530000000000001 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.769 HD12 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.109999999999999 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.409999999999997 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 74.420000000000002 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.200000000000003 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.409999999999997 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.329999999999998 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.150000000000006 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 55.530000000000001 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 63.399999999999999 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.611 ' HB2' HG23 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 72.239999999999995 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 72.409999999999997 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.769 ' HB2' HD12 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 71.120000000000005 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.530000000000001 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 51.240000000000002 109.222 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 43.329999999999998 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 64.400000000000006 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 74.439999999999998 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.030000000000001 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 51.439999999999998 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.120000000000005 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.299999999999997 111.226 -176.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.140000000000001 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.430000000000007 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.420000000000002 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.648 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 62.149999999999999 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 70.450000000000003 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.54 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 53.350000000000001 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.430000000000007 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 53.210000000000001 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.509999999999998 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.149999999999999 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.409999999999997 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.794 ' HA ' ' HE2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 60.0 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.761 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.200000000000003 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.591 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.420000000000002 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.455 HG22 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.519999999999996 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.239999999999995 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.310000000000002 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 189' ' ' VAL . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.530000000000001 111.147 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 64.310000000000002 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 63.439999999999998 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.129999999999995 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 55.100000000000001 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 62.310000000000002 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.239999999999995 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 71.409999999999997 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.319999999999993 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.329999999999998 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 72.099999999999994 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 141' ' ' LEU . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 71.409999999999997 108.233 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 72.319999999999993 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.409999999999997 110.165 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.310000000000002 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.349999999999994 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.209999999999994 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 72.439999999999998 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.319999999999993 110.908 179.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 175' ' ' THR . 2.6 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.153 0.502 . . . . 75.349999999999994 110.978 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.406 ' N ' HD22 ' A' ' 174' ' ' ASN . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.409999999999997 109.714 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 71.5 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.219999999999999 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.129999999999995 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.010000000000005 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 61.240000000000002 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 42.340000000000003 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.319999999999993 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.598 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.010000000000005 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 70.530000000000001 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.463 HD13 HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.010000000000005 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.319999999999993 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.540000000000006 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 63.229999999999997 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.049999999999997 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.963 HD21 ' HB2' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 35.020000000000003 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.350000000000001 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.329999999999998 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 71.299999999999997 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 190' ' ' LEU . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.230000000000004 110.48 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.963 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 45.399999999999999 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.140000000000001 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 198' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.129999999999995 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.200000000000003 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.109999999999999 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.129999999999995 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 70.230000000000004 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.340000000000003 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.140000000000001 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 61.530000000000001 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.299999999999997 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 43.43 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.209999999999994 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.409999999999997 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.409999999999997 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.349999999999994 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.591 HG13 HG11 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.319999999999993 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.239999999999995 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.400000000000006 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.0 t30 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.019999999999996 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.530000000000001 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.120000000000005 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.762 HG12 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.319999999999993 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 64.340000000000003 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 64.120000000000005 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.209999999999994 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.507 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 52.43 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.916 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG23 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.340000000000003 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.219999999999999 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.530000000000001 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.409999999999997 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 74.420000000000002 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.642 ' HB3' HG22 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.200000000000003 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.411 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.329999999999998 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.150000000000006 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 63.399999999999999 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.678 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 72.239999999999995 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 72.409999999999997 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.68 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 71.120000000000005 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.530000000000001 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 51.240000000000002 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 43.329999999999998 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.837 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 64.400000000000006 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.916 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 74.439999999999998 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.030000000000001 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 51.439999999999998 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.120000000000005 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.299999999999997 110.467 -177.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.140000000000001 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.230000000000004 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.430000000000007 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.420000000000002 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.762 HG12 HG12 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 62.149999999999999 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 70.450000000000003 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 53.350000000000001 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.430000000000007 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 53.210000000000001 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 71.510000000000005 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.509999999999998 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.149999999999999 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 73.25 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.606 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 60.0 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.606 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.200000000000003 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.420000000000002 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.519999999999996 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.239999999999995 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.310000000000002 111.41 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.530000000000001 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 64.310000000000002 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 63.439999999999998 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.129999999999995 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 55.100000000000001 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 62.310000000000002 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.239999999999995 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 71.409999999999997 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.319999999999993 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 72.099999999999994 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.420000000000002 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 71.409999999999997 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 72.319999999999993 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.476 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.409999999999997 110.15 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.310000000000002 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.349999999999994 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.209999999999994 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 72.439999999999998 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.119999999999997 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.319999999999993 112.289 -174.653 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.409999999999997 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 71.5 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.219999999999999 109.805 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.129999999999995 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.010000000000005 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 61.240000000000002 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.571 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 42.340000000000003 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.319999999999993 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.010000000000005 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 70.530000000000001 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.319999999999993 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.540000000000006 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 63.229999999999997 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.049999999999997 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.420000000000002 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 35.020000000000003 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.350000000000001 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.329999999999998 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 71.299999999999997 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.230000000000004 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.721 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 45.399999999999999 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.129999999999995 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.109999999999999 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.129999999999995 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 70.230000000000004 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.852 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.140000000000001 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 61.530000000000001 110.294 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.299999999999997 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 43.43 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.209999999999994 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.409999999999997 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.409999999999997 109.198 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.688 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.349999999999994 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.319999999999993 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.400000000000006 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.019999999999996 109.403 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.486 ' N ' HD22 ' A' ' 216' ' ' ASN . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.530000000000001 111.458 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.120000000000005 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.319999999999993 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 64.340000000000003 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 64.120000000000005 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.209999999999994 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.743 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.504 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.209999999999994 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 52.43 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 73.219999999999999 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.239999999999995 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.791 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.219999999999999 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.530000000000001 111.95 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.109999999999999 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.409999999999997 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 74.420000000000002 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.200000000000003 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.329999999999998 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.150000000000006 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 55.530000000000001 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 63.399999999999999 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.688 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 72.239999999999995 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.752 ' HB2' HD12 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 71.120000000000005 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.530000000000001 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 51.240000000000002 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 43.329999999999998 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.611 ' HB3' HD12 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 64.400000000000006 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.882 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 74.439999999999998 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.030000000000001 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 51.439999999999998 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.120000000000005 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 0.2 OUTLIER -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.299999999999997 111.177 -176.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.140000000000001 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.230000000000004 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.430000000000007 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.420000000000002 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 62.149999999999999 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 70.450000000000003 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 53.350000000000001 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.430000000000007 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.63 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 53.210000000000001 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 71.510000000000005 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.509999999999998 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.149999999999999 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 73.25 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.409999999999997 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 60.0 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.200000000000003 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.61 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.420000000000002 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.519999999999996 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.239999999999995 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.310000000000002 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.530000000000001 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 64.310000000000002 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 63.439999999999998 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.129999999999995 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 55.100000000000001 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 62.310000000000002 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 71.409999999999997 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.319999999999993 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.329999999999998 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.476 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 72.099999999999994 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 71.409999999999997 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 72.319999999999993 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.409999999999997 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.239999999999995 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.485 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p30 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.409999999999997 109.543 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.310000000000002 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.349999999999994 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.209999999999994 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 72.439999999999998 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 109.193 169.513 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.14 0.495 . . . . 75.349999999999994 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.409999999999997 110.179 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 71.5 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.219999999999999 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 181' ' ' THR . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.129999999999995 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.010000000000005 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 61.240000000000002 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 42.340000000000003 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.319999999999993 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.705 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.010000000000005 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 70.530000000000001 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.010000000000005 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.319999999999993 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.540000000000006 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 63.229999999999997 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.049999999999997 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.836 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.420000000000002 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 35.020000000000003 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.350000000000001 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.329999999999998 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 71.299999999999997 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.230000000000004 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 45.399999999999999 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.455 ' OG1' HG12 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.140000000000001 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.129999999999995 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.200000000000003 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.109999999999999 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.129999999999995 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 70.230000000000004 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.140000000000001 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.651 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 61.530000000000001 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.299999999999997 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 43.43 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.209999999999994 110.823 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.666 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.409999999999997 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG12 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.409999999999997 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 210' ' ' VAL . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.349999999999994 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 210' ' ' VAL . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 109.993 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.400000000000006 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.019999999999996 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.530000000000001 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.120000000000005 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.827 ' HB ' HD11 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.319999999999993 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 64.340000000000003 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 64.120000000000005 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.209999999999994 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.209999999999994 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 52.43 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 73.219999999999999 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.239999999999995 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.340000000000003 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.219999999999999 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.530000000000001 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.109999999999999 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.409999999999997 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 74.420000000000002 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.200000000000003 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.409999999999997 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.999 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.329999999999998 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.666 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.150000000000006 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 55.530000000000001 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.999 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 63.399999999999999 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 72.409999999999997 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.766 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 71.120000000000005 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' OG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.530000000000001 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 51.240000000000002 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 43.329999999999998 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.836 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 64.400000000000006 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.847 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 74.439999999999998 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.030000000000001 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 51.439999999999998 112.068 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . 0.548 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.299999999999997 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.140000000000001 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.430000000000007 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 62.149999999999999 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.662 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 70.450000000000003 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 53.350000000000001 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.430000000000007 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 53.210000000000001 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 71.510000000000005 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.509999999999998 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.149999999999999 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 73.25 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.409999999999997 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 60.0 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.200000000000003 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.239999999999995 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.310000000000002 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.530000000000001 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 64.310000000000002 108.568 173.737 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.055 -0.418 . . . . 63.439999999999998 112.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.95 102.26 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.715 2.277 . . . . 71.129999999999995 112.256 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -110.86 -12.51 14.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.179 -0.464 . . . . 55.100000000000001 110.121 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.74 59.56 4.83 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.904 -0.589 . . . . 62.310000000000002 112.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.0 m -87.24 151.47 23.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.031 -0.359 . . . . 72.239999999999995 110.031 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.33 -53.67 4.67 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.938 -0.648 . . . . 71.409999999999997 112.402 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.5 m 60.94 32.21 19.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.41 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.6 138.92 31.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.631 -0.713 . . . . 72.329999999999998 110.2 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.4 116.53 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.329 0.585 . . . . 72.099999999999994 109.591 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 mtmt -64.44 107.0 1.24 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.82 -1.082 . . . . 74.420000000000002 111.431 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.7 113.8 12.39 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.443 -0.947 . . . . 71.409999999999997 108.443 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.65 165.11 13.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.916 0.389 . . . . 72.319999999999993 110.997 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 143' ' ' ILE . 4.3 mp -95.34 133.25 36.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 71.409999999999997 109.932 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -97.31 121.62 39.42 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.0 -0.28 . . . . 74.239999999999995 110.686 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 m120 39.35 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.398 1.062 . . . . 72.409999999999997 112.723 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -100.98 6.78 43.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.221 -0.659 . . . . 70.310000000000002 109.221 -176.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t 42.91 48.5 5.06 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 124.546 1.154 . . . . 73.349999999999994 110.371 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.24 -43.16 74.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.489 -1.232 . . . . 75.209999999999994 110.827 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.56 139.57 56.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.628 -0.715 . . . . 72.439999999999998 110.481 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.46 11.15 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.057 -0.52 . . . . 63.119999999999997 109.926 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -51.49 135.49 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.496 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.24 103.37 13.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.394 -0.366 . . . . 71.340000000000003 111.783 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.3 m -79.75 101.46 8.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.557 -0.535 . . . . 74.219999999999999 109.557 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -136.59 39.58 1.62 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.483 -0.865 . . . . 54.32 113.027 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -119.83 152.8 36.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.867 0.365 . . . . 61.140000000000001 110.74 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 p -112.53 161.61 25.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 74.340000000000003 111.423 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.96 -178.23 3.4 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.723 2.282 . . . . 72.420000000000002 111.3 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.3 m -76.1 150.05 82.88 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.837 0.351 . . . . 73.439999999999998 110.841 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 16.9 Cg_exo -68.53 143.83 58.6 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.767 2.311 . . . . 72.400000000000006 111.464 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.8 m -58.71 140.82 54.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 54.43 110.26 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.7 m -105.92 -154.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 120.899 0.381 . . . . 51.420000000000002 111.017 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.2 t -125.96 -166.88 1.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.813 -0.631 . . . . 45.240000000000002 109.926 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.69 177.74 11.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.504 -0.316 . . . . 74.409999999999997 110.521 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -69.21 164.58 22.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.294 0.568 . . . . 71.200000000000003 112.442 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -116.14 151.11 36.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.531 -0.759 . . . . 74.420000000000002 110.92 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -110.43 -174.31 2.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 74.120000000000005 110.79 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 5.5 mt 63.88 24.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.82 1.295 . . . . 70.040000000000006 110.39 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.07 -24.41 16.9 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.39 -1.277 . . . . 54.109999999999999 109.961 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.8 m -142.24 -50.2 0.38 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.706 -1.134 . . . . 71.030000000000001 108.776 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 170' ' ' GLU . 8.0 pt-20 -92.11 47.57 1.35 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.724 -1.126 . . . . 73.299999999999997 110.52 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 6.3 t -50.92 155.22 1.24 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.117 -0.947 . . . . 75.109999999999999 112.362 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.3 tt -102.7 153.73 5.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 73.040000000000006 110.236 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -85.47 68.88 10.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.601 0.715 . . . . 72.200000000000003 110.165 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -78.78 -162.06 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.05 -0.977 . . . . 75.349999999999994 111.452 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.6 m -111.89 131.1 22.6 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.58 -0.737 . . . . 73.409999999999997 110.753 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.942 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 84.3 Cg_endo -88.01 166.87 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.059 2.506 . . . . 71.5 112.239 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 1.1 t -160.18 118.59 1.57 Allowed Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.14 -0.689 . . . . 44.219999999999999 109.14 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 1.9 Cg_endo -77.17 1.08 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.553 2.168 . . . . 73.129999999999995 112.714 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -62.96 -33.96 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.143 0.497 . . . . 72.010000000000005 110.013 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 mt -103.16 10.19 37.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.359 -0.837 . . . . 61.240000000000002 109.5 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.915 HG22 ' HG3' ' A' ' 183' ' ' MET . 1.2 m -97.29 141.91 29.82 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.918 -1.037 . . . . 42.340000000000003 111.618 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 201' ' ' ILE . 2.7 p -108.87 92.8 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 122.026 0.917 . . . . 71.319999999999993 109.483 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.915 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -120.47 94.03 4.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 72.010000000000005 110.023 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.9 m -148.26 173.07 13.39 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.583 0.706 . . . . 70.530000000000001 111.313 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.1 tt -145.15 125.12 6.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.913 -1.039 . . . . 70.010000000000005 108.92 173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.0 72.61 0.79 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.729 -0.471 . . . . 73.319999999999993 109.729 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -179.37 90.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.848 -1.069 . . . . 74.540000000000006 110.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m -93.91 57.89 2.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.601 0.715 . . . . 63.229999999999997 109.447 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.462 HG13 ' HD2' ' A' ' 275' ' ' ARG . 98.9 t -151.7 122.67 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.66 -1.155 . . . . 62.049999999999997 108.549 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.1 OUTLIER -134.48 112.52 10.98 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.198 0.523 . . . . 73.420000000000002 110.508 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.5 m -95.5 149.3 35.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 114.836 -1.075 . . . . 35.020000000000003 110.455 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.419 ' HB3' ' H ' ' A' ' 250' ' ' GLY . 20.0 Cg_endo -59.76 99.71 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.578 2.186 . . . . 63.350000000000001 111.645 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.31 -22.35 4.73 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.583 -0.817 . . . . 64.329999999999998 112.627 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.37 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.125 0.462 . . . . 71.299999999999997 110.363 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.1 p -144.06 148.22 34.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.466 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -100.82 129.84 46.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.242 -0.436 . . . . 45.399999999999999 110.102 176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 7.2 m -105.53 114.91 29.36 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.269 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 270' ' ' ILE . 3.9 mp -80.94 131.82 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.212 -0.662 . . . . 72.129999999999995 109.212 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 11.6 m -107.06 108.3 19.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.255 -0.43 . . . . 71.200000000000003 110.865 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.776 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -119.08 113.5 21.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.121 -0.491 . . . . 73.109999999999999 111.141 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 181' ' ' THR . 6.9 mm -110.26 102.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.461 0.648 . . . . 71.129999999999995 110.48 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 HG21 ' A' ' 210' ' ' VAL . 18.3 t -79.41 138.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.639 -0.71 . . . . 70.230000000000004 110.405 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.413 ' N ' ' OG1' ' A' ' 181' ' ' THR . 7.9 tptm -130.44 158.81 38.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.951 -0.759 . . . . 74.340000000000003 108.951 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.942 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 29.0 m-20 -81.19 173.7 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 75.140000000000001 111.042 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.02 -22.08 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.194 -0.912 . . . . 61.530000000000001 110.041 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -93.67 -9.15 38.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 74.299999999999997 110.054 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.3 27.92 24.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.83 -0.7 . . . . 43.43 113.624 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.659 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 44.4 m-80 -100.45 160.15 27.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 117.245 0.523 . . . . 64.209999999999994 109.794 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 20.5 Cg_exo -67.02 112.32 2.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.163 2.575 . . . . 74.409999999999997 112.988 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 HG13 ' A' ' 213' ' ' VAL . 75.6 t -63.53 135.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.473 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.17 -58.66 5.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 75.409999999999997 110.116 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -168.46 149.97 4.96 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.243 0.544 . . . . 75.349999999999994 111.727 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 HG11 ' A' ' 210' ' ' VAL . 32.1 m -133.95 177.56 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.199 -0.91 . . . . 74.319999999999993 108.73 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -97.09 138.65 34.29 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.208 -0.664 . . . . 74.239999999999995 109.208 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 233' ' ' LEU . 61.5 mt -137.81 122.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.903 0.383 . . . . 74.400000000000006 110.103 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -110.25 157.49 19.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 71.019999999999996 109.472 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 230' ' ' TYR . 27.9 mtmm -95.59 154.73 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 111.303 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.959 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 79.2 m -149.69 122.18 8.52 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.689 -0.856 . . . . 74.120000000000005 108.689 173.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.723 HG13 HD11 ' A' ' 256' ' ' ILE . 62.0 t -100.62 114.02 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.18 0.514 . . . . 63.5 111.848 -170.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -100.07 107.33 19.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.859 -0.61 . . . . 73.319999999999993 109.497 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.719 ' HD3' ' H ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -133.31 154.84 50.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 64.340000000000003 110.492 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.57 -33.67 6.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.641 -0.424 . . . . 64.120000000000005 110.458 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -111.81 165.96 11.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 110.416 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.17 0.56 11.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 75.5 109.726 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -72.16 -28.91 63.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.031 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -68.45 147.09 46.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.263 -0.88 . . . . 52.43 112.596 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 94.6 mt -109.79 78.31 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 73.219999999999999 109.082 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 230' ' ' TYR . 0.7 OUTLIER -88.36 116.12 26.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.232 -0.895 . . . . 75.239999999999995 109.734 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 2.0 m-20 -91.38 111.54 23.08 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 109.944 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . 0.776 ' HB3' ' HE3' ' A' ' 217' ' ' LYS . 85.8 m-85 -103.21 102.66 12.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 109.914 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -75.58 178.58 47.7 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.304 -0.95 . . . . 72.219999999999999 111.262 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.09 155.06 42.5 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.322 2.015 . . . . 75.530000000000001 111.122 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.3 tp -72.11 122.8 21.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.163 -0.68 . . . . 72.109999999999999 109.163 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -82.18 115.9 21.49 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.775 0.798 . . . . 75.409999999999997 110.323 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 13.8 tmtt? -105.32 106.65 17.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.798 -1.546 . . . . 74.420000000000002 108.624 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 238' ' ' VAL . 26.5 tt0 -96.48 176.66 5.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.62 -0.718 . . . . 70.200000000000003 110.428 -171.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.465 ' H ' ' HG2' ' A' ' 236' ' ' GLU . 30.3 p30 -80.4 3.62 20.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.174 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 236' ' ' GLU . 1.3 m -86.12 150.26 51.94 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.348 -0.842 . . . . 63.329999999999998 112.019 -173.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 27.4 Cg_endo -63.92 108.03 0.86 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.008 2.472 . . . . 73.150000000000006 113.152 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 71.44 -5.57 10.01 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.776 -0.647 . . . . 55.530000000000001 114.041 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 238' ' ' VAL . 50.9 tttm -84.57 109.97 18.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.519 0.659 . . . . 63.399999999999999 111.769 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.776 ' HB2' HG23 ' A' ' 200' ' ' THR . 96.0 m-85 -109.93 143.24 40.14 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.545 -0.752 . . . . 72.239999999999995 109.25 170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -143.47 138.82 29.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.044 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.795 ' HB2' HD12 ' A' ' 233' ' ' LEU . 9.9 tt0 -140.93 134.87 30.61 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.527 -0.469 . . . . 71.120000000000005 109.918 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.67 115.41 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.353 0.597 . . . . 61.530000000000001 111.412 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.18 120.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.767 -0.651 . . . . 51.240000000000002 109.273 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 6.5 m -105.96 155.76 19.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.625 -0.509 . . . . 43.329999999999998 109.625 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.605 ' HB3' HD12 ' A' ' 190' ' ' LEU . 36.4 t80 -145.53 139.38 26.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.086 0.47 . . . . 64.400000000000006 111.429 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 27.7 mmm-85 -104.85 142.2 35.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.028 -0.73 . . . . 74.439999999999998 109.028 174.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 192' ' ' PRO . . . -76.1 76.98 1.38 Allowed Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.218 -0.515 . . . . 74.030000000000001 113.351 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -105.05 -44.49 4.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.066 0.46 . . . . 51.439999999999998 109.96 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.9 t -126.3 179.86 5.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 2.1 t-20 -138.97 82.89 1.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 71.299999999999997 109.715 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -142.94 -176.79 5.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.65 . . . . 73.140000000000001 110.514 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 255' ' ' ARG . 36.7 mtt180 -105.56 149.54 26.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.711 -0.677 . . . . 72.230000000000004 110.614 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.723 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -142.67 124.85 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.218 -0.66 . . . . 73.430000000000007 109.218 175.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.22 133.55 45.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.023 0.44 . . . . 73.420000000000002 110.427 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.6 mt -109.18 111.75 37.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.79 0.805 . . . . 62.149999999999999 110.342 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.959 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 2.5 m -82.71 112.15 19.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.645 -1.161 . . . . 70.450000000000003 110.039 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.8 m-85 -89.84 112.94 24.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.048 0.451 . . . . 53.350000000000001 110.883 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 267' ' ' THR . 1.2 tmmm? -88.87 106.89 18.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.582 -0.735 . . . . 75.430000000000007 109.064 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.0 m-85 -76.3 -144.81 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.039 0.447 . . . . 53.210000000000001 110.258 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.505 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -62.27 168.18 3.61 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.621 -0.881 . . . . 71.510000000000005 108.621 173.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.37 60.78 0.86 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.495 0.664 . . . . 63.509999999999998 110.307 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 8.6 t -150.4 -51.91 0.14 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.219 -0.9 . . . . 63.149999999999999 110.784 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.24 152.17 48.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.715 0.293 . . . . 73.25 111.184 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 261' ' ' LYS . 23.3 p -134.79 141.36 46.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.577 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 -176.71 3.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 60.0 110.501 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 42.4 tt0 -157.37 136.67 11.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 65.200000000000003 110.45 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -122.18 162.62 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 110.595 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.1 m -112.03 130.03 56.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.163 0.506 . . . . 71.5 111.748 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 256' ' ' ILE . 37.9 mm -118.47 127.82 75.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.243 -0.89 . . . . 71.519999999999996 109.179 173.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -122.74 122.24 38.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.928 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.2 129.42 9.08 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.779 -0.725 . . . . 55.310000000000002 112.681 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 189' ' ' VAL . 22.3 ttt-85 -106.24 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.284 -0.636 . . . . 74.530000000000001 109.284 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.739 -0.648 . . . . 64.310000000000002 109.54 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.231 -0.348 . . . . 63.439999999999998 112.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.81 156.85 39.52 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.704 2.269 . . . . 71.129999999999995 111.803 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -95.48 106.2 18.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.59 -0.522 . . . . 55.100000000000001 109.59 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.9 110.03 3.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.731 -0.747 . . . . 62.310000000000002 112.535 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.4 p -113.52 113.92 25.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.993 0.425 . . . . 72.239999999999995 110.222 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -122.7 169.04 15.06 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.606 -0.807 . . . . 71.409999999999997 111.984 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.5 p -159.33 110.78 2.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.738 0.269 . . . . 73.319999999999993 110.725 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -122.72 157.2 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.489 -0.323 . . . . 72.329999999999998 110.511 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.54 128.42 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 116.013 -0.539 . . . . 72.099999999999994 109.621 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -74.06 95.16 2.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 110.644 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -119.1 99.65 6.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.05 114.84 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.833 -0.622 . . . . 72.319999999999993 110.781 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.97 109.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.003 -0.544 . . . . 71.409999999999997 110.127 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -84.39 111.38 19.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 74.239999999999995 110.187 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.499 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -71.57 131.59 43.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.181 -0.918 . . . . 72.409999999999997 110.358 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -110.14 -16.33 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.935 -0.575 . . . . 70.310000000000002 110.799 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 t -117.34 25.24 10.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.602 0.715 . . . . 73.349999999999994 109.434 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 32.2 t70 -64.86 -43.27 93.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.202 -0.908 . . . . 75.209999999999994 111.15 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -100.35 164.06 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.111 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.71 -69.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.712 0.291 . . . . 63.119999999999997 110.929 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.6 p -155.06 162.73 40.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 111.257 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.66 124.31 45.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.949 -0.569 . . . . 71.340000000000003 110.021 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 p -97.45 146.61 25.05 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 110.671 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.7 139.46 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.781 -0.724 . . . . 54.32 112.251 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -144.11 138.53 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.588 0.233 . . . . 61.140000000000001 110.639 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 22.0 p -101.71 144.32 28.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.9 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 31.3 Cg_exo -62.87 147.98 93.98 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.696 2.264 . . . . 72.420000000000002 112.404 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -99.94 134.95 20.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 73.439999999999998 111.243 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -84.9 178.76 4.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.934 2.423 . . . . 72.400000000000006 112.144 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -140.5 -162.29 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.541 -0.3 . . . . 54.43 110.39 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.77 145.72 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.129 -0.693 . . . . 51.420000000000002 109.129 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.4 t -87.72 172.5 9.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.902 -0.59 . . . . 45.240000000000002 110.753 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -80.62 151.46 29.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 74.409999999999997 110.719 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.01 144.32 48.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.157 -0.474 . . . . 71.200000000000003 110.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 -174.95 4.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.282 -0.417 . . . . 74.420000000000002 110.172 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.493 ' HB3' HD12 ' A' ' 167' ' ' ILE . 2.9 t80 -101.15 164.88 11.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.567 -0.531 . . . . 74.120000000000005 109.567 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.827 HG23 ' HA ' ' A' ' 171' ' ' THR . 4.2 mp 60.82 45.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.298 1.047 . . . . 70.040000000000006 110.638 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.55 -33.79 11.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.16 -0.927 . . . . 54.109999999999999 109.421 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.3 m -137.87 -31.43 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 71.030000000000001 110.331 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.48 -52.21 65.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.572 . . . . 73.299999999999997 111.001 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.827 ' HA ' HG23 ' A' ' 167' ' ' ILE . 34.1 p 41.64 75.32 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.862 -1.063 . . . . 75.109999999999999 111.885 -172.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 174' ' ' ASN . 7.9 tp -100.62 133.9 42.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.83 -1.077 . . . . 73.040000000000006 110.837 -172.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.2 m -86.19 58.43 5.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.401 0.619 . . . . 72.200000000000003 109.978 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 172' ' ' ILE . 2.7 p-10 -82.83 -170.78 3.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.307 -0.86 . . . . 75.349999999999994 111.364 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 7.3 m -109.42 127.37 27.32 Favored Pre-proline 0 N--CA 1.446 -0.651 0 CA-C-N 115.278 -0.873 . . . . 73.409999999999997 110.013 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.6 Cg_endo -72.38 152.73 55.39 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.597 2.198 . . . . 71.5 110.992 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 72.9 m -150.16 98.97 3.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.303 0.573 . . . . 44.219999999999999 110.883 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 49.8 Cg_endo -68.41 -8.02 21.87 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.222 2.615 . . . . 73.129999999999995 113.656 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.55 -35.42 72.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.476 . . . . 72.010000000000005 110.402 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 78.4 mt -100.65 14.37 31.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.72 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER -118.8 179.41 4.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.985 0.421 . . . . 42.340000000000003 111.358 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.26 107.01 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.327 0.584 . . . . 71.319999999999993 110.021 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.801 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.01 65.34 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.549 0.69 . . . . 72.010000000000005 110.94 -175.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 p -128.54 176.47 7.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.696 -0.684 . . . . 70.530000000000001 111.807 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 2.4 tt -138.67 113.05 7.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.638 -0.71 . . . . 70.010000000000005 110.593 177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -108.64 76.06 1.0 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.34 -0.846 . . . . 73.319999999999993 109.53 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 11.6 ptmt -175.11 75.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.277 1.037 . . . . 74.540000000000006 110.501 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.1 m -97.31 52.34 1.12 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.982 -1.008 . . . . 63.229999999999997 110.229 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.76 98.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.834 -1.076 . . . . 62.049999999999997 109.221 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.03 HD21 ' HB2' ' A' ' 196' ' ' ALA . 2.0 mm? -104.8 121.02 42.77 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 111.51 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 m -105.95 149.47 38.09 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.139 -0.937 . . . . 35.020000000000003 110.592 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.9 101.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.994 2.462 . . . . 63.350000000000001 112.216 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.14 -19.56 5.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.719 -0.753 . . . . 64.329999999999998 112.79 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -114.06 -178.57 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.138 0.469 . . . . 71.299999999999997 110.901 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 190' ' ' LEU . 32.6 p -140.23 153.55 46.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.939 0.4 . . . . 70.230000000000004 111.352 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 1.03 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -91.84 117.68 30.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.625 -0.509 . . . . 45.399999999999999 109.625 174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -102.46 106.46 17.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.074 -0.512 . . . . 73.140000000000001 110.448 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 272' ' ' ILE . 4.0 mp -72.91 118.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.598 -0.889 . . . . 72.129999999999995 108.598 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.0 m -91.22 97.02 10.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.061 -0.518 . . . . 71.200000000000003 110.281 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.84 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -112.4 102.57 10.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.509 0.671 . . . . 73.109999999999999 111.348 -175.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 7.0 mm -98.91 139.92 19.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.693 -1.225 . . . . 71.129999999999995 107.693 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.584 HG12 HG21 ' A' ' 210' ' ' VAL . 21.9 t -120.4 129.79 75.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.975 0.417 . . . . 70.230000000000004 111.181 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.1 155.45 39.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.340000000000003 109.317 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 23.3 m-20 -81.13 178.32 8.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.408 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.3 tp -64.41 -19.4 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.744 0.783 . . . . 61.530000000000001 109.948 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -75.47 -25.59 57.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.009 -0.996 . . . . 74.299999999999997 110.616 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.23 56.5 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.059 -1.216 . . . . 43.43 110.059 -168.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 209' ' ' PRO . 4.3 t-20 -92.67 140.77 23.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.613 -0.793 . . . . 64.209999999999994 109.888 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 84.8 Cg_exo -51.17 111.23 0.52 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.292 2.661 . . . . 74.409999999999997 113.887 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 202' ' ' VAL . 99.2 t -67.46 141.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 74.25 110.355 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.9 -65.69 0.65 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.547 -0.538 . . . . 75.409999999999997 109.547 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 210' ' ' VAL . 6.6 mt-10 -160.12 154.69 23.95 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.769 -0.65 . . . . 75.349999999999994 111.354 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.495 HG13 HG11 ' A' ' 210' ' ' VAL . 29.5 m -141.28 149.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.232 -0.895 . . . . 74.319999999999993 108.797 173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 15.9 t60 -72.23 129.34 38.21 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.846 -0.427 . . . . 74.239999999999995 109.846 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 49.6 mt -124.53 105.41 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.173 0.511 . . . . 74.400000000000006 109.922 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.59 145.82 26.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.72 -0.673 . . . . 71.019999999999996 109.866 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.401 ' HE3' ' OE1' ' A' ' 244' ' ' GLN . 36.1 mttp -80.57 155.66 26.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.615 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 97.5 m -153.67 90.98 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.059 -1.089 . . . . 74.120000000000005 108.059 169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 258' ' ' ILE . 35.0 m -93.04 140.3 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.299 0.571 . . . . 63.5 111.571 -170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -122.04 100.52 7.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.449 -0.796 . . . . 73.319999999999993 109.624 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -89.92 115.04 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.411 0.624 . . . . 64.340000000000003 110.98 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -83.67 -10.65 58.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.799 -0.637 . . . . 64.120000000000005 110.444 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 45.2 t-20 -141.09 122.87 15.3 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.852 -0.796 . . . . 64.209999999999994 108.852 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.29 -6.16 56.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.936 0.398 . . . . 75.5 111.241 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -93.18 -0.58 56.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 109.845 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -81.43 130.74 9.9 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.422 -1.071 . . . . 52.43 110.422 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 79.3 mt -88.2 84.59 6.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.536 0.684 . . . . 73.219999999999999 109.586 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.682 -1.144 . . . . 75.239999999999995 109.809 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.82 114.3 27.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.457 0.646 . . . . 72.209999999999994 110.358 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.93 104.46 16.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 110.439 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.53 167.85 53.22 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.363 -0.923 . . . . 72.219999999999999 111.272 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.89 149.99 88.76 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.976 1.784 . . . . 75.530000000000001 111.556 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 244' ' ' GLN . 67.4 tp -72.89 105.54 4.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.4 -0.963 . . . . 72.109999999999999 108.4 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.706 ' HB3' ' O ' ' A' ' 243' ' ' THR . 37.2 tptt -80.35 115.24 19.78 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.032 0.92 . . . . 75.409999999999997 110.756 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 236' ' ' GLU . 3.1 tmmm? -114.22 106.16 14.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.889 -1.505 . . . . 74.420000000000002 108.55 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 8.7 tp10 -90.06 165.55 13.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.857 -0.794 . . . . 70.200000000000003 108.857 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -74.42 74.81 1.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.412 0.625 . . . . 72.409999999999997 109.332 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -141.85 160.53 55.55 Favored Pre-proline 0 N--CA 1.439 -0.99 0 CA-C-N 115.191 -0.913 . . . . 63.329999999999998 110.728 -175.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.907 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 30.0 Cg_endo -64.36 94.97 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.694 2.262 . . . . 73.150000000000006 113.496 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 55.12 23.56 32.8 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-N 115.685 -0.689 . . . . 55.530000000000001 113.865 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.702 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 56.9 tttp -93.21 101.85 14.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.517 0.659 . . . . 63.399999999999999 111.093 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.84 ' HB2' HG23 ' A' ' 200' ' ' THR . 97.9 m-85 -104.7 139.09 40.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.846 . . . . 72.239999999999995 109.388 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.706 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.4 p -139.23 115.2 10.2 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.792 -0.64 . . . . 72.409999999999997 109.706 176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.711 ' HB2' HD12 ' A' ' 233' ' ' LEU . 34.8 tt0 -114.23 133.41 55.64 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.326 -0.549 . . . . 71.120000000000005 110.177 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.78 102.07 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.702 0.763 . . . . 61.530000000000001 111.836 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.55 108.99 18.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.638 -0.875 . . . . 51.240000000000002 108.638 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.5 m -92.2 135.66 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.863 -0.608 . . . . 43.329999999999998 110.31 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' A' ' 190' ' ' LEU . 49.6 t80 -108.65 128.96 55.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.056 0.455 . . . . 64.400000000000006 110.686 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 1.5 tmt_? -97.02 127.92 43.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.593 -0.73 . . . . 74.439999999999998 109.068 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -58.3 92.49 0.04 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.216 -0.516 . . . . 74.030000000000001 113.366 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -132.01 -61.75 0.87 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.184 -0.206 . . . . 51.439999999999998 111.538 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 21.7 t -137.73 142.09 41.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.859 0.361 . . . . 73.120000000000005 111.183 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.2 t-20 -86.55 106.56 17.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.254 -0.43 . . . . 71.299999999999997 111.223 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 2.0 mm-40 -160.5 -174.81 4.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.983 -0.553 . . . . 73.140000000000001 110.581 172.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -117.6 145.4 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.903 -0.59 . . . . 72.230000000000004 110.558 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 272' ' ' ILE . 3.2 tt -121.84 116.26 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.236 -0.653 . . . . 73.430000000000007 109.236 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.34 128.57 44.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.195 -0.669 . . . . 73.420000000000002 109.195 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.488 ' HB ' HD11 ' A' ' 270' ' ' ILE . 65.6 mt -120.8 121.49 65.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.58 0.705 . . . . 62.149999999999999 111.96 -171.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.692 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 4.6 m -87.9 120.04 28.84 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.042 -0.981 . . . . 70.450000000000003 109.536 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.602 ' HB2' ' HD2' ' A' ' 268' ' ' LYS . 12.6 m-85 -100.39 121.77 42.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.562 0.696 . . . . 53.350000000000001 110.947 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 267' ' ' THR . 14.1 mtpt -89.3 110.24 21.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.669 -1.151 . . . . 75.430000000000007 109.986 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' A' ' 268' ' ' LYS . 2.9 m-85 -83.27 -145.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.976 -0.556 . . . . 53.210000000000001 109.688 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 173.13 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.244 -0.435 . . . . 71.510000000000005 110.486 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.97 56.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 110.321 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 58.7 m -149.71 -49.93 0.14 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.833 -0.621 . . . . 63.149999999999999 111.436 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.67 148.91 44.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.007 0.432 . . . . 73.25 111.81 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.53 HG22 ' HG2' ' A' ' 261' ' ' LYS . 37.5 p -121.26 141.97 50.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.5 -0.773 . . . . 73.409999999999997 109.795 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 260' ' ' PHE . 0.0 OUTLIER -127.78 172.05 11.18 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.061 -0.348 . . . . 60.0 110.061 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -147.31 138.92 24.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.924 0.392 . . . . 65.200000000000003 110.824 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.545 HG23 ' HE2' ' A' ' 268' ' ' LYS . 2.2 pp -132.66 164.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 72.420000000000002 110.138 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.7 m -120.72 129.0 53.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 71.5 111.894 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.776 ' HB ' HG23 ' A' ' 256' ' ' ILE . 51.0 mm -113.84 118.03 57.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.417 -0.81 . . . . 71.519999999999996 109.435 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -115.46 118.77 34.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.081 0.467 . . . . 73.239999999999995 111.594 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -85.89 120.49 5.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.658 -0.701 . . . . 55.310000000000002 111.563 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -100.52 105.46 16.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 109.915 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 1.3 tm? . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.708 -0.849 . . . . 64.310000000000002 108.708 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.625 -0.59 . . . . 63.439999999999998 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.0 139.47 12.03 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.502 2.135 . . . . 71.129999999999995 111.927 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.57 177.3 4.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.112 0.482 . . . . 55.100000000000001 110.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.12 72.02 0.47 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 111.669 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.0 m -85.29 117.79 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.186 -0.302 . . . . 72.239999999999995 110.186 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.79 96.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.586 -0.816 . . . . 71.409999999999997 112.215 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 p -131.23 132.5 44.68 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.184 -0.302 . . . . 73.319999999999993 110.184 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.49 133.21 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.976 0.417 . . . . 72.329999999999998 110.145 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.5 mm -97.36 105.28 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 72.099999999999994 111.991 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -117.69 84.92 2.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.864 -0.607 . . . . 74.420000000000002 109.968 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.45 135.97 38.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 109.822 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -113.16 133.9 54.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.482 -0.327 . . . . 72.319999999999993 110.244 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.2 mt -122.67 138.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.96 -0.564 . . . . 71.409999999999997 110.245 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -137.94 162.73 33.3 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.308 -0.256 . . . . 74.239999999999995 110.308 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 19.0 m-80 -59.76 163.63 4.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.636 0.606 . . . . 72.409999999999997 112.636 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.21 -32.2 6.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 70.310000000000002 111.84 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.0 t -132.01 33.69 3.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.257 -1.016 . . . . 73.349999999999994 108.257 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 33.4 t70 -46.41 -48.83 18.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 113.278 -1.783 . . . . 75.209999999999994 113.075 -173.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.555 ' HG3' ' OD2' ' A' ' 148' ' ' ASP . 67.7 mtt -129.77 147.01 51.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.781 -0.368 . . . . 72.439999999999998 111.572 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.9 109.48 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.59 -0.732 . . . . 63.119999999999997 109.9 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 153.88 32.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.59 -0.277 . . . . 74.319999999999993 111.225 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -163.09 127.89 3.05 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.346 -0.388 . . . . 71.340000000000003 110.256 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.7 m -156.94 103.41 2.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.692 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.45 124.19 5.9 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.582 -0.607 . . . . 54.32 111.582 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -84.45 127.71 34.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.862 0.363 . . . . 61.140000000000001 110.893 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.7 p -75.97 126.91 86.34 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.708 -0.678 . . . . 74.340000000000003 111.172 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.67 139.51 7.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.656 2.238 . . . . 72.420000000000002 112.384 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.53 136.62 20.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.116 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.53 177.66 8.53 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.766 2.311 . . . . 72.400000000000006 112.396 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -87.16 156.55 19.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.109 -0.496 . . . . 54.43 110.7 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.28 176.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 109.316 -0.624 . . . . 51.420000000000002 109.316 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 t -92.38 178.57 5.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.44 -0.8 . . . . 45.240000000000002 110.33 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.11 150.3 51.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.359 -0.837 . . . . 74.409999999999997 109.694 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -97.62 -172.03 2.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 71.200000000000003 110.014 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.701 ' HB2' ' HG2' ' A' ' 168' ' ' GLU . 11.8 mm100 -69.55 151.91 45.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.099 0.476 . . . . 74.420000000000002 110.897 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.571 ' HB3' HD12 ' A' ' 167' ' ' ILE . 7.9 m-85 -102.63 152.71 20.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.816 -0.629 . . . . 74.120000000000005 109.823 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.987 HG23 ' HA ' ' A' ' 171' ' ' THR . 3.8 mp 56.76 37.78 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.37 1.081 . . . . 70.040000000000006 110.794 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -107.4 -16.95 14.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.458 -0.792 . . . . 54.109999999999999 109.331 173.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -139.81 -39.12 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.808 -1.087 . . . . 71.030000000000001 109.257 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.19 33.32 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.392 -0.822 . . . . 73.299999999999997 110.675 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.987 ' HA ' HG23 ' A' ' 167' ' ' ILE . 9.1 t -49.5 143.73 6.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 75.109999999999999 112.604 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.19 148.13 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.109 -0.95 . . . . 73.040000000000006 110.146 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -81.92 55.42 2.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 72.200000000000003 110.238 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.22 -173.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 75.349999999999994 111.073 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.1 m -116.78 136.07 23.13 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 73.409999999999997 109.904 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 49.5 Cg_endo -71.52 162.5 42.05 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.447 2.098 . . . . 71.5 111.292 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 18.3 m -155.88 108.03 2.13 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.318 0.58 . . . . 44.219999999999999 110.337 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.951 ' HA ' ' HB ' ' A' ' 181' ' ' THR . 58.7 Cg_endo -74.03 3.51 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.63 2.22 . . . . 73.129999999999995 112.549 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.84 -28.03 69.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 72.010000000000005 109.721 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.9 17.84 21.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 61.240000000000002 109.224 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.951 ' HB ' ' HA ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -106.61 151.03 25.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 42.340000000000003 111.887 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.11 104.84 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.683 -0.689 . . . . 71.319999999999993 109.587 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 181' ' ' THR . 0.0 OUTLIER -135.56 117.34 15.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.324 0.583 . . . . 72.010000000000005 110.86 -176.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.1 t -171.43 -177.5 2.1 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.658 -0.701 . . . . 70.530000000000001 110.474 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.03 118.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.472 -0.936 . . . . 70.010000000000005 108.472 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -92.9 32.92 1.2 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.761 -0.654 . . . . 73.319999999999993 110.787 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -155.74 89.09 1.15 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.939 0.876 . . . . 74.540000000000006 112.995 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 273' ' ' ARG . 58.2 m -84.83 58.35 4.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 63.229999999999997 108.866 168.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 92.3 t -153.42 127.8 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 62.049999999999997 108.483 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -135.7 117.33 14.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.045 0.45 . . . . 73.420000000000002 110.017 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 194' ' ' GLU . 15.6 m -105.13 155.17 38.14 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 114.897 -1.047 . . . . 35.020000000000003 110.231 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.27 105.65 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.77 2.314 . . . . 63.350000000000001 111.93 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.74 5.83 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.31 -0.948 . . . . 64.329999999999998 113.143 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.531 ' HG3' HD13 ' A' ' 190' ' ' LEU . 10.9 pt-20 -94.94 -172.68 2.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.271 0.535 . . . . 71.299999999999997 110.517 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.8 m -147.63 171.12 16.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.58 -0.526 . . . . 70.230000000000004 109.58 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -113.04 115.92 29.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 45.399999999999999 110.248 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -107.2 114.64 28.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 73.140000000000001 109.401 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 272' ' ' ILE . 3.8 mp -79.25 119.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 72.129999999999995 109.711 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 16.7 m -88.26 99.0 11.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.268 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -119.67 113.57 20.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 110.896 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 181' ' ' THR . 9.9 mm -112.69 105.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.637 -0.71 . . . . 71.129999999999995 110.659 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.611 HG12 HG21 ' A' ' 210' ' ' VAL . 11.9 t -85.84 136.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 70.230000000000004 110.821 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.413 ' H ' ' HG1' ' A' ' 181' ' ' THR . 1.9 tptp -124.05 152.72 42.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.51 -0.922 . . . . 74.340000000000003 108.51 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 17.3 m-20 -80.87 174.18 11.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.665 -0.494 . . . . 75.140000000000001 109.665 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -60.9 -33.31 55.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.954 -0.566 . . . . 61.530000000000001 110.932 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.86 -8.29 58.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.055 0.455 . . . . 74.299999999999997 110.641 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.4 4.02 56.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 43.43 112.096 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.4 159.58 57.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 122.348 0.259 . . . . 64.209999999999994 111.004 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 2.7 Cg_exo -77.47 103.47 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.048 2.499 . . . . 74.409999999999997 112.044 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG12 ' A' ' 202' ' ' VAL . 21.0 t -56.48 128.97 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.14 0.495 . . . . 74.25 111.507 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -78.22 -57.64 3.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.9 -0.591 . . . . 75.409999999999997 110.004 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.681 ' HA ' ' OH ' ' A' ' 242' ' ' TYR . 12.6 pt-20 -151.6 133.88 15.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.396 0.617 . . . . 75.349999999999994 111.685 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG13 HG11 ' A' ' 210' ' ' VAL . 16.6 m -123.18 -172.91 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 74.319999999999993 109.156 172.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 263' ' ' ALA . 46.2 t60 -95.46 131.61 41.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.329 -0.619 . . . . 74.239999999999995 109.329 175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 28.4 mt -131.9 102.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.789 -0.449 . . . . 74.400000000000006 109.789 172.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.757 ' HB3' ' HB2' ' A' ' 261' ' ' LYS . 1.6 t30 -84.0 137.68 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 71.019999999999996 110.083 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 217' ' ' LYS . 17.0 mmmt -86.92 100.7 12.77 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.431 -0.804 . . . . 73.530000000000001 111.358 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 259' ' ' SER . 97.8 m -124.29 124.54 42.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.767 -0.651 . . . . 74.120000000000005 109.488 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 258' ' ' ILE . 28.7 m -118.26 141.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.29 0.566 . . . . 63.5 111.726 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.79 94.52 3.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.512 -0.767 . . . . 73.319999999999993 109.972 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -94.04 141.74 28.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 64.340000000000003 110.378 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -83.44 -32.04 26.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.28 0.562 . . . . 64.120000000000005 110.086 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.508 HD21 ' HD3' ' A' ' 225' ' ' LYS . 48.0 t30 -136.6 170.36 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.44 -0.578 . . . . 64.209999999999994 109.44 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -131.83 13.52 4.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 75.5 111.498 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 223' ' ' ASN . 29.9 mtpp -87.13 -9.57 54.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.063 0.459 . . . . 73.209999999999994 110.276 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' A' ' 254' ' ' GLU . . . -85.99 -173.44 49.34 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.841 -0.695 . . . . 52.43 112.192 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 79.1 mt -131.76 97.19 4.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 73.219999999999999 109.938 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 49.9 m95 -96.76 110.83 23.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 75.239999999999995 109.977 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.1 t0 -96.39 140.5 30.95 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.127 -0.694 . . . . 72.209999999999994 109.127 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . 0.58 ' HD1' HD12 ' A' ' 246' ' ' ILE . 78.1 m-85 -122.67 112.73 18.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.823 -0.626 . . . . 73.340000000000003 110.595 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -79.44 166.17 50.83 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.023 -1.231 . . . . 72.219999999999999 110.023 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.91 143.99 68.71 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.203 1.935 . . . . 75.530000000000001 111.29 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.9 tp -61.53 107.3 0.77 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.987 -0.746 . . . . 72.109999999999999 108.987 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -75.88 113.24 13.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.623 0.725 . . . . 75.409999999999997 109.482 -179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -99.2 106.8 19.0 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.86 -1.064 . . . . 74.420000000000002 108.559 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.682 ' HB3' HG22 ' A' ' 238' ' ' VAL . 20.0 tt0 -94.26 159.62 15.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.863 -1.062 . . . . 70.200000000000003 109.429 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -78.1 63.3 3.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.932 0.872 . . . . 72.409999999999997 110.62 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 ' HE3' ' A' ' 241' ' ' LYS . 0.5 OUTLIER -134.17 163.34 51.89 Favored Pre-proline 0 N--CA 1.44 -0.932 0 CA-C-N 114.443 -1.253 . . . . 63.329999999999998 110.225 -177.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.701 ' HB3' ' HB3' ' A' ' 209' ' ' PRO . 43.0 Cg_endo -69.55 93.36 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.35 2.033 . . . . 73.150000000000006 113.26 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.38 56.36 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.382 -0.827 . . . . 55.530000000000001 113.98 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.724 ' HE3' HG21 ' A' ' 238' ' ' VAL . 29.0 ttpp -89.32 102.86 15.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.699 0.749 . . . . 63.399999999999999 110.944 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.681 ' OH ' ' HA ' ' A' ' 212' ' ' GLU . 84.1 m-85 -104.04 136.94 42.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.193 -0.669 . . . . 72.239999999999995 109.193 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 7.9 p -139.62 118.03 12.12 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.935 0.397 . . . . 72.409999999999997 111.108 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.682 ' HB2' HD12 ' A' ' 233' ' ' LEU . 44.1 tt0 -123.99 136.17 54.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 71.120000000000005 109.236 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.7 121.67 48.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.423 0.63 . . . . 61.530000000000001 111.226 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.58 HD12 ' HD1' ' A' ' 230' ' ' TYR . 24.1 mm -101.22 114.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.421 -0.809 . . . . 51.240000000000002 109.002 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 20.7 m -103.33 109.79 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.135 0.493 . . . . 43.329999999999998 110.735 -175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.531 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 25.9 t80 -88.21 133.75 33.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.144 -0.48 . . . . 64.400000000000006 110.496 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 15.0 mmm180 -105.38 132.71 51.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.731 . . . . 74.439999999999998 109.025 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -65.39 85.13 0.08 OUTLIER Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.309 -0.472 . . . . 74.030000000000001 113.866 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -116.45 -43.4 2.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.86 0.362 . . . . 51.439999999999998 110.5 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 254' ' ' GLU . 34.0 t -156.99 145.82 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.261 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.742 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 2.0 t-20 -75.47 103.62 5.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 71.299999999999997 110.11 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 1.7 mm-40 -124.89 163.0 23.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 73.140000000000001 111.375 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.51 131.53 54.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 72.230000000000004 110.191 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.527 HG23 ' HB ' ' A' ' 272' ' ' ILE . 7.1 tt -131.5 137.4 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 73.430000000000007 110.65 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.84 116.42 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.955 -0.566 . . . . 73.420000000000002 109.532 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 270' ' ' ILE . 55.3 mt -97.12 123.82 49.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.374 0.607 . . . . 62.149999999999999 110.673 -177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 218' ' ' THR . 21.5 m -94.22 89.67 6.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.411 -0.813 . . . . 70.450000000000003 110.034 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.434 ' HE1' ' HD2' ' A' ' 217' ' ' LYS . 16.3 m-85 -77.51 105.07 8.41 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 122.08 0.943 . . . . 53.350000000000001 109.937 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.757 ' HB2' ' HB3' ' A' ' 216' ' ' ASN . 79.7 mttt -81.12 120.21 24.55 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.962 -1.472 . . . . 75.430000000000007 110.717 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -75.68 -154.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.341 -0.845 . . . . 53.210000000000001 110.462 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 214' ' ' HIS . . . -60.53 165.4 3.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 71.510000000000005 109.142 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 57.3 mtp -72.44 58.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.235 0.54 . . . . 63.509999999999998 111.125 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.8 t -150.81 -35.42 0.15 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.479 -0.782 . . . . 63.149999999999999 109.776 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 159.58 42.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 73.25 110.862 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 261' ' ' LYS . 21.4 p -138.06 164.11 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.737 -0.21 . . . . 73.409999999999997 111.454 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.592 ' HD3' ' H ' ' A' ' 269' ' ' GLU . 5.5 tmtt? -140.28 158.34 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.643 0.258 . . . . 60.0 110.498 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.592 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 34.5 tt0 -141.61 122.28 14.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.509 . . . . 65.200000000000003 109.672 174.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.8 pp -109.93 167.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.721 -0.672 . . . . 72.420000000000002 111.22 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.6 p -113.98 132.03 56.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.898 -0.592 . . . . 71.5 111.692 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 198' ' ' ILE . 67.4 mt -133.57 120.87 39.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 71.519999999999996 110.063 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 188' ' ' SER . 8.6 ttm180 -114.06 120.95 42.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 110.67 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.47 95.15 1.66 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.144 -1.183 . . . . 55.310000000000002 110.144 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -79.77 108.1 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 110.648 -167.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 6.2 tt . . . . . 0 C--O 1.247 0.957 0 N-CA-C 108.628 -0.878 . . . . 64.310000000000002 108.628 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.086 -0.406 . . . . 63.439999999999998 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 -33.91 83.14 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.858 2.372 . . . . 71.129999999999995 112.707 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.2 tm? 61.97 89.76 0.08 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.551 0.691 . . . . 55.100000000000001 110.753 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.08 120.1 1.4 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.456 -0.793 . . . . 62.310000000000002 111.288 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.0 t -142.89 -178.44 5.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.901 0.351 . . . . 72.239999999999995 110.17 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.25 -118.89 3.24 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.783 -0.722 . . . . 71.409999999999997 111.668 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 p 46.88 74.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.666 0.787 . . . . 73.319999999999993 112.47 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.74 153.64 34.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.614 . . . . 72.329999999999998 109.417 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.6 tp -141.6 125.69 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.269 0.556 . . . . 72.099999999999994 110.633 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -93.41 111.3 22.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 110.906 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.06 158.09 16.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.155 -0.683 . . . . 71.409999999999997 109.155 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.98 133.41 21.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.947 0.403 . . . . 72.319999999999993 111.035 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.6 pt -100.14 172.2 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 71.409999999999997 109.834 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.92 151.48 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.719 0.295 . . . . 74.239999999999995 110.947 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -57.14 136.08 56.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 111.756 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.59 -4.14 2.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.601 -0.727 . . . . 70.310000000000002 111.142 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 24.56 2.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.696 0.76 . . . . 73.349999999999994 109.368 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -85.05 8.54 17.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.898 -1.046 . . . . 75.209999999999994 111.489 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 51.5 ttp -88.12 120.4 29.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.31 -0.405 . . . . 72.439999999999998 110.4 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -119.58 -150.45 0.46 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 t -150.15 179.26 8.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 109.982 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.23 -177.32 3.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.017 0.437 . . . . 71.340000000000003 111.286 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.6 m -99.22 -171.35 2.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.921 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.01 153.76 25.52 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.729 -0.949 . . . . 54.32 110.729 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -115.49 159.74 20.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.959 0.409 . . . . 61.140000000000001 111.522 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.7 p -88.4 128.81 51.73 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 74.340000000000003 111.267 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.53 115.54 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.419 2.079 . . . . 72.420000000000002 112.297 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 26.2 m -81.43 145.08 54.53 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 73.439999999999998 110.503 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 158' ' ' VAL . 8.2 Cg_exo -72.04 155.86 56.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.867 2.378 . . . . 72.400000000000006 112.388 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -82.62 178.84 8.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.525 . . . . 54.43 110.412 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.27 112.86 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.756 0.789 . . . . 51.420000000000002 111.554 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.1 m -111.6 148.56 33.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.066 -0.97 . . . . 45.240000000000002 109.428 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG3' ' H ' ' A' ' 164' ' ' PHE . 12.1 pt-20 -80.4 -60.75 2.2 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 111.46 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.589 ' H ' ' HG3' ' A' ' 163' ' ' GLU . 94.7 m-85 -138.1 153.59 49.27 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.308 -0.256 . . . . 71.200000000000003 110.308 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -137.46 -166.37 1.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.654 -0.498 . . . . 74.420000000000002 109.654 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -84.83 -168.98 2.42 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.85 -0.426 . . . . 74.120000000000005 109.85 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.905 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 4.2 mt 65.16 36.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.208 1.004 . . . . 70.040000000000006 109.857 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' A' ' 169' ' ' THR . 2.2 pt-20 -114.11 86.85 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.003 -0.999 . . . . 54.109999999999999 109.853 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 39.9 m 80.73 -39.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.191 -0.913 . . . . 71.030000000000001 108.901 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.85 71.67 0.86 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.432 1.111 . . . . 73.299999999999997 109.057 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.905 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 29.8 p -55.37 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.215 -1.811 . . . . 75.109999999999999 113.582 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.76 151.61 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.365 -0.834 . . . . 73.040000000000006 110.615 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.2 m -83.43 62.4 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 110.416 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.7 -173.22 4.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 75.349999999999994 110.799 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.6 m -112.05 134.7 21.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 73.409999999999997 109.806 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.6 Cg_endo -75.46 160.88 38.19 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.721 2.281 . . . . 71.5 112.546 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.74 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 35.8 t -143.0 99.87 5.46 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.18 0.514 . . . . 44.219999999999999 109.782 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 56.3 Cg_endo -71.32 -10.15 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.618 2.212 . . . . 73.129999999999995 113.114 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.49 -28.55 70.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.744 0.783 . . . . 72.010000000000005 109.661 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.3 mt -105.1 17.32 24.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.733 -1.121 . . . . 61.240000000000002 110.377 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -124.45 177.8 5.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 42.340000000000003 111.107 -178.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.3 p -130.43 107.88 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 71.319999999999993 110.319 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.808 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -129.9 76.17 1.7 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.42 0.629 . . . . 72.010000000000005 110.231 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 m -145.19 177.23 8.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.553 -0.749 . . . . 70.530000000000001 110.731 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -133.46 125.22 49.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.109 -0.496 . . . . 70.010000000000005 110.437 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.15 64.89 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.604 0.716 . . . . 73.319999999999993 110.183 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -169.41 78.4 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.627 176.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 36.1 m -87.82 55.27 3.41 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.198 -0.91 . . . . 63.229999999999997 109.738 178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.573 HG13 ' HG3' ' A' ' 275' ' ' ARG . 95.3 t -153.41 111.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.424 -1.262 . . . . 62.049999999999997 108.24 -175.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 196' ' ' ALA . 0.2 OUTLIER -128.79 118.59 23.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.273 0.559 . . . . 73.420000000000002 111.138 -177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.3 m -108.4 153.26 42.13 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 114.874 -1.057 . . . . 35.020000000000003 110.678 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.657 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 39.2 Cg_exo -59.35 89.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.084 2.523 . . . . 63.350000000000001 112.274 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.85 -29.42 1.02 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.729 -0.748 . . . . 64.329999999999998 112.08 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.47 -177.87 3.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.506 -0.477 . . . . 71.299999999999997 110.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 p -140.33 147.58 40.07 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 70.230000000000004 110.651 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -90.98 115.66 28.17 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.136 -0.484 . . . . 45.399999999999999 109.75 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.8 m -104.07 112.31 25.25 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.832 -0.622 . . . . 73.140000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.62 HG12 HD13 ' A' ' 270' ' ' ILE . 4.2 mp -76.42 119.86 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.411 -0.588 . . . . 72.129999999999995 109.411 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 21.4 m -86.65 98.02 10.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.1 -0.5 . . . . 71.200000000000003 109.897 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.3 t -116.67 102.1 9.15 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.937 0.875 . . . . 73.109999999999999 110.576 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 8.0 mm -106.44 139.85 26.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.359 -1.292 . . . . 71.129999999999995 108.556 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.593 HG12 HG21 ' A' ' 210' ' ' VAL . 6.3 t -115.16 133.48 61.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.782 -0.367 . . . . 70.230000000000004 110.533 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -120.85 149.89 41.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.22 -0.659 . . . . 74.340000000000003 109.22 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 32.6 m-20 -76.99 178.14 7.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.045 0.45 . . . . 75.140000000000001 111.241 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.74 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 8.4 tp -57.72 -35.42 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.339 -0.846 . . . . 61.530000000000001 113.102 -171.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.74 10.5 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.115 0.483 . . . . 74.299999999999997 111.209 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.01 46.64 3.83 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.929 -0.653 . . . . 43.43 113.25 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 204' ' ' ASP . 87.3 m-20 -108.98 167.3 9.34 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.861 -0.199 . . . . 64.209999999999994 110.74 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 239' ' ' PRO . 4.9 Cg_exo -78.53 107.32 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.809 2.34 . . . . 74.409999999999997 112.152 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 213' ' ' VAL . 72.3 t -60.94 131.75 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.189 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -58.13 -58.8 6.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 75.409999999999997 109.783 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -176.0 146.92 0.72 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.256 0.551 . . . . 75.349999999999994 111.398 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 210' ' ' VAL . 27.4 m -122.51 -179.15 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.206 -0.906 . . . . 74.319999999999993 108.595 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -105.22 130.01 53.47 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.497 -0.557 . . . . 74.239999999999995 109.497 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 70.3 mt -127.0 110.32 22.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.355 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.9 t30 -98.15 165.19 12.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.006 -0.739 . . . . 71.019999999999996 109.006 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.705 ' HD2' HE22 ' A' ' 244' ' ' GLN . 38.0 mtpt -101.52 161.1 13.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.44 0.638 . . . . 73.530000000000001 112.009 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 52.7 m -160.06 94.35 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.347 -1.297 . . . . 74.120000000000005 108.865 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.35 132.57 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.239 0.542 . . . . 63.5 111.47 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.51 103.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 110.003 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 256' ' ' ILE . 81.8 mtm180 -93.47 123.18 36.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.949 -0.569 . . . . 64.340000000000003 110.573 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.27 -29.29 53.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.917 -0.771 . . . . 64.120000000000005 108.917 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.471 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 46.2 t30 -152.42 151.84 31.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.027 -0.988 . . . . 64.209999999999994 108.482 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.6 pt? -125.07 12.81 8.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.29 0.478 . . . . 75.5 112.29 -169.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -63.05 -17.86 62.71 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.687 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 251' ' ' HIS . . . -90.15 176.65 42.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.615 -0.802 . . . . 52.43 112.789 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 251' ' ' HIS . 77.4 mt -103.26 106.24 16.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.3 -0.63 . . . . 73.219999999999999 109.3 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.637 ' HH2' ' HB2' ' A' ' 254' ' ' GLU . 5.2 m95 -108.68 113.03 25.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.94 -0.573 . . . . 75.239999999999995 110.889 -172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 24.6 t70 -109.43 143.64 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.536 -0.542 . . . . 72.209999999999994 109.536 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -128.19 106.52 9.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.434 -173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.83 155.91 50.05 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.395 -0.907 . . . . 72.219999999999999 111.189 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 146.07 78.84 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.226 1.951 . . . . 75.530000000000001 111.985 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 244' ' ' GLN . 41.6 tp -63.0 114.48 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 72.109999999999999 109.816 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 243' ' ' THR . 0.0 OUTLIER -78.72 114.47 17.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.522 0.677 . . . . 75.409999999999997 109.305 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 242' ' ' TYR . 14.7 tmtt? -109.49 103.46 12.36 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.48 -1.236 . . . . 74.420000000000002 108.605 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.589 ' HG3' ' CG2' ' A' ' 238' ' ' VAL . 6.4 pt-20 -107.64 161.26 15.03 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.061 -0.972 . . . . 70.200000000000003 110.535 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -78.39 85.83 4.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 72.409999999999997 110.613 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.673 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -145.29 169.1 10.43 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.461 -1.245 . . . . 63.329999999999998 109.175 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 238' ' ' VAL . 44.5 Cg_endo -68.62 79.24 0.65 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.55 2.167 . . . . 73.150000000000006 113.555 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 66.66 20.91 70.55 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.279 -0.873 . . . . 55.530000000000001 113.642 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.673 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 60.6 tttt -92.4 123.93 36.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.632 0.716 . . . . 63.399999999999999 111.213 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.745 ' HB2' HG23 ' A' ' 200' ' ' THR . 56.3 m-85 -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 173.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 1.1 p -144.4 125.03 14.05 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.603 -0.439 . . . . 72.409999999999997 111.045 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.705 HE22 ' HD2' ' A' ' 217' ' ' LYS . 34.4 tt0 -122.24 132.24 54.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.455 -0.338 . . . . 71.120000000000005 110.09 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.65 113.27 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.57 0.7 . . . . 61.530000000000001 111.467 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 38.4 mm -98.17 123.53 50.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.81 -0.632 . . . . 51.240000000000002 109.57 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 9.6 m -114.03 111.58 21.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.833 0.349 . . . . 43.329999999999998 111.106 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 17.0 m-30 -111.76 142.02 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.966 0.412 . . . . 64.400000000000006 111.056 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 6.3 mmm180 -104.21 145.27 30.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.128 -0.693 . . . . 74.439999999999998 109.128 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.657 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -71.13 77.23 0.57 Allowed Glycine 0 C--O 1.229 -0.184 0 O-C-N 123.361 0.413 . . . . 74.030000000000001 112.996 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.606 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 6.7 t-80 -110.92 -33.59 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.345 -0.613 . . . . 51.439999999999998 109.345 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 26.5 t -155.48 140.92 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.332 -0.849 . . . . 73.120000000000005 109.893 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 3.8 t30 -90.81 102.87 15.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.227 -0.442 . . . . 71.299999999999997 109.846 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.637 ' HB2' ' HH2' ' A' ' 228' ' ' TRP . 69.2 mm-40 -142.45 177.67 8.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.437 0.636 . . . . 73.140000000000001 112.25 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.5 mtm-85 -117.82 145.06 44.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.67 -1.15 . . . . 72.230000000000004 109.385 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -145.44 120.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.385 0.612 . . . . 73.430000000000007 109.444 176.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.6 135.07 36.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.018 -0.537 . . . . 73.420000000000002 109.701 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 270' ' ' ILE . 64.1 mt -115.83 117.33 55.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.435 0.636 . . . . 62.149999999999999 110.693 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.811 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 15.0 m -86.16 107.55 17.92 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.295 -0.866 . . . . 70.450000000000003 109.698 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -87.4 111.39 21.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.289 0.566 . . . . 53.350000000000001 110.196 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 85.5 tttt -75.86 105.88 7.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.226 -0.897 . . . . 75.430000000000007 109.949 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.8 m-85 -75.74 -157.04 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.024 -0.535 . . . . 53.210000000000001 110.433 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -62.69 170.55 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 71.510000000000005 110.601 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtp -73.31 55.78 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.318 0.58 . . . . 63.509999999999998 110.405 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 59.8 m -151.47 -46.08 0.11 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.521 -0.763 . . . . 63.149999999999999 110.496 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.62 171.27 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 73.25 109.988 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 13.4 p -143.79 179.13 7.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.566 -0.161 . . . . 73.409999999999997 110.566 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 269' ' ' GLU . 3.8 tmtp? -148.5 149.53 31.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.598 -0.519 . . . . 60.0 109.598 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.707 ' N ' ' HD3' ' A' ' 268' ' ' LYS . 35.2 tt0 -128.37 128.7 45.01 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.863 -0.421 . . . . 65.200000000000003 109.863 176.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.64 HD11 ' HB ' ' A' ' 258' ' ' ILE . 1.9 pp -115.56 160.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.868 -0.605 . . . . 72.420000000000002 110.456 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 57.5 m -111.56 131.68 55.08 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.183 -0.462 . . . . 71.5 110.955 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 256' ' ' ILE . 47.9 mm -114.99 129.04 71.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.735 -0.666 . . . . 71.519999999999996 109.531 176.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.0 ttt180 -123.16 119.07 29.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.817 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.37 135.92 14.44 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.822 -0.911 . . . . 55.310000000000002 110.822 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.573 ' HG3' HG13 ' A' ' 189' ' ' VAL . 2.8 tmt_? -112.23 103.59 11.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.981 0.419 . . . . 74.530000000000001 110.197 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 1.021 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.708 -0.678 . . . . 64.310000000000002 109.861 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 CA-C-O 119.988 -0.34 . . . . 63.439999999999998 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 151.19 86.66 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.171 2.581 . . . . 71.129999999999995 113.025 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.18 -165.59 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 55.100000000000001 109.347 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.34 -32.97 2.65 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.629 -0.796 . . . . 62.310000000000002 112.742 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 t 55.62 68.72 0.82 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.336 0.589 . . . . 72.239999999999995 110.274 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.22 -162.24 15.73 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.699 -0.682 . . . . 71.409999999999997 112.743 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.5 t -91.51 144.57 25.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.692 -0.485 . . . . 73.319999999999993 109.692 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 41.5 mtmt -111.82 -163.73 0.87 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 72.329999999999998 110.673 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.8 mm -132.66 123.85 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 72.099999999999994 111.038 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 18.4 ptmt -128.51 149.15 50.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 74.420000000000002 109.713 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.8 144.03 46.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.982 -0.377 . . . . 71.409999999999997 109.982 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -84.76 135.96 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.019 0.438 . . . . 72.319999999999993 110.271 178.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -72.58 127.26 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.614 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -78.65 152.86 31.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.049 -0.523 . . . . 74.239999999999995 110.229 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 148' ' ' ASP . 2.2 p30 -86.36 145.66 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.396 0.617 . . . . 72.409999999999997 111.753 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.39 -21.96 1.76 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.056 -0.975 . . . . 70.310000000000002 109.84 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -111.76 20.75 16.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.312 0.577 . . . . 73.349999999999994 110.067 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' ASN . 25.4 t70 -73.88 -23.51 59.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 75.209999999999994 110.419 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.1 mmt -69.94 150.4 46.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 72.439999999999998 110.301 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -139.32 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.244 -0.435 . . . . 63.119999999999997 110.596 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -120.23 -177.65 3.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.282 -0.417 . . . . 74.319999999999993 110.601 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.18 -163.21 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 71.340000000000003 110.145 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 t -78.78 175.46 10.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.206 -0.294 . . . . 74.219999999999999 110.206 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.7 -149.52 9.45 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.94 -0.647 . . . . 54.32 112.292 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.75 176.08 7.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.659 0.266 . . . . 61.140000000000001 110.434 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 8.2 t -121.99 139.77 30.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.8 0.334 . . . . 74.340000000000003 110.908 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 3.0 Cg_exo -76.86 173.16 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.952 2.435 . . . . 72.420000000000002 111.264 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.4 t -112.17 107.52 55.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.461 -0.336 . . . . 73.439999999999998 110.624 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.28 115.42 2.52 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.984 2.456 . . . . 72.400000000000006 112.09 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 m -81.56 176.89 9.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.509 -0.768 . . . . 54.43 110.876 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 162' ' ' SER . 9.4 p -141.67 -170.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.354 -0.98 . . . . 51.420000000000002 108.354 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.801 ' H ' HG22 ' A' ' 161' ' ' VAL . 8.5 t -81.38 -167.31 1.42 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.941 0.4 . . . . 45.240000000000002 110.098 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.35 -54.03 2.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.995 -0.548 . . . . 74.409999999999997 111.577 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -142.68 160.06 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.855 -0.424 . . . . 71.200000000000003 109.855 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.48 165.77 22.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.552 -0.536 . . . . 74.420000000000002 109.552 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -93.76 176.58 6.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.247 0.546 . . . . 74.120000000000005 111.121 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.807 HG23 HG23 ' A' ' 171' ' ' THR . 2.5 mp 58.65 67.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.841 -1.072 . . . . 70.040000000000006 111.231 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.43 -31.72 2.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.463 -1.244 . . . . 54.109999999999999 108.887 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 90.4 m -148.49 -36.36 0.19 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.729 -1.578 . . . . 71.030000000000001 107.387 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.03 68.7 5.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.836 -1.075 . . . . 73.299999999999997 109.074 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.807 HG23 HG23 ' A' ' 167' ' ' ILE . 30.0 m -75.91 151.09 37.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.532 -1.213 . . . . 75.109999999999999 110.603 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.1 tt -58.89 142.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.843 -0.429 . . . . 73.040000000000006 109.843 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.3 m -84.78 68.55 10.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.687 0.756 . . . . 72.200000000000003 110.356 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.86 -164.59 1.09 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.821 -1.081 . . . . 75.349999999999994 110.919 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.3 m -110.39 137.01 20.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.409999999999997 110.095 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.829 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.1 Cg_endo -75.32 164.14 33.31 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.407 2.071 . . . . 71.5 111.966 173.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 22.9 t -157.38 103.03 1.85 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.979 0.418 . . . . 44.219999999999999 110.119 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 35.9 Cg_endo -67.74 -8.7 23.19 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.764 2.309 . . . . 73.129999999999995 113.144 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.83 -34.02 67.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.36 0.6 . . . . 72.010000000000005 110.332 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.7 mt -101.82 8.56 41.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.325 -0.852 . . . . 61.240000000000002 110.906 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.2 t -114.2 -179.75 3.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.192 0.52 . . . . 42.340000000000003 112.112 -172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.97 109.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.402 -0.817 . . . . 71.319999999999993 110.312 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -130.47 91.15 3.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.282 0.563 . . . . 72.010000000000005 110.123 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.3 m -137.19 177.09 8.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.559 0.695 . . . . 70.530000000000001 111.963 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 198' ' ' ILE . 1.7 tt -155.25 123.29 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.711 -1.131 . . . . 70.010000000000005 108.85 173.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.07 35.71 4.02 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.588 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 187' ' ' LYS . 18.9 ptmt -137.78 87.55 2.26 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.117 0.961 . . . . 74.540000000000006 111.567 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 43.9 m -95.71 62.87 2.36 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.848 -1.069 . . . . 63.229999999999997 109.345 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 275' ' ' ARG . 6.0 p -173.26 105.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.003 -0.999 . . . . 62.049999999999997 109.636 -174.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -119.86 121.93 40.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.003 -0.544 . . . . 73.420000000000002 111.301 -171.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -101.68 149.95 36.89 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.967 -1.015 . . . . 35.020000000000003 111.493 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HG3' ' H ' ' A' ' 250' ' ' GLY . 51.1 Cg_exo -55.51 104.0 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.033 2.488 . . . . 63.350000000000001 112.234 176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.72 -28.15 3.79 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.363 -0.923 . . . . 64.329999999999998 112.374 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -104.84 -175.49 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 71.299999999999997 110.317 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.402 ' C ' HD21 ' A' ' 190' ' ' LEU . 35.0 p -141.58 154.9 45.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.087 -0.506 . . . . 70.230000000000004 110.686 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -101.03 116.16 32.2 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.562 . . . . 45.399999999999999 109.484 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 3.9 m -106.66 113.28 26.69 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.888 -0.596 . . . . 73.140000000000001 109.926 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.565 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -76.56 117.9 22.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.01 -0.737 . . . . 72.129999999999995 109.01 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.4 m -86.25 95.37 9.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.419 0.628 . . . . 71.200000000000003 110.155 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -106.77 105.54 15.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.532 -0.758 . . . . 73.109999999999999 111.084 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.5 mm -99.83 142.85 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.25 -1.019 . . . . 71.129999999999995 108.25 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 210' ' ' VAL . 11.6 t -121.83 135.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 70.230000000000004 110.298 176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -120.39 151.94 38.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.347 -0.612 . . . . 74.340000000000003 109.347 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 12.3 m-20 -77.68 175.86 9.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.05 0.452 . . . . 75.140000000000001 110.865 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 10.6 tp -64.69 -18.53 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.62 0.724 . . . . 61.530000000000001 109.964 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.6 -24.41 29.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.325 -0.852 . . . . 74.299999999999997 110.011 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.34 12.09 39.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.895 -0.669 . . . . 43.43 112.295 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.61 165.74 21.78 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.678 0.275 . . . . 64.209999999999994 111.476 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.708 ' HB3' ' CB ' ' A' ' 239' ' ' PRO . 36.2 Cg_exo -61.71 109.61 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.297 2.665 . . . . 74.409999999999997 112.607 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 202' ' ' VAL . 11.4 t -60.76 136.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 74.25 111.593 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -73.4 -55.17 6.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.374 -0.83 . . . . 75.409999999999997 110.798 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -156.44 143.57 18.92 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.085 0.469 . . . . 75.349999999999994 112.226 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.566 HG13 HG11 ' A' ' 210' ' ' VAL . 16.9 m -143.53 151.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.034 -1.098 . . . . 74.319999999999993 108.034 170.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -85.85 119.19 25.9 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.097 -0.334 . . . . 74.239999999999995 110.097 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 61.4 mt -117.86 115.91 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.175 0.512 . . . . 74.400000000000006 110.921 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.89 152.77 21.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 71.019999999999996 109.447 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.545 ' HD3' ' OE1' ' A' ' 244' ' ' GLN . 28.1 mtmm -87.66 152.09 22.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.43 . . . . 73.530000000000001 111.408 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 259' ' ' SER . 54.3 m -153.35 96.07 2.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 74.120000000000005 109.553 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 258' ' ' ILE . 27.4 m -94.71 139.06 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 63.5 112.064 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -124.1 102.76 7.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.29 -0.868 . . . . 73.319999999999993 109.966 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.62 HH11 ' HD1' ' A' ' 228' ' ' TRP . 25.3 ptt180 -129.34 152.72 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 64.340000000000003 111.281 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -108.54 -18.28 13.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.772 -0.649 . . . . 64.120000000000005 110.862 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 254' ' ' GLU . 44.3 t-20 -111.21 121.89 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.093 -0.503 . . . . 64.209999999999994 110.769 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -106.82 -8.09 16.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 75.5 111.198 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.67 -34.95 74.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.234 0.54 . . . . 73.209999999999994 109.577 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.457 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -64.08 136.76 40.53 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.196 -0.911 . . . . 52.43 111.949 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 249' ' ' ARG . 72.2 mt -84.11 83.67 7.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.226 0.536 . . . . 73.219999999999999 109.762 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.62 ' HD1' HH11 ' A' ' 221' ' ' ARG . 13.1 m95 -94.67 122.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.057 -0.974 . . . . 75.239999999999995 109.852 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -112.99 133.2 55.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.484 0.659 . . . . 72.209999999999994 110.488 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -125.97 114.69 18.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.955 -1.021 . . . . 73.340000000000003 110.172 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.62 -177.04 41.42 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.407 -0.902 . . . . 72.219999999999999 111.72 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.94 166.25 30.12 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.617 2.211 . . . . 75.530000000000001 111.332 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' A' ' 244' ' ' GLN . 55.1 tp -82.06 116.82 21.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.767 -0.457 . . . . 72.109999999999999 109.767 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 243' ' ' THR . 22.7 tptp -82.21 111.05 17.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.845 0.831 . . . . 75.409999999999997 110.481 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -110.8 118.83 37.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.472 -1.24 . . . . 74.420000000000002 109.398 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -110.55 168.86 9.14 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.171 -0.678 . . . . 70.200000000000003 109.171 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -78.78 73.34 5.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.659 0.743 . . . . 72.409999999999997 110.337 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -132.58 157.7 77.62 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.575 -1.193 . . . . 63.329999999999998 109.319 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.708 ' CB ' ' HB3' ' A' ' 209' ' ' PRO . 37.3 Cg_endo -65.22 91.59 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.462 2.108 . . . . 73.150000000000006 113.292 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 60.41 14.95 36.7 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.486 -0.779 . . . . 55.530000000000001 113.695 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 39.5 ttpt -92.26 120.42 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.84 0.82 . . . . 63.399999999999999 111.366 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 200' ' ' THR . 76.6 m-85 -117.67 143.09 46.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.285 -0.87 . . . . 72.239999999999995 109.271 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 15.2 p -138.2 134.53 34.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.229 -0.442 . . . . 72.409999999999997 110.553 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.692 ' HB2' HD12 ' A' ' 233' ' ' LEU . 36.1 tt0 -138.76 122.7 17.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.49 -0.559 . . . . 71.120000000000005 109.49 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.9 m -92.0 102.59 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.671 0.748 . . . . 61.530000000000001 111.488 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.86 117.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.576 -0.738 . . . . 51.240000000000002 109.238 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.7 m -105.75 123.36 47.82 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.967 -0.293 . . . . 43.329999999999998 110.273 -172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.686 ' HB2' HD12 ' A' ' 190' ' ' LEU . 13.0 m-30 -121.41 149.35 43.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.668 0.747 . . . . 64.400000000000006 112.269 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 227' ' ' LEU . 2.5 tmt_? -115.68 116.01 27.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.646 -1.161 . . . . 74.439999999999998 107.872 170.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.534 ' H ' ' HG3' ' A' ' 192' ' ' PRO . . . -63.82 85.49 0.06 OUTLIER Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.296 -0.478 . . . . 74.030000000000001 112.607 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -107.78 -45.13 4.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 51.439999999999998 110.06 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -130.08 147.51 51.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.61 -0.723 . . . . 73.120000000000005 110.033 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 276' ' ' LEU . 3.1 t-20 -100.25 104.64 16.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 111.376 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 223' ' ' ASN . 0.0 OUTLIER -156.26 173.49 16.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 110.626 172.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -101.88 163.07 12.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 111.359 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.524 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -151.49 129.4 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.028 -0.987 . . . . 73.430000000000007 108.674 173.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -108.05 133.63 52.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.028 -0.36 . . . . 73.420000000000002 110.028 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.684 ' HB ' HD11 ' A' ' 270' ' ' ILE . 58.9 mt -112.77 118.13 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.119 0.485 . . . . 62.149999999999999 110.803 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 218' ' ' THR . 8.7 t -92.97 111.33 22.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.011 -0.737 . . . . 70.450000000000003 109.011 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -86.36 116.57 24.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.561 0.696 . . . . 53.350000000000001 110.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.474 ' HA ' HG22 ' A' ' 267' ' ' THR . 3.0 tptp -81.73 100.15 9.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.843 -1.071 . . . . 75.430000000000007 109.632 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 11.7 m-85 -76.59 -152.6 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.803 -0.635 . . . . 53.210000000000001 109.532 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -60.24 160.76 7.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.526 -0.546 . . . . 71.510000000000005 109.526 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 24.9 mmt -74.04 56.84 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.568 0.699 . . . . 63.509999999999998 110.593 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 23.1 t -145.7 -44.59 0.21 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.114 -0.948 . . . . 63.149999999999999 109.943 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -149.72 155.82 40.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.831 -0.622 . . . . 73.25 110.476 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 261' ' ' LYS . 19.1 p -134.7 172.82 12.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.479 -0.328 . . . . 73.409999999999997 111.148 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -147.41 147.07 29.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 60.0 110.364 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.36 135.14 54.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.964 -0.562 . . . . 65.200000000000003 110.782 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.0 pp -121.78 159.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.673 -0.694 . . . . 72.420000000000002 110.193 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.1 m -109.66 132.61 53.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.241 -0.436 . . . . 71.5 111.225 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 256' ' ' ILE . 41.1 mm -121.8 141.85 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.255 -0.43 . . . . 71.519999999999996 110.007 177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 57.5 ttt180 -140.88 127.14 19.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 73.239999999999995 110.796 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.77 141.28 20.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.956 -0.64 . . . . 55.310000000000002 111.964 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 189' ' ' VAL . 40.2 ttt180 -95.01 102.51 14.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 74.530000000000001 110.258 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 253' ' ' ASN . 2.9 tm? . . . . . 0 C--O 1.248 1.001 0 N-CA-C 109.213 -0.662 . . . . 64.310000000000002 109.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.853 -0.499 . . . . 63.439999999999998 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.24 123.25 11.55 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.892 2.395 . . . . 71.129999999999995 112.31 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.02 106.48 18.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 55.100000000000001 110.897 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.08 120.73 5.75 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.238 -0.745 . . . . 62.310000000000002 111.238 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -138.86 135.63 34.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.978 0.389 . . . . 72.239999999999995 110.615 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -103.46 154.3 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.869 -0.681 . . . . 71.409999999999997 112.107 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.8 m -115.63 128.87 56.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.566 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -82.63 97.96 8.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 109.934 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 32.6 pt -99.67 -174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 116.093 -0.503 . . . . 72.099999999999994 110.13 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -115.28 119.46 36.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.763 -0.653 . . . . 74.420000000000002 110.451 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -86.33 87.05 7.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.035 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 104.33 11.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.208 -0.664 . . . . 72.319999999999993 109.208 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.872 HD13 ' H ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -66.96 105.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.504 0.668 . . . . 71.409999999999997 111.278 -177.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -84.77 154.14 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.415 -0.812 . . . . 74.239999999999995 110.681 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.501 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 3.2 p30 -75.02 163.95 27.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.463 -0.789 . . . . 72.409999999999997 110.413 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.42 9.89 15.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.213 -1.032 . . . . 70.310000000000002 108.213 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.1 t 42.63 44.1 3.54 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 114.517 -1.22 . . . . 73.349999999999994 110.147 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.33 13.66 0.89 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.458 -1.247 . . . . 75.209999999999994 112.438 -173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.2 ttp -62.25 119.16 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.931 -0.396 . . . . 72.439999999999998 109.931 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.38 84.03 5.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.557 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.3 m -96.32 11.01 36.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.49 -0.777 . . . . 74.319999999999993 110.451 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 160.37 28.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.62 . . . . 71.340000000000003 110.98 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.4 t -162.48 156.35 20.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.258 -0.645 . . . . 74.219999999999999 109.258 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.73 -161.35 37.35 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.021 -0.609 . . . . 54.32 111.842 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -139.04 -173.34 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.4 . . . . 61.140000000000001 111.493 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 2.4 p -76.99 144.0 71.46 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 74.340000000000003 111.853 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 156' ' ' THR . 6.0 Cg_exo -79.5 178.56 7.24 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.516 2.81 . . . . 72.420000000000002 112.11 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.0 139.4 34.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.125 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.37 165.91 30.71 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.665 2.243 . . . . 72.400000000000006 111.936 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.9 m -116.53 135.35 53.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.588 -0.278 . . . . 54.43 110.405 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -163.29 137.26 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.289 -0.414 . . . . 51.420000000000002 110.023 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -134.99 151.4 50.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.156 -0.475 . . . . 45.240000000000002 110.329 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 112.63 18.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.941 -0.572 . . . . 74.409999999999997 110.423 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -97.28 151.18 20.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.535 -0.543 . . . . 71.200000000000003 109.535 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -69.25 123.25 20.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 74.420000000000002 111.007 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 167' ' ' ILE . 13.4 t80 -155.94 148.11 23.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 74.120000000000005 109.753 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.847 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 8.8 mt 67.38 27.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 122.511 1.148 . . . . 70.040000000000006 110.737 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 170' ' ' GLU . 5.5 pt-20 -125.78 95.34 4.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.076 -0.966 . . . . 54.109999999999999 109.091 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m 80.88 -24.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.077 -1.419 . . . . 71.030000000000001 109.424 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 168' ' ' GLU . 8.2 pt-20 -123.99 57.8 1.19 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.172 -0.922 . . . . 73.299999999999997 110.464 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 8.9 t -65.86 164.05 15.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.704 -0.68 . . . . 75.109999999999999 110.801 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.11 127.97 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.371 0.605 . . . . 73.040000000000006 110.999 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 m -85.31 64.75 8.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.517 0.675 . . . . 72.200000000000003 109.806 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.3 -167.8 1.98 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.061 -0.972 . . . . 75.349999999999994 110.92 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 25.3 m -122.54 139.55 31.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 73.409999999999997 110.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 4.9 Cg_exo -75.58 157.53 40.31 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.801 2.334 . . . . 71.5 111.42 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 205' ' ' ILE . 26.7 t -151.48 100.72 2.95 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.134 0.492 . . . . 44.219999999999999 110.11 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.539 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 48.9 Cg_endo -69.43 -9.6 26.65 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.648 2.232 . . . . 73.129999999999995 112.164 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -54.36 -33.19 58.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.453 -0.794 . . . . 72.010000000000005 110.523 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.06 22.02 14.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.361 -0.836 . . . . 61.240000000000002 110.734 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 1.3 t -121.25 -178.58 3.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.974 0.416 . . . . 42.340000000000003 111.488 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.24 102.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.61 0.719 . . . . 71.319999999999993 110.107 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -126.99 80.13 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.817 -0.629 . . . . 72.010000000000005 110.463 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.4 m -144.81 166.2 25.93 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.731 -0.668 . . . . 70.530000000000001 111.176 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 187' ' ' LYS . 0.9 OUTLIER -128.72 110.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.311 -0.858 . . . . 70.010000000000005 109.316 174.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -98.58 54.39 1.05 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.452 -0.795 . . . . 73.319999999999993 110.882 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 185' ' ' ILE . 17.2 ptmt -158.53 98.61 1.54 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.891 0.853 . . . . 74.540000000000006 111.613 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.786 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 19.5 m -86.59 58.47 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.96 0.886 . . . . 63.229999999999997 108.851 173.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.655 HG13 ' NE ' ' A' ' 275' ' ' ARG . 53.1 t -140.52 113.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.35 -1.296 . . . . 62.049999999999997 110.853 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -138.9 137.15 36.24 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 110.613 175.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 194' ' ' GLU . 15.9 m -144.51 159.75 50.37 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.943 -0.571 . . . . 35.020000000000003 110.264 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 191' ' ' SER . 48.3 Cg_endo -68.82 11.09 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.892 2.394 . . . . 63.350000000000001 112.711 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -135.89 13.07 4.18 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.914 -0.584 . . . . 64.329999999999998 111.682 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 191' ' ' SER . 16.1 pt-20 -150.33 173.33 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.668 -0.493 . . . . 71.299999999999997 109.668 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.6 m -149.83 143.03 25.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.59 0.233 . . . . 70.230000000000004 110.467 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.43 123.42 32.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.281 -0.418 . . . . 45.399999999999999 110.341 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.2 m -102.6 105.72 16.26 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.098 -0.704 . . . . 73.140000000000001 109.098 173.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 272' ' ' ILE . 3.7 mp -69.31 119.8 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.13 -0.693 . . . . 72.129999999999995 109.13 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -88.58 95.6 10.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.929 -0.578 . . . . 71.200000000000003 110.401 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 0.1 OUTLIER -106.59 102.98 12.32 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 110.614 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 241' ' ' LYS . 11.0 mm -100.54 139.41 22.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.372 -0.973 . . . . 71.129999999999995 108.372 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 213' ' ' VAL . 21.4 t -116.68 138.13 48.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.961 0.41 . . . . 70.230000000000004 110.459 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 181' ' ' THR . 5.6 tptm -120.56 151.58 39.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.699 . . . . 74.340000000000003 109.111 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 25.7 m-20 -84.15 176.0 9.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.574 -0.45 . . . . 75.140000000000001 110.049 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 177' ' ' SER . 9.6 tp -64.95 -28.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.649 -0.705 . . . . 61.530000000000001 111.199 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.61 -6.66 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.812 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.4 ' O ' ' HE2' ' A' ' 203' ' ' LYS . . . 88.18 18.64 55.26 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.712 -0.756 . . . . 43.43 111.736 -175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 71.5 m-20 -80.21 158.81 71.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.181 -0.303 . . . . 64.209999999999994 110.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 5.6 Cg_exo -75.84 106.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.785 2.323 . . . . 74.409999999999997 111.19 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 202' ' ' VAL . 71.7 t -57.18 140.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.879 -177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.39 -56.54 10.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.944 -0.571 . . . . 75.409999999999997 110.041 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.7 150.18 3.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.034 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 202' ' ' VAL . 27.0 m -129.94 160.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 109.787 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 34.6 t-80 -68.44 134.32 49.98 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.49 -0.559 . . . . 74.239999999999995 109.49 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' LYS . 29.8 mt -144.71 119.07 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 74.400000000000006 110.813 173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.3 t30 -110.29 161.26 15.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.748 -0.66 . . . . 71.019999999999996 109.223 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.597 ' HG2' ' HE1' ' A' ' 260' ' ' PHE . 52.9 mtmt -101.35 151.77 21.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.233 0.539 . . . . 73.530000000000001 111.532 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 63.1 m -143.05 113.46 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.846 -1.07 . . . . 74.120000000000005 109.122 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 256' ' ' ILE . 56.6 t -98.38 117.33 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.001 0.429 . . . . 63.5 111.272 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -120.37 134.2 55.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 73.319999999999993 109.376 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -131.14 150.07 52.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.51 -0.314 . . . . 64.340000000000003 111.425 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 255' ' ' ARG . 51.1 mt-10 -94.89 -29.4 14.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.264 0.554 . . . . 64.120000000000005 110.12 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.4 HD21 ' HD3' ' A' ' 225' ' ' LYS . 54.5 t30 -161.56 155.86 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.609 -0.723 . . . . 64.209999999999994 109.917 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -108.46 10.3 27.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.966 0.358 . . . . 75.5 111.966 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 223' ' ' ASN . 44.5 mtpt -66.35 -20.68 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.387 . . . . 73.209999999999994 110.767 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.68 148.77 19.68 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.761 -0.733 . . . . 52.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.2 mt -112.17 108.61 17.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.206 -0.664 . . . . 73.219999999999999 109.206 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.604 ' HZ2' ' HB2' ' A' ' 254' ' ' GLU . 29.2 m95 -105.72 133.74 49.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.864 -0.607 . . . . 75.239999999999995 110.802 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 3.0 t70 -99.09 135.98 39.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.605 -0.887 . . . . 72.209999999999994 108.605 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -128.55 118.16 22.53 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.119 0.415 . . . . 73.340000000000003 112.119 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.92 148.37 24.52 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.675 -1.37 . . . . 72.219999999999999 109.675 165.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 233' ' ' LEU . 35.5 Cg_exo -56.53 -77.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.408 2.072 . . . . 75.530000000000001 111.667 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 244' ' ' GLN . 30.8 tp 178.89 112.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.604 -0.887 . . . . 72.109999999999999 108.604 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 243' ' ' THR . 17.0 tptm -78.63 118.51 20.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 109.926 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.457 ' HG2' ' CE1' ' A' ' 242' ' ' TYR . 13.4 tmtt? -95.58 92.89 6.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.566 -1.197 . . . . 74.420000000000002 108.88 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.446 ' HB3' HG22 ' A' ' 238' ' ' VAL . 9.3 tp10 -82.46 150.09 27.24 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.055 -0.975 . . . . 70.200000000000003 109.999 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.52 69.9 8.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.62 0.724 . . . . 72.409999999999997 109.439 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -135.65 162.55 56.38 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.828 -1.078 . . . . 63.329999999999998 110.172 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 39.9 Cg_endo -67.11 95.3 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 73.150000000000006 112.655 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.67 59.63 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.233 -0.894 . . . . 55.530000000000001 114.141 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 1.8 ttmp? -96.97 116.24 28.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.786 0.793 . . . . 63.399999999999999 111.423 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 235' ' ' LYS . 93.3 m-85 -106.87 146.34 31.08 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.115 -0.698 . . . . 72.239999999999995 109.115 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 10.0 p -142.35 137.67 30.68 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.439 -0.504 . . . . 72.409999999999997 110.95 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 233' ' ' LEU . 0.1 OUTLIER -146.75 149.7 33.91 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.388 -0.597 . . . . 71.120000000000005 109.388 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.43 120.76 56.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.375 0.607 . . . . 61.530000000000001 111.159 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 28.2 mm -107.0 121.19 59.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.638 -0.875 . . . . 51.240000000000002 108.638 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.7 m -109.87 161.02 15.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.466 -0.334 . . . . 43.329999999999998 110.262 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.492 ' HB3' HD12 ' A' ' 190' ' ' LEU . 30.3 t80 -126.53 133.14 51.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.736 0.303 . . . . 64.400000000000006 110.339 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 4.3 mmm180 -98.95 130.31 45.31 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.285 -1.006 . . . . 74.439999999999998 108.285 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -64.55 85.76 0.07 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.236 -0.507 . . . . 74.030000000000001 113.126 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -122.58 -48.77 2.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.59 0.234 . . . . 51.439999999999998 110.978 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 159.39 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 110.456 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.476 HD22 ' C ' ' A' ' 253' ' ' ASN . 0.2 OUTLIER -92.71 88.15 6.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 71.299999999999997 110.086 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.604 ' HB2' ' HZ2' ' A' ' 228' ' ' TRP . 44.6 mm-40 -113.67 176.5 5.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.354 -0.384 . . . . 73.140000000000001 110.009 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.43 ' HB2' ' OE1' ' A' ' 222' ' ' GLU . 43.7 mtm180 -122.73 136.08 54.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.426 -0.583 . . . . 72.230000000000004 109.426 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.08 140.91 47.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.479 -0.563 . . . . 73.430000000000007 109.479 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.557 ' N ' HD13 ' A' ' 256' ' ' ILE . 16.3 t70 -121.32 129.98 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.354 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.479 ' HB ' HD11 ' A' ' 270' ' ' ILE . 4.9 mp -114.16 117.29 55.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.556 0.693 . . . . 62.149999999999999 110.099 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 12.8 m -94.47 110.56 22.34 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.334 -0.848 . . . . 70.450000000000003 110.191 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.597 ' HE1' ' HG2' ' A' ' 217' ' ' LYS . 18.1 m-85 -84.1 124.56 31.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.676 0.751 . . . . 53.350000000000001 111.018 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 215' ' ' ILE . 4.2 ttmp? -89.7 93.93 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.406 -0.815 . . . . 75.430000000000007 109.366 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 266' ' ' PHE . 10.0 m-85 -70.74 -151.5 0.02 OUTLIER 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.64 0.587 . . . . 53.210000000000001 111.109 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -56.69 158.48 4.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.749 -0.659 . . . . 71.510000000000005 110.023 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 83.3 mmm -67.4 8.75 0.29 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.27 0.557 . . . . 63.509999999999998 111.644 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 263' ' ' ALA . 50.4 m -101.41 -35.47 9.19 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.46 -0.791 . . . . 63.149999999999999 110.724 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -156.66 153.82 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.951 -178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 28.9 p -127.91 169.06 14.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.599 -0.273 . . . . 73.409999999999997 110.601 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 260' ' ' PHE . 23.5 tptm -163.97 139.52 6.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.86 0.838 . . . . 60.0 110.915 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 259' ' ' SER . 0.6 OUTLIER -119.13 166.83 12.43 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 114.281 -1.327 . . . . 65.200000000000003 111.454 -171.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 198' ' ' ILE . 2.6 pp -143.66 162.58 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.667 -0.697 . . . . 72.420000000000002 110.313 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.7 m -119.94 143.68 47.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.367 . . . . 71.5 111.436 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 198' ' ' ILE . 43.4 mm -122.42 129.95 74.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 71.519999999999996 110.053 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.786 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 36.3 ttt180 -124.69 119.09 27.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 111.059 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.93 134.12 12.75 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.742 -0.663 . . . . 55.310000000000002 112.301 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.655 ' NE ' HG13 ' A' ' 189' ' ' VAL . 50.1 mtm180 -91.01 114.02 26.43 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.809 0.338 . . . . 74.530000000000001 110.616 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.247 0.937 0 N-CA-C 108.322 -0.992 . . . . 64.310000000000002 108.322 170.725 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.672 -0.571 . . . . 63.439999999999998 111.672 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 131' ' ' GLY . 34.1 Cg_endo -64.7 159.25 46.17 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 71.129999999999995 111.606 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -111.12 -58.69 2.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 55.100000000000001 110.208 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.86 112.41 0.44 Allowed Glycine 0 C--N 1.312 -0.785 0 CA-C-N 114.82 -1.082 . . . . 62.310000000000002 111.282 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.4 m -103.87 106.81 17.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 72.239999999999995 111.455 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.87 131.21 23.21 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.448 -0.882 . . . . 71.409999999999997 111.487 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -85.02 98.98 10.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.067 0.46 . . . . 73.319999999999993 110.599 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -132.52 153.33 51.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 72.329999999999998 110.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 38.2 pt -136.65 157.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 72.099999999999994 110.219 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -117.42 153.89 32.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 74.420000000000002 110.166 175.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.96 146.47 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 110.206 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.18 139.86 30.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.906 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.0 tt -97.92 132.69 42.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 71.409999999999997 109.596 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -106.75 155.64 19.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.665 0.269 . . . . 74.239999999999995 110.84 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 6.7 m-80 -69.36 164.48 22.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 72.409999999999997 110.803 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.84 5.38 35.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.495 -0.557 . . . . 70.310000000000002 109.495 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.69 67.3 0.52 Allowed 'General case' 0 C--O 1.233 0.202 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 110.537 -170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.99 -20.42 66.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.796 -1.093 . . . . 75.209999999999994 110.728 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.6 tpt -55.58 138.34 47.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.536 -0.756 . . . . 72.439999999999998 110.7 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.81 127.58 7.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.715 -0.476 . . . . 63.119999999999997 109.715 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.5 m -62.84 137.69 58.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 110.273 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -102.86 -162.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 71.340000000000003 111.331 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.7 m -76.42 174.03 10.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 110.612 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -111.33 -160.79 16.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.67 -0.776 . . . . 54.32 112.13 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.27 -173.04 2.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.178 -0.304 . . . . 61.140000000000001 110.178 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.7 t -127.97 140.52 38.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.579 -0.282 . . . . 74.340000000000003 110.627 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 165.45 25.98 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.678 2.252 . . . . 72.420000000000002 112.194 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.77 161.25 72.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 73.439999999999998 111.121 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.25 179.61 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.958 2.439 . . . . 72.400000000000006 113.071 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -69.0 179.03 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 54.43 112.198 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.34 117.15 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.408 -0.814 . . . . 51.420000000000002 108.991 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.0 m -68.03 158.22 33.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 45.240000000000002 111.935 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.94 126.58 32.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.594 -0.73 . . . . 74.409999999999997 111.061 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -99.38 178.84 4.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.35 -0.386 . . . . 71.200000000000003 110.031 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.49 128.51 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.994 0.425 . . . . 74.420000000000002 110.326 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -102.17 179.7 4.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.602 0.715 . . . . 74.120000000000005 112.696 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 2.6 mt 59.33 30.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 114.188 -1.369 . . . . 70.040000000000006 112.277 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.03 -8.27 5.99 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.075 -0.966 . . . . 54.109999999999999 108.872 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.8 m -137.27 -68.29 0.48 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.57 -1.196 . . . . 71.030000000000001 108.132 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.38 70.67 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.955 0.883 . . . . 73.299999999999997 110.014 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 9.0 t -64.7 179.0 0.69 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.364 -1.289 . . . . 75.109999999999999 111.263 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.6 tt -103.6 138.68 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 110.878 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -83.43 63.72 7.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.491 0.662 . . . . 72.200000000000003 109.459 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -81.03 -165.13 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.006 -0.997 . . . . 75.349999999999994 111.654 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.4 m -115.24 126.38 27.87 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 115.352 -0.84 . . . . 73.409999999999997 109.961 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 72.4 Cg_endo -80.49 165.39 20.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.958 2.438 . . . . 71.5 112.572 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.617 ' HB3' ' HA ' ' A' ' 205' ' ' ILE . 43.5 t -165.03 112.56 0.84 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 44.219999999999999 110.144 174.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HA ' ' CG2' ' A' ' 181' ' ' THR . 42.9 Cg_endo -71.59 -9.01 24.34 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.622 2.214 . . . . 73.129999999999995 112.62 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.26 0.553 . . . . 72.010000000000005 110.316 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 41.9 mt -109.76 16.81 21.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.338 -0.846 . . . . 61.240000000000002 111.053 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.656 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.7 t -110.57 -176.01 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.374 -0.531 . . . . 42.340000000000003 111.114 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -128.76 106.72 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.523 0.678 . . . . 71.319999999999993 110.04 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -136.83 71.37 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.666 -0.697 . . . . 72.010000000000005 109.813 -178.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.5 m -134.09 170.15 16.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.683 0.754 . . . . 70.530000000000001 111.548 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.58 139.22 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.797 -1.092 . . . . 70.010000000000005 109.064 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -126.78 76.63 1.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.412 . . . . 73.319999999999993 110.19 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -178.8 92.45 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.4 -0.818 . . . . 74.540000000000006 111.369 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 29.4 m -85.51 56.28 3.89 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.165 -1.05 . . . . 63.229999999999997 108.165 169.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.4 HG22 HH11 ' A' ' 275' ' ' ARG . 97.4 t -148.79 107.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.177 -1.374 . . . . 62.049999999999997 109.386 -168.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.541 ' HG ' ' CD2' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -123.12 115.25 21.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.218 0.532 . . . . 73.420000000000002 109.899 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.1 m -103.67 150.0 37.67 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 114.832 -1.076 . . . . 35.020000000000003 110.172 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.7 97.98 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.563 2.175 . . . . 63.350000000000001 111.637 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.22 -18.15 4.74 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.702 -0.761 . . . . 64.329999999999998 112.668 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.71 169.5 8.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.479 0.639 . . . . 71.299999999999997 110.894 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.6 m -134.56 135.32 42.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 70.230000000000004 110.122 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' H ' HD21 ' A' ' 190' ' ' LEU . . . -77.93 121.89 24.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 45.399999999999999 109.967 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.1 m -108.97 111.09 22.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 109.797 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.53 HG12 HD13 ' A' ' 270' ' ' ILE . 4.1 mp -78.06 119.55 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.248 -0.649 . . . . 72.129999999999995 109.248 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.8 m -83.9 98.52 9.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.056 -0.52 . . . . 71.200000000000003 110.017 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.0 OUTLIER -114.33 111.01 20.8 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.523 0.678 . . . . 73.109999999999999 111.021 -176.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.7 mm -110.14 144.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 107.818 -1.178 . . . . 71.129999999999995 107.818 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 210' ' ' VAL . 22.0 t -117.92 129.68 73.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 70.230000000000004 110.487 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 181' ' ' THR . 32.2 mmtp -117.72 165.4 13.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 74.340000000000003 109.701 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 44.2 m-20 -74.91 176.61 6.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.419 0.628 . . . . 75.140000000000001 111.269 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 9.7 tp -66.6 -16.89 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.613 -1.176 . . . . 61.530000000000001 109.497 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -100.27 -5.5 27.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.206 -0.907 . . . . 74.299999999999997 110.576 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.94 21.49 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.821 -0.704 . . . . 43.43 112.792 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.727 ' HB2' ' OD2' ' A' ' 204' ' ' ASP . 77.6 m-20 -103.81 167.62 9.82 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.652 -0.499 . . . . 64.209999999999994 109.652 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 4.7 Cg_exo -78.36 113.96 3.44 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.808 2.338 . . . . 74.409999999999997 112.886 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 212' ' ' GLU . 97.2 t -69.08 142.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.163 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.618 ' ND2' ' HG2' ' A' ' 212' ' ' GLU . 9.1 t30 -58.74 -56.29 24.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.892 -0.595 . . . . 75.409999999999997 109.869 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.618 ' HG2' ' ND2' ' A' ' 211' ' ' ASN . 14.3 pt-20 -177.8 162.62 1.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.351 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.34 -169.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 74.319999999999993 110.3 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 6.0 t60 -108.25 137.44 46.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.972 -0.751 . . . . 74.239999999999995 108.972 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.3 mt -132.68 117.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.231 0.538 . . . . 74.400000000000006 111.207 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.48 124.31 45.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.381 -0.827 . . . . 71.019999999999996 109.638 178.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.54 ' HD3' ' HE1' ' A' ' 260' ' ' PHE . 1.1 mmmp? -77.23 116.02 17.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.479 . . . . 73.530000000000001 111.293 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 259' ' ' SER . 57.0 m -131.69 138.93 48.9 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.14 -0.689 . . . . 74.120000000000005 109.14 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 256' ' ' ILE . 26.2 m -130.58 151.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.52 . . . . 63.5 111.678 -176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.88 109.37 6.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 110.057 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -83.6 147.31 27.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.071 -0.513 . . . . 64.340000000000003 111.627 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.27 -21.21 18.58 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.526 -0.916 . . . . 64.120000000000005 108.526 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 254' ' ' GLU . 15.1 t-20 -163.38 178.99 7.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.908 -1.145 . . . . 64.209999999999994 107.908 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.02 16.96 2.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.059 0.762 . . . . 75.5 113.059 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -75.11 -9.54 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 73.209999999999994 110.957 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -98.79 148.25 18.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.7 -0.762 . . . . 52.43 111.906 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 2.9 mm? -86.94 102.37 14.3 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.784 -0.45 . . . . 73.219999999999999 109.784 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.61 ' HA ' ' CD1' ' A' ' 248' ' ' TYR . 8.4 m95 -93.32 118.58 31.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 75.239999999999995 110.272 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.53 146.14 35.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 72.209999999999994 110.05 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -128.32 112.53 14.55 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 111.079 -174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -78.45 162.91 49.78 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.609 -0.996 . . . . 72.219999999999999 110.609 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.43 149.09 68.56 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.365 2.044 . . . . 75.530000000000001 111.819 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.769 HD12 ' HB2' ' A' ' 244' ' ' GLN . 34.6 tp -64.33 113.55 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.88 -0.415 . . . . 72.109999999999999 109.88 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 243' ' ' THR . 14.5 tptp -84.33 111.27 19.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.684 0.754 . . . . 75.409999999999997 110.299 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.66 118.34 33.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.724 -1.125 . . . . 74.420000000000002 108.386 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.451 ' HB3' HG22 ' A' ' 238' ' ' VAL . 28.1 tt0 -106.32 158.45 16.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.286 -0.635 . . . . 70.200000000000003 109.286 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -75.24 74.09 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.409 0.623 . . . . 72.409999999999997 110.396 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -144.95 156.17 55.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.961 -1.018 . . . . 63.329999999999998 110.266 -177.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 24.7 Cg_endo -62.01 98.43 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.107 2.538 . . . . 73.150000000000006 113.488 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 57.9 21.19 43.91 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.479 -0.782 . . . . 55.530000000000001 114.151 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 85.9 tttt -97.62 124.63 41.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.434 0.617 . . . . 63.399999999999999 111.48 -176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.611 ' HB2' HG23 ' A' ' 200' ' ' THR . 87.1 m-85 -122.58 148.79 44.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 72.239999999999995 109.547 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.8 p -142.65 121.91 13.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 72.409999999999997 110.202 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.769 ' HB2' HD12 ' A' ' 233' ' ' LEU . 46.4 tt0 -127.89 136.3 51.19 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.241 -0.584 . . . . 71.120000000000005 110.176 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.4 120.93 48.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.437 0.637 . . . . 61.530000000000001 111.016 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.08 121.77 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.698 -0.683 . . . . 51.240000000000002 109.222 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 m -112.77 133.38 54.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.773 -0.194 . . . . 43.329999999999998 110.563 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.61 ' CD1' ' HA ' ' A' ' 228' ' ' TRP . 22.4 m-30 -122.24 140.95 52.01 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.982 -0.449 . . . . 64.400000000000006 111.105 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 1.0 OUTLIER -83.42 143.8 30.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.047 -0.723 . . . . 74.439999999999998 109.047 175.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.32 67.28 1.85 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.23 -0.51 . . . . 74.030000000000001 113.093 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -107.85 -41.36 5.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.382 . . . . 51.439999999999998 109.967 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.3 t -140.72 174.25 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.002 0.43 . . . . 73.120000000000005 111.776 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -120.88 19.15 11.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 71.299999999999997 111.226 -176.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 223' ' ' ASN . 7.8 mt-10 -71.77 166.44 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.954 -0.566 . . . . 73.140000000000001 112.152 -175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -102.71 151.04 22.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.66 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -141.78 131.21 23.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.003 -0.74 . . . . 73.430000000000007 109.003 172.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -102.57 130.71 49.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.836 -0.431 . . . . 73.420000000000002 109.836 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.648 HG12 HG12 ' A' ' 219' ' ' VAL . 70.6 mt -111.98 118.8 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.563 0.697 . . . . 62.149999999999999 111.383 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.497 ' O ' ' HB ' ' A' ' 218' ' ' THR . 19.3 m -95.48 104.72 16.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.135 -0.939 . . . . 70.450000000000003 110.331 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.54 ' HE1' ' HD3' ' A' ' 217' ' ' LYS . 18.7 m-85 -87.18 110.22 20.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.469 . . . . 53.350000000000001 110.657 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 36.8 ttpt -84.86 115.88 23.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.934 -0.576 . . . . 75.430000000000007 109.654 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 263' ' ' ALA . 3.3 m-85 -81.01 -149.89 0.07 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.11 -0.495 . . . . 53.210000000000001 110.847 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.12 170.24 1.72 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 110.545 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' A' ' 264' ' ' MET . 11.9 mmt -73.99 51.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.13 0.49 . . . . 63.509999999999998 110.506 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 70.9 m -145.36 -46.96 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.834 -0.621 . . . . 63.149999999999999 110.581 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -147.36 161.92 40.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.755 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 261' ' ' LYS . 15.2 p -125.29 156.53 38.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.422 -0.354 . . . . 73.409999999999997 111.53 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.794 ' HA ' ' HE2' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -120.89 -173.98 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.501 -0.555 . . . . 60.0 109.501 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.761 ' H ' ' HD3' ' A' ' 268' ' ' LYS . 20.4 tt0 -177.83 141.9 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.746 -0.464 . . . . 65.200000000000003 109.746 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.591 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.3 pp -141.54 160.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.483 0.49 . . . . 72.420000000000002 110.256 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.4 m -113.93 135.02 54.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.974 0.416 . . . . 71.5 111.624 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.455 HG22 ' HE2' ' A' ' 248' ' ' TYR . 33.2 mm -124.9 154.95 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.916 -0.584 . . . . 71.519999999999996 109.735 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 42.4 ttt180 -152.23 142.37 22.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.558 0.218 . . . . 73.239999999999995 110.823 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.74 146.06 23.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.347 -0.701 . . . . 55.310000000000002 111.347 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 189' ' ' VAL . 8.6 tpt180 -106.36 106.19 16.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 74.530000000000001 111.147 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 253' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.246 0.882 0 N-CA-C 108.848 -0.797 . . . . 64.310000000000002 108.848 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.758 -0.537 . . . . 63.439999999999998 111.758 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.65 151.33 81.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.828 2.352 . . . . 71.129999999999995 112.306 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -116.42 -168.06 1.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.049 -0.523 . . . . 55.100000000000001 109.898 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.29 64.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.719 -0.753 . . . . 62.310000000000002 112.076 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -68.44 -36.03 78.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 72.239999999999995 110.074 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.04 -143.75 16.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.867 -0.683 . . . . 71.409999999999997 111.817 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 p -131.94 150.32 52.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.822 0.344 . . . . 73.319999999999993 110.76 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 96.71 10.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.714 -0.476 . . . . 72.329999999999998 109.714 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.53 108.07 20.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.031 -0.531 . . . . 72.099999999999994 110.164 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -86.3 142.2 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 110.803 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 141' ' ' LEU . 1.7 tm? -123.48 121.3 35.35 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.233 -1.025 . . . . 71.409999999999997 108.233 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 131.12 42.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.572 . . . . 72.319999999999993 111.032 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.3 mt -90.83 111.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 110.476 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.6 125.01 38.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 109.846 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.02 151.94 44.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.851 0.358 . . . . 72.409999999999997 110.165 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.62 1.45 48.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.797 -0.638 . . . . 70.310000000000002 109.405 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.5 t 44.17 49.14 7.69 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.931 -1.031 . . . . 73.349999999999994 109.419 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -49.37 -44.08 44.58 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 113.537 -1.665 . . . . 75.209999999999994 110.705 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.9 ttt 58.08 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.187 -0.915 . . . . 72.439999999999998 111.873 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.15 86.24 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 109.728 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 m -67.34 107.91 2.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.479 -0.782 . . . . 74.319999999999993 110.908 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.05 152.3 45.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 71.340000000000003 111.324 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -83.58 179.58 7.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.793 -0.639 . . . . 74.219999999999999 109.69 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.69 -160.87 34.04 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.673 -0.775 . . . . 54.32 112.162 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -102.53 154.67 18.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 61.140000000000001 110.976 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.8 p -90.98 158.36 41.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.657 -0.701 . . . . 74.340000000000003 110.976 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.25 136.17 58.47 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.431 2.088 . . . . 72.420000000000002 112.114 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.607 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 27.5 m -83.74 162.98 51.13 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.755 -0.657 . . . . 73.439999999999998 110.779 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 158' ' ' VAL . 38.3 Cg_endo -67.2 -168.38 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 113.075 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 t -125.31 -167.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 54.43 110.301 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.69 138.13 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.355 -0.609 . . . . 51.420000000000002 109.355 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.1 p -69.9 163.62 25.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.282 -0.872 . . . . 45.240000000000002 112.009 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.34 159.72 30.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.804 -0.634 . . . . 74.409999999999997 111.375 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -86.71 -78.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 71.200000000000003 111.322 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -146.25 175.05 10.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.215 0.531 . . . . 74.420000000000002 112.002 -174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.651 ' CD2' HG13 ' A' ' 167' ' ' ILE . 42.9 t80 -148.27 160.73 42.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.77 -1.196 . . . . 74.120000000000005 107.77 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 7.9 mt 67.18 36.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 122.558 1.171 . . . . 70.040000000000006 109.741 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -15.85 7.37 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.605 -1.18 . . . . 54.109999999999999 109.821 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.1 m -149.03 -44.28 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.078 -1.419 . . . . 71.030000000000001 107.508 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -119.78 88.49 2.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.241 -1.345 . . . . 73.299999999999997 108.517 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 24.3 p -50.88 161.87 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.492 -1.231 . . . . 75.109999999999999 112.144 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.94 160.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 109.977 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 58.72 2.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.198 0.523 . . . . 72.200000000000003 111.383 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 175' ' ' THR . 2.6 p-10 -96.74 -167.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 110.978 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.406 ' N ' HD22 ' A' ' 174' ' ' ASN . 19.3 m -122.82 135.52 25.85 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 115.685 -0.688 . . . . 73.409999999999997 109.714 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 40.2 Cg_endo -68.72 149.58 73.38 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.796 2.331 . . . . 71.5 111.393 172.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.566 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 71.3 m -155.57 97.01 2.37 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.251 0.548 . . . . 44.219999999999999 111.012 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 181' ' ' THR . 40.4 Cg_endo -67.61 -9.16 24.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.505 2.804 . . . . 73.129999999999995 113.791 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.24 -13.32 62.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.155 0.502 . . . . 72.010000000000005 110.618 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 96.1 mt -117.62 17.35 14.44 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.862 -0.608 . . . . 61.240000000000002 110.642 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 178' ' ' PRO . 2.5 t -115.7 -178.92 3.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 42.340000000000003 111.188 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 103.69 5.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.654 0.74 . . . . 71.319999999999993 109.819 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.598 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -135.08 76.73 1.64 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.422 0.63 . . . . 72.010000000000005 110.2 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.7 m -125.19 -178.04 4.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.081 -0.509 . . . . 70.530000000000001 111.565 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.463 HD13 HG13 ' A' ' 198' ' ' ILE . 2.5 tt -160.19 126.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 70.010000000000005 110.793 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -133.27 74.63 1.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.893 0.854 . . . . 73.319999999999993 110.091 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -156.74 66.59 0.54 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.817 1.294 . . . . 74.540000000000006 109.788 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 273' ' ' ARG . 20.3 m -88.18 59.73 5.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.56 -1.655 . . . . 63.229999999999997 109.768 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.9 t -154.63 106.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.221 -1.354 . . . . 62.049999999999997 108.408 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.963 HD21 ' HB2' ' A' ' 196' ' ' ALA . 1.3 mm? -112.74 130.21 56.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 111.354 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -123.66 152.98 66.34 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.752 -1.113 . . . . 35.020000000000003 110.879 -174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.46 83.77 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.576 2.184 . . . . 63.350000000000001 111.693 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.55 -13.96 1.21 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.655 -0.702 . . . . 64.329999999999998 112.479 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -126.23 -179.55 4.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.077 0.438 . . . . 71.299999999999997 111.085 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 190' ' ' LEU . 20.0 p -142.02 155.58 45.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.203 -0.453 . . . . 70.230000000000004 110.48 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.963 ' HB2' HD21 ' A' ' 190' ' ' LEU . . . -93.16 126.47 38.27 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.819 -0.352 . . . . 45.399999999999999 110.208 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 245' ' ' VAL . 2.9 m -120.34 115.27 23.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.136 -0.483 . . . . 73.140000000000001 109.972 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 198' ' ' ILE . 4.0 mp -77.41 120.87 28.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.727 -0.842 . . . . 72.129999999999995 108.727 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.9 m -84.97 95.37 9.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.333 0.587 . . . . 71.200000000000003 109.99 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -114.35 109.92 19.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.212 0.53 . . . . 73.109999999999999 111.965 -173.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 240' ' ' GLY . 9.4 mm -104.83 142.58 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.219 -1.03 . . . . 71.129999999999995 108.219 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 213' ' ' VAL . 13.2 t -117.46 133.93 62.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.076 0.465 . . . . 70.230000000000004 110.288 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -122.36 155.73 35.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.675 -0.693 . . . . 74.340000000000003 109.925 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 30.0 m-20 -85.01 -179.77 7.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.028 -0.533 . . . . 75.140000000000001 110.285 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 8.9 tp -65.34 -19.17 25.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.356 0.598 . . . . 61.530000000000001 110.948 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.07 1.03 57.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 74.299999999999997 110.604 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.58 7.06 88.24 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.847 -0.901 . . . . 43.43 110.847 -172.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.57 145.6 97.2 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.971 -0.615 . . . . 64.209999999999994 110.547 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.22 111.01 2.36 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.669 2.246 . . . . 74.409999999999997 112.936 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 213' ' ' VAL . 89.1 t -65.46 144.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.695 -0.684 . . . . 74.25 110.673 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -71.93 -56.16 6.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 75.409999999999997 110.185 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 210' ' ' VAL . 11.4 pt-20 -166.0 153.04 9.83 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.292 -0.413 . . . . 75.349999999999994 111.118 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.591 HG13 HG11 ' A' ' 210' ' ' VAL . 31.5 m -135.42 170.86 18.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 74.319999999999993 110.081 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 48.9 t-80 -77.94 134.24 37.91 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.989 -0.55 . . . . 74.239999999999995 109.518 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 50.5 mt -142.18 105.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 74.400000000000006 110.146 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 2.0 t30 -92.12 156.16 17.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 71.019999999999996 110.001 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -104.61 111.16 23.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.044 0.449 . . . . 73.530000000000001 111.481 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 259' ' ' SER . 86.2 m -118.56 119.15 33.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.738 -0.664 . . . . 74.120000000000005 109.312 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.762 HG12 HG12 ' A' ' 258' ' ' ILE . 8.3 m -125.09 137.21 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.251 0.548 . . . . 63.5 112.243 -174.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -133.1 121.14 22.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.278 -0.873 . . . . 73.319999999999993 109.649 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 19.1 ptp180 -102.51 141.67 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 64.340000000000003 111.411 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 254' ' ' GLU . 51.7 mm-40 -76.46 -28.91 56.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 64.120000000000005 110.143 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 254' ' ' GLU . 38.3 t-20 -141.69 142.14 33.34 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.828 -0.624 . . . . 64.209999999999994 109.354 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.7 pt? -89.28 -13.77 37.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 75.5 110.916 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.94 -12.72 59.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 111.34 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.507 ' HA3' ' CZ2' ' A' ' 228' ' ' TRP . . . -74.74 131.11 12.38 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.407 -0.901 . . . . 52.43 111.069 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.916 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 80.4 mt -83.12 79.88 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.938 0.399 . . . . 73.219999999999999 109.945 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.512 ' HE3' ' CD1' ' A' ' 248' ' ' TYR . 11.1 m95 -91.89 108.2 19.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.917 -0.583 . . . . 75.239999999999995 109.792 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 247' ' ' THR . 9.0 t70 -103.66 140.32 37.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . 0.511 ' HA ' HG23 ' A' ' 246' ' ' ILE . 84.0 m-85 -116.62 122.32 44.26 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.498 -0.319 . . . . 73.340000000000003 111.28 -171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -94.23 172.43 31.96 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.72 -0.673 . . . . 72.219999999999999 111.489 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.56 153.89 30.77 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.986 2.458 . . . . 75.530000000000001 112.29 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 244' ' ' GLN . 62.6 tp -73.96 112.38 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 243' ' ' THR . 16.7 tptm -92.13 122.91 35.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.373 0.606 . . . . 75.409999999999997 110.968 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.6 tmtp? -101.23 105.86 17.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.254 -1.017 . . . . 74.420000000000002 108.254 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.642 ' HB3' HG22 ' A' ' 238' ' ' VAL . 6.5 tp10 -81.3 171.31 14.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.769 -0.651 . . . . 70.200000000000003 109.588 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.411 ' H ' ' HG3' ' A' ' 236' ' ' GLU . 17.3 m120 -78.69 59.49 2.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.6 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -141.15 148.55 52.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.211 -0.904 . . . . 63.329999999999998 110.553 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.42 112.33 1.72 Allowed 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.406 2.738 . . . . 73.150000000000006 113.796 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 201' ' ' ILE . . . 60.34 10.94 18.42 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 114.194 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 64.0 tttm -96.71 111.43 23.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.603 0.702 . . . . 63.399999999999999 111.288 -174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.678 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.2 m-85 -106.85 146.14 31.31 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.3 -0.864 . . . . 72.239999999999995 109.74 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 3.1 p -142.03 118.37 10.83 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 72.409999999999997 110.096 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.68 ' HB2' HD12 ' A' ' 233' ' ' LEU . 8.3 tt0 -122.9 114.48 20.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.496 -0.557 . . . . 71.120000000000005 109.496 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' A' ' 197' ' ' THR . 17.8 m -90.22 112.54 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.511 0.672 . . . . 61.530000000000001 111.087 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 230' ' ' TYR . 7.7 mm -103.27 134.73 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.622 -0.717 . . . . 51.240000000000002 109.928 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 229' ' ' ASP . 3.5 m -104.83 97.16 7.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.042 0.449 . . . . 43.329999999999998 110.989 -173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.837 ' HB2' ' HG ' ' A' ' 190' ' ' LEU . 75.9 m-85 -101.95 118.57 37.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.511 -0.313 . . . . 64.400000000000006 110.157 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.916 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 9.9 mmm180 -85.32 132.79 34.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.297 -0.41 . . . . 74.439999999999998 110.222 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -74.52 63.35 2.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.121 -0.491 . . . . 74.030000000000001 112.818 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -89.76 -30.85 17.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.451 0.643 . . . . 51.439999999999998 109.271 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 6.1 t -145.74 153.73 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.716 -1.129 . . . . 73.120000000000005 108.215 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 254' ' ' GLU . 0.2 OUTLIER -79.15 -102.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 71.299999999999997 110.467 -177.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 223' ' ' ASN . 2.2 mp0 48.19 -154.17 0.09 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.883 -1.053 . . . . 73.140000000000001 111.129 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 254' ' ' GLU . 41.0 mtm180 -136.33 172.49 12.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.524 -0.547 . . . . 72.230000000000004 109.524 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 272' ' ' ILE . 0.0 OUTLIER -139.01 128.47 30.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.464 -0.939 . . . . 73.430000000000007 108.464 171.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 132.82 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.632 -0.713 . . . . 73.420000000000002 111.004 -173.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.762 HG12 HG12 ' A' ' 219' ' ' VAL . 60.0 mt -122.59 112.09 32.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 62.149999999999999 110.851 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 218' ' ' THR . 1.2 t -94.03 100.01 12.22 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.534 -0.757 . . . . 70.450000000000003 109.034 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -81.86 113.62 19.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.727 -0.67 . . . . 53.350000000000001 111.299 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 39.2 ttmt -84.67 98.1 10.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.342 -0.845 . . . . 75.430000000000007 109.752 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 3.3 m-85 -73.12 -150.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 53.210000000000001 110.947 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -59.41 156.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.296 -0.631 . . . . 71.510000000000005 109.296 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 78.8 mmm -73.28 21.71 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.189 0.44 . . . . 63.509999999999998 112.189 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 263' ' ' ALA . 24.6 t -108.47 -34.74 6.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.254 -0.43 . . . . 63.149999999999999 109.905 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.59 142.05 30.9 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.104 0.478 . . . . 73.25 111.378 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 8.6 p -110.06 165.34 11.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.566 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.606 ' HG2' ' N ' ' A' ' 269' ' ' GLU . 74.5 tttt -142.61 170.1 16.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.53 -0.304 . . . . 60.0 110.395 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.606 ' N ' ' HG2' ' A' ' 268' ' ' LYS . 28.5 tt0 -159.19 140.77 13.23 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 65.200000000000003 109.79 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.1 pp -135.25 154.09 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.027 0.442 . . . . 72.420000000000002 110.405 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.8 m -108.94 134.65 51.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.969 -0.559 . . . . 71.5 111.289 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 248' ' ' TYR . 27.7 mm -124.89 149.29 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 71.519999999999996 109.939 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' A' ' 188' ' ' SER . 25.4 ttp180 -139.61 138.64 36.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.475 -0.329 . . . . 73.239999999999995 110.716 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -93.0 153.06 21.29 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.41 -0.676 . . . . 55.310000000000002 111.41 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -100.06 104.52 16.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.879 0.339 . . . . 74.530000000000001 110.112 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.898 -0.778 . . . . 64.310000000000002 108.898 174.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.857 0 N-CA-C 111.736 -0.546 . . . . 63.439999999999998 111.736 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.52 109.39 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.482 2.121 . . . . 71.129999999999995 112.057 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.6 tt -141.31 86.22 2.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.332 -0.618 . . . . 55.100000000000001 109.332 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.48 87.33 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.626 -0.715 . . . . 62.310000000000002 111.623 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 m -58.31 -50.98 71.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 72.239999999999995 111.513 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 154.95 116.91 0.58 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.944 -0.646 . . . . 71.409999999999997 112.378 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.8 t -116.23 94.22 4.56 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 73.319999999999993 109.478 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -124.27 154.7 39.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.194 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -123.43 115.41 45.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.14 0.495 . . . . 72.099999999999994 110.026 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -87.82 136.38 32.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.099 0.476 . . . . 74.420000000000002 111.135 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.1 -165.11 1.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.657 -0.701 . . . . 71.409999999999997 110.315 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.11 179.74 6.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.085 -0.339 . . . . 72.319999999999993 110.085 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.17 122.13 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.158 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -132.9 154.57 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.442 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.476 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -77.08 81.13 3.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.767 -0.651 . . . . 72.409999999999997 110.15 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.75 73.19 10.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.333 0.587 . . . . 70.310000000000002 110.494 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.7 p 58.23 19.09 5.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.583 -1.189 . . . . 73.349999999999994 111.378 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.14 -27.76 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.035 -0.529 . . . . 75.209999999999994 111.833 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.55 147.72 22.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.031 0.443 . . . . 72.439999999999998 111.8 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.76 111.73 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.173 -0.921 . . . . 63.119999999999997 109.145 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.2 m -75.18 82.68 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.495 . . . . 74.319999999999993 112.289 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 68.89 148.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.699 1.0 . . . . 71.340000000000003 113.699 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -130.25 126.86 38.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.961 -1.018 . . . . 74.219999999999999 108.867 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.51 -106.89 0.9 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.667 -0.778 . . . . 54.32 112.745 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -123.8 122.28 37.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.048 0.451 . . . . 61.140000000000001 110.624 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 12.4 p -74.18 148.97 86.85 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.462 -0.79 . . . . 74.340000000000003 111.034 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.1 140.49 95.33 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.582 2.188 . . . . 72.420000000000002 111.834 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.42 135.04 65.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.183 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.61 137.06 24.51 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.605 2.203 . . . . 72.400000000000006 112.122 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -74.13 139.74 44.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.068 -0.514 . . . . 54.43 110.417 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.24 73.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.324 -0.621 . . . . 51.420000000000002 109.324 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 m -104.74 134.61 47.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.634 -0.712 . . . . 45.240000000000002 110.158 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -67.11 -62.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 74.409999999999997 111.336 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -136.04 165.34 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 71.200000000000003 110.801 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -131.22 166.64 20.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.582 -0.736 . . . . 74.420000000000002 109.102 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -123.7 -172.23 2.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 74.120000000000005 110.418 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 171' ' ' THR . 2.2 mp 55.44 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.305 -0.861 . . . . 70.040000000000006 111.166 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.34 -18.59 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.763 -0.653 . . . . 54.109999999999999 109.399 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.1 m -135.81 -66.54 0.55 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.932 -1.031 . . . . 71.030000000000001 108.794 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.64 58.15 3.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.387 -0.824 . . . . 73.299999999999997 110.319 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.466 ' HA ' HG23 ' A' ' 167' ' ' ILE . 5.2 t -57.46 148.75 22.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 75.109999999999999 111.485 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.5 tp -79.96 126.67 39.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.567 0.699 . . . . 73.040000000000006 110.982 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.4 m -88.64 62.12 6.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.328 0.585 . . . . 72.200000000000003 111.488 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.91 -166.3 1.36 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.902 -0.59 . . . . 75.349999999999994 110.302 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.7 m -118.02 133.14 23.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 73.409999999999997 109.831 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 59.8 Cg_endo -76.89 167.58 24.98 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.713 2.275 . . . . 71.5 112.236 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.4 t -157.45 99.11 1.92 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 44.219999999999999 109.805 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 181' ' ' THR . 37.8 Cg_endo -67.85 -9.96 27.27 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.819 2.346 . . . . 73.129999999999995 113.217 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.94 -21.03 65.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.108 0.48 . . . . 72.010000000000005 110.535 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 81.3 mt -112.97 12.62 19.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 61.240000000000002 110.906 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.571 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.8 t -116.1 -176.89 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 42.340000000000003 111.447 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.41 104.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.684 0.754 . . . . 71.319999999999993 110.224 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 181' ' ' THR . 0.0 OUTLIER -131.84 77.62 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 72.010000000000005 110.319 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 m -137.01 179.72 6.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.332 0.587 . . . . 70.530000000000001 111.565 -171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 196' ' ' ALA . 0.8 OUTLIER -145.18 132.8 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 109.676 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.67 76.86 1.46 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.001 0.429 . . . . 73.319999999999993 111.313 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 196' ' ' ALA . 20.4 ptmt -169.25 88.15 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.016 0.912 . . . . 74.540000000000006 110.474 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -85.61 55.63 3.6 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.988 0.899 . . . . 63.229999999999997 109.108 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.9 t -158.83 115.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.28 -1.327 . . . . 62.049999999999997 108.822 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -124.68 149.92 46.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.938 0.399 . . . . 73.420000000000002 110.029 177.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 70.1 m -149.57 149.2 28.0 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 115.579 -0.737 . . . . 35.020000000000003 110.507 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 108.47 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.756 2.304 . . . . 63.350000000000001 111.435 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 125.55 -19.41 6.67 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.67 -0.776 . . . . 64.329999999999998 111.923 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.82 174.22 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 71.299999999999997 110.876 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 190' ' ' LEU . 19.4 p -140.38 163.2 33.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.765 -0.652 . . . . 70.230000000000004 110.45 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.721 ' HA ' ' HD3' ' A' ' 187' ' ' LYS . . . -100.04 118.51 36.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.497 -0.557 . . . . 45.399999999999999 109.497 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 244' ' ' GLN . 4.8 m -101.6 115.29 30.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.412 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 272' ' ' ILE . 4.3 mp -78.82 114.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.293 -0.632 . . . . 72.129999999999995 109.293 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 15.7 m -89.37 96.97 10.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.244 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 242' ' ' TYR . 0.0 OUTLIER -107.15 106.17 16.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.281 0.562 . . . . 73.109999999999999 111.413 -176.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.2 mm -101.42 137.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.278 -1.008 . . . . 71.129999999999995 108.278 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 210' ' ' VAL . 15.8 t -114.55 136.07 52.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.132 0.491 . . . . 70.230000000000004 110.768 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -121.51 148.66 44.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 109.137 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.852 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 41.7 m-20 -77.01 175.77 9.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.276 0.56 . . . . 75.140000000000001 110.775 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -29.58 47.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.353 -0.84 . . . . 61.530000000000001 110.294 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -87.51 3.64 46.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 74.299999999999997 110.844 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.99 59.05 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.661 -0.78 . . . . 43.43 112.697 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -105.16 164.78 14.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.126 -0.324 . . . . 64.209999999999994 110.126 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' A' ' 239' ' ' PRO . 14.7 Cg_exo -70.21 115.09 4.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.733 2.289 . . . . 74.409999999999997 112.847 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 202' ' ' VAL . 63.3 t -65.14 145.08 14.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.56 -0.745 . . . . 74.25 110.557 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 167' ' ' ILE . 2.3 t-20 -56.43 -61.61 2.29 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.198 -0.668 . . . . 75.409999999999997 109.198 169.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.688 ' HB2' ' OH ' ' A' ' 242' ' ' TYR . 15.7 pt-20 178.57 171.63 0.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.123 -0.944 . . . . 75.349999999999994 109.508 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 202' ' ' VAL . 34.8 m -137.29 -172.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.45 0.643 . . . . 74.319999999999993 111.209 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 262' ' ' TYR . 29.6 t-80 -98.63 139.58 34.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.067 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.0 mt -140.55 107.08 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.396 0.617 . . . . 74.400000000000006 110.749 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.889 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -100.06 125.41 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.267 -0.879 . . . . 71.019999999999996 109.403 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.486 ' N ' HD22 ' A' ' 216' ' ' ASN . 0.4 OUTLIER -70.02 135.4 49.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.857 0.361 . . . . 73.530000000000001 111.458 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 259' ' ' SER . 99.1 m -135.71 94.96 3.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.579 -0.737 . . . . 74.120000000000005 109.125 172.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 256' ' ' ILE . 17.6 m -91.14 128.02 43.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.772 0.796 . . . . 63.5 112.173 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.59 104.56 11.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.043 -0.981 . . . . 73.319999999999993 109.367 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -106.95 119.45 39.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.759 -0.655 . . . . 64.340000000000003 111.09 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.84 -9.69 57.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.438 0.637 . . . . 64.120000000000005 110.121 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 254' ' ' GLU . 47.5 t-20 -131.56 128.09 38.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.223 -0.899 . . . . 64.209999999999994 109.45 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.743 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.9 pt? -100.85 -19.78 15.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 75.5 110.756 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.504 ' HD2' ' HG ' ' A' ' 224' ' ' LEU . 5.7 mptp? -76.51 -25.73 54.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 73.209999999999994 110.302 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -63.81 132.98 40.67 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.692 -0.963 . . . . 52.43 110.692 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 75.4 mt -96.98 95.49 7.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.064 0.459 . . . . 73.219999999999999 110.031 -175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 223' ' ' ASN . 9.8 m95 -92.48 112.07 23.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.418 -0.81 . . . . 75.239999999999995 109.624 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.791 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 3.3 m-20 -88.16 117.85 27.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.224 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.302 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -92.49 166.85 29.53 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.509 -1.037 . . . . 72.219999999999999 110.509 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 57.1 Cg_endo -71.2 158.61 54.35 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.233 1.955 . . . . 75.530000000000001 111.95 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 244' ' ' GLN . 37.1 tp -72.87 108.9 6.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.764 -0.458 . . . . 72.109999999999999 109.764 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 243' ' ' THR . 35.0 tptt -78.89 121.63 25.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.736 0.779 . . . . 75.409999999999997 110.104 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 234' ' ' LYS . 1.2 tmtp? -115.64 108.93 17.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.294 -1.321 . . . . 74.420000000000002 108.704 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 234' ' ' LYS . 8.5 tp10 -98.52 168.77 9.98 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.715 -0.476 . . . . 70.200000000000003 109.715 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -75.49 70.61 2.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 109.813 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 241' ' ' LYS . 1.4 m -137.48 153.0 74.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.698 -0.683 . . . . 63.329999999999998 110.922 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 209' ' ' PRO . 33.3 Cg_endo -65.41 100.59 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.198 2.599 . . . . 73.150000000000006 113.191 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 53.82 28.25 38.7 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.657 -0.701 . . . . 55.530000000000001 113.881 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.586 ' HB3' ' CG2' ' A' ' 238' ' ' VAL . 86.6 tttt -106.68 118.92 37.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 63.399999999999999 111.474 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.688 ' OH ' ' HB2' ' A' ' 212' ' ' GLU . 97.5 m-85 -115.52 146.02 42.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.302 -0.863 . . . . 72.239999999999995 109.604 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 4.0 p -139.48 121.72 15.9 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.163 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.752 ' HB2' HD12 ' A' ' 233' ' ' LEU . 45.7 tt0 -129.6 139.36 51.48 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.343 -0.543 . . . . 71.120000000000005 109.837 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 m -103.36 124.25 57.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 61.530000000000001 111.849 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.72 115.77 49.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.028 -0.73 . . . . 51.240000000000002 109.028 173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.791 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 7.8 m -98.76 155.36 17.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.888 -0.412 . . . . 43.329999999999998 109.888 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.611 ' HB3' HD12 ' A' ' 190' ' ' LEU . 28.3 t80 -132.97 126.21 31.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.906 0.384 . . . . 64.400000000000006 111.243 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.882 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 16.4 mmt180 -86.31 146.14 26.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.926 -0.579 . . . . 74.439999999999998 109.606 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.17 77.49 1.17 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.752 -0.737 . . . . 74.030000000000001 112.094 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -120.68 -54.47 2.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.474 0.178 . . . . 51.439999999999998 111.247 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 16.1 t -147.45 132.09 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 73.120000000000005 110.745 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 276' ' ' LEU . 0.2 OUTLIER -79.65 108.18 13.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 71.299999999999997 111.177 -176.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 223' ' ' ASN . 0.3 OUTLIER -162.93 -171.52 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.486 -0.779 . . . . 73.140000000000001 109.582 171.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -128.08 151.19 49.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.304 -0.407 . . . . 72.230000000000004 110.63 -177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -123.72 122.55 65.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.491 -0.929 . . . . 73.430000000000007 108.491 174.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.7 128.29 46.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 73.420000000000002 110.066 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 270' ' ' ILE . 52.6 mt -112.5 117.22 54.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 62.149999999999999 110.956 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 218' ' ' THR . 13.8 m -86.26 114.62 23.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.162 -0.927 . . . . 70.450000000000003 109.096 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 270' ' ' ILE . 9.5 m-85 -91.57 114.46 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.422 0.629 . . . . 53.350000000000001 111.411 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 3.8 tppp? -79.62 95.4 5.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 75.430000000000007 109.092 174.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.63 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 9.0 m-85 -71.96 -145.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 53.210000000000001 110.448 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 265' ' ' SER . . . -60.89 164.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.418 . . . . 71.510000000000005 109.87 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 mmt -73.15 31.68 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.014 0.435 . . . . 63.509999999999998 111.132 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 263' ' ' ALA . 74.0 m -128.26 -39.12 1.73 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.663 -0.699 . . . . 63.149999999999999 110.987 -174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -153.65 156.64 38.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.477 -0.329 . . . . 73.25 110.821 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.66 HG21 ' HD3' ' A' ' 261' ' ' LYS . 29.9 p -136.53 174.71 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.405 -0.361 . . . . 73.409999999999997 110.691 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' A' ' 262' ' ' TYR . 0.0 OUTLIER -161.35 158.91 27.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.799 0.333 . . . . 60.0 110.685 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.28 145.11 48.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.842 0.353 . . . . 65.200000000000003 111.069 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.61 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -127.66 163.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.812 -0.631 . . . . 72.420000000000002 110.381 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 44.8 m -121.85 131.7 54.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 71.5 111.751 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 198' ' ' ILE . 46.7 mm -112.72 96.82 5.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 71.519999999999996 109.28 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -89.43 118.91 29.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 73.239999999999995 111.264 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 190' ' ' LEU . . . -82.29 140.73 20.84 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.418 -0.673 . . . . 55.310000000000002 111.418 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -123.38 110.19 14.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.461 . . . . 74.530000000000001 110.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.027 -0.731 . . . . 64.310000000000002 109.027 174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.09 -0.404 . . . . 63.439999999999998 112.09 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.7 95.35 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.485 2.123 . . . . 71.129999999999995 112.884 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.8 mp -95.87 -33.37 12.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.786 -0.643 . . . . 55.100000000000001 109.43 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.38 72.55 1.23 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 114.883 -1.053 . . . . 62.310000000000002 111.955 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t -68.57 144.16 54.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 110.322 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -140.03 70.36 0.45 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.66 -0.781 . . . . 71.409999999999997 112.396 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -148.83 147.98 29.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 73.319999999999993 110.031 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 139' ' ' ILE . 53.4 tttm -149.92 159.68 44.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.006 -0.368 . . . . 72.329999999999998 110.006 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.476 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 44.4 mm -88.38 115.33 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 120.978 0.418 . . . . 72.099999999999994 109.96 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -93.6 99.18 11.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 109.776 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 141' ' ' LEU . 1.5 pt? -108.06 97.31 7.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.32 0.581 . . . . 71.409999999999997 110.876 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.72 108.41 20.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.875 -0.787 . . . . 72.319999999999993 108.875 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.67 157.54 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.114 -0.494 . . . . 71.409999999999997 111.733 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -167.65 160.5 12.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.905 -1.043 . . . . 74.239999999999995 108.93 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.485 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p30 -89.14 160.13 17.16 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.543 -0.54 . . . . 72.409999999999997 109.543 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.66 2.3 55.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.33 -0.619 . . . . 70.310000000000002 109.33 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.7 t 40.23 40.09 0.76 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.291 1.043 . . . . 73.349999999999994 109.477 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.19 -41.96 66.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.715 -1.584 . . . . 75.209999999999994 111.44 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.9 mtt 52.05 45.42 28.37 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.273 -0.639 . . . . 72.439999999999998 109.273 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.56 87.97 0.04 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 112.219 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.0 m -83.06 136.51 34.46 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.63 -1.168 . . . . 74.319999999999993 109.193 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.4 110.95 13.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.17 0.509 . . . . 71.340000000000003 110.815 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.5 m -105.91 144.26 32.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.869 -0.605 . . . . 74.219999999999999 110.356 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -105.77 108.03 2.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.799 -0.715 . . . . 54.32 112.226 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -111.58 118.08 34.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 61.140000000000001 110.074 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 15.2 p -67.87 134.88 92.07 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.66 -0.7 . . . . 74.340000000000003 111.716 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 154.87 67.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.71 2.274 . . . . 72.420000000000002 112.225 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.73 156.24 35.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.063 -0.517 . . . . 73.439999999999998 111.028 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.1 167.62 24.65 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.874 2.382 . . . . 72.400000000000006 112.114 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.5 t -111.66 155.27 23.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.135 -0.484 . . . . 54.43 110.0 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.6 122.63 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 51.420000000000002 110.511 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.2 m -112.05 133.93 53.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.118 -0.492 . . . . 45.240000000000002 110.315 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 106.85 11.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 74.409999999999997 111.312 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.32 -179.37 3.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.999 -0.546 . . . . 71.200000000000003 110.036 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 168' ' ' GLU . 14.5 tt0 -95.73 113.13 24.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.942 0.401 . . . . 74.420000000000002 111.685 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -163.04 145.47 10.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 74.120000000000005 109.858 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 1.033 ' HA ' ' HA ' ' A' ' 171' ' ' THR . 10.2 mt 65.79 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.921 1.343 . . . . 70.040000000000006 110.287 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 165' ' ' GLN . 6.3 pt-20 -130.07 91.96 3.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.315 -1.312 . . . . 54.109999999999999 108.435 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.2 m 88.09 -22.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.328 -1.306 . . . . 71.030000000000001 108.847 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.09 71.39 1.42 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.111 -0.949 . . . . 73.299999999999997 110.609 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 1.033 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 14.6 t -64.47 157.57 26.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 75.109999999999999 110.828 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.8 tt -86.6 137.57 20.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 73.040000000000006 110.894 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.9 t -85.41 62.67 7.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.516 0.674 . . . . 72.200000000000003 109.684 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.67 -172.98 4.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.395 -0.821 . . . . 75.349999999999994 111.187 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 28.3 m -112.27 135.52 21.38 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.604 . . . . 73.409999999999997 110.179 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.4 Cg_exo -78.06 161.68 29.44 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.836 2.358 . . . . 71.5 111.242 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 205' ' ' ILE . 45.4 m -154.69 97.39 2.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.375 0.607 . . . . 44.219999999999999 110.826 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 181' ' ' THR . 38.7 Cg_endo -66.27 -8.17 19.64 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.423 2.749 . . . . 73.129999999999995 113.615 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.08 -16.01 63.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.914 0.388 . . . . 72.010000000000005 110.877 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 94.3 mt -113.02 9.8 18.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.095 -0.502 . . . . 61.240000000000002 110.733 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 183' ' ' MET . 1.0 OUTLIER -118.85 -178.92 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.021 0.439 . . . . 42.340000000000003 111.628 -173.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 p -131.83 114.06 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.33 0.586 . . . . 71.319999999999993 110.329 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.705 ' HA ' ' HA ' ' A' ' 200' ' ' THR . 0.0 OUTLIER -143.67 92.05 2.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.019 -0.537 . . . . 72.010000000000005 110.736 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 m -154.97 173.75 16.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.306 0.574 . . . . 70.530000000000001 111.753 -174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' A' ' 187' ' ' LYS . 1.2 tt -142.83 109.65 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.173 -0.921 . . . . 70.010000000000005 109.866 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.99 54.62 0.69 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.925 -0.579 . . . . 73.319999999999993 110.873 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 185' ' ' ILE . 20.3 ptmt -146.83 82.22 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.24 1.019 . . . . 74.540000000000006 110.657 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 273' ' ' ARG . 58.9 m -92.38 45.09 1.18 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.721 -1.127 . . . . 63.229999999999997 110.367 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 99.1 t -146.22 114.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.562 -1.199 . . . . 62.049999999999997 108.778 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.836 ' HG ' ' CD1' ' A' ' 248' ' ' TYR . 0.2 OUTLIER -133.3 118.51 18.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.219 0.533 . . . . 73.420000000000002 111.298 -177.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.5 m -98.54 147.73 33.55 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 114.83 -1.077 . . . . 35.020000000000003 110.84 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.25 106.68 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.867 2.378 . . . . 63.350000000000001 112.314 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.47 -36.94 2.15 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.919 -0.658 . . . . 64.329999999999998 112.062 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -96.68 -173.38 2.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.613 -0.435 . . . . 71.299999999999997 110.562 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 p -149.48 155.48 40.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.929 0.395 . . . . 70.230000000000004 110.66 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 190' ' ' LEU . . . -107.21 116.59 32.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.276 0.56 . . . . 45.399999999999999 110.066 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.455 ' OG1' HG12 ' A' ' 245' ' ' VAL . 3.9 m -99.39 117.8 34.62 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.669 -0.696 . . . . 73.140000000000001 110.418 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 272' ' ' ILE . 4.1 mp -74.33 113.61 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.671 -0.863 . . . . 72.129999999999995 108.671 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 23.9 m -84.54 97.55 9.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.112 0.482 . . . . 71.200000000000003 109.913 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 183' ' ' MET . 1.8 t -121.03 110.63 16.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.619 0.723 . . . . 73.109999999999999 111.056 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.26 141.46 28.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.891 -1.049 . . . . 71.129999999999995 108.452 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 210' ' ' VAL . 12.1 t -115.1 139.11 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.882 0.372 . . . . 70.230000000000004 111.047 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -129.77 151.58 50.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 176' ' ' PRO . 13.5 m-20 -77.74 174.86 10.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 75.140000000000001 110.679 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.651 ' HA ' ' HB2' ' A' ' 177' ' ' SER . 0.0 OUTLIER -63.97 -28.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.574 -0.739 . . . . 61.530000000000001 110.788 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.9 -13.8 59.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.56 . . . . 74.299999999999997 110.183 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.69 36.76 8.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.707 -0.758 . . . . 43.43 111.465 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -107.94 163.53 16.75 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.492 0.187 . . . . 64.209999999999994 110.823 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.666 ' CB ' ' HB3' ' A' ' 239' ' ' PRO . 49.4 Cg_endo -71.29 108.44 2.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.775 2.316 . . . . 74.409999999999997 112.948 176.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG12 ' A' ' 202' ' ' VAL . 96.1 t -62.81 137.05 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 74.25 111.327 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.83 -61.36 2.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.604 -0.725 . . . . 75.409999999999997 109.212 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 210' ' ' VAL . 8.4 pt-20 178.31 154.68 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.244 -0.889 . . . . 75.349999999999994 109.759 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 210' ' ' VAL . 33.5 m -119.75 176.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 109.993 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -89.88 123.77 34.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 109.502 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.7 mt -125.07 123.12 64.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.381 . . . . 74.400000000000006 110.162 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.683 ' HB3' ' HB3' ' A' ' 261' ' ' LYS . 3.6 t30 -108.23 148.95 29.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 71.019999999999996 110.504 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -86.99 101.92 13.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.195 -0.457 . . . . 73.530000000000001 110.675 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 259' ' ' SER . 87.8 m -119.89 96.52 5.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.988 -0.551 . . . . 74.120000000000005 109.828 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.827 ' HB ' HD11 ' A' ' 256' ' ' ILE . 33.4 m -101.97 144.1 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.288 0.566 . . . . 63.5 111.773 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.37 123.58 36.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 73.319999999999993 109.771 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -121.59 152.43 39.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.786 0.327 . . . . 64.340000000000003 111.019 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.85 -48.57 2.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.132 0.492 . . . . 64.120000000000005 110.246 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -107.08 124.22 49.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.522 . . . . 64.209999999999994 109.779 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 224' ' ' LEU . 2.5 pt? -74.24 -12.73 60.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 75.5 111.479 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -69.1 -5.99 25.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.543 -0.298 . . . . 73.209999999999994 111.531 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 252' ' ' SER . . . -78.88 103.36 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.803 -0.713 . . . . 52.43 112.683 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 249' ' ' ARG . 81.6 mt -83.73 96.84 8.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.19 -0.67 . . . . 73.219999999999999 109.19 174.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -109.83 131.44 55.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.868 -0.605 . . . . 75.239999999999995 109.655 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 5.7 m-20 -105.44 111.14 23.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 72.209999999999994 110.693 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -104.24 127.76 51.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.668 -0.697 . . . . 73.340000000000003 110.06 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -102.97 -177.53 26.68 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.346 -0.93 . . . . 72.219999999999999 111.661 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 140.79 42.27 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 75.530000000000001 111.25 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 244' ' ' GLN . 26.0 tp -67.16 122.59 18.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 72.109999999999999 110.433 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 243' ' ' THR . 21.2 tptp -86.3 114.88 23.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.424 0.63 . . . . 75.409999999999997 110.072 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -107.47 115.59 30.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 74.420000000000002 109.197 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 238' ' ' VAL . 29.1 tt0 -102.59 161.82 13.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.554 . . . . 70.200000000000003 109.882 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -75.98 49.08 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.445 0.64 . . . . 72.409999999999997 111.939 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.999 HG21 ' HD3' ' A' ' 241' ' ' LYS . 0.1 OUTLIER -124.64 163.38 37.19 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.633 -0.712 . . . . 63.329999999999998 110.747 -175.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.666 ' HB3' ' CB ' ' A' ' 209' ' ' PRO . 19.7 Cg_endo -59.74 88.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.147 2.565 . . . . 73.150000000000006 113.7 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 55.36 28.58 50.85 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.377 -0.829 . . . . 55.530000000000001 113.572 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.999 ' HD3' HG21 ' A' ' 238' ' ' VAL . 65.7 tttt -92.56 116.91 29.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.285 0.564 . . . . 63.399999999999999 110.992 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 200' ' ' THR . 94.6 m-85 -115.17 144.07 44.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 110.104 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 234' ' ' LYS . 8.4 p -142.38 133.59 26.16 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.757 -0.656 . . . . 72.409999999999997 110.486 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.766 ' HB2' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -143.76 121.72 12.06 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.066 -1.087 . . . . 71.120000000000005 108.066 176.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' OG1' ' A' ' 197' ' ' THR . 8.1 m -85.42 96.8 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.544 0.687 . . . . 61.530000000000001 111.237 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' A' ' 244' ' ' GLN . 25.4 mm -73.28 120.67 22.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 51.240000000000002 109.446 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 229' ' ' ASP . 20.8 m -101.19 143.47 31.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.981 -0.748 . . . . 43.329999999999998 108.981 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.836 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -120.12 165.97 14.04 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.502 -0.555 . . . . 64.400000000000006 109.502 -177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.847 ' HB2' ' HB2' ' A' ' 227' ' ' LEU . 39.2 mmt-85 -113.94 5.7 16.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.742 -0.383 . . . . 74.439999999999998 111.135 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 62.51 -0.84 1.85 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 114.425 0.53 . . . . 74.030000000000001 114.425 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -53.6 -30.72 43.88 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.123 0.569 . . . . 51.439999999999998 112.068 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.548 ' HB3' ' HA2' ' A' ' 226' ' ' GLY . 41.8 t -128.38 148.93 50.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.985 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.56 -29.0 14.59 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.736 0.779 . . . . 71.299999999999997 110.361 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.26 144.37 35.82 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.594 -1.185 . . . . 73.140000000000001 110.579 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 273' ' ' ARG . 9.4 mtm180 -78.8 157.8 28.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.213 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.827 HD11 ' HB ' ' A' ' 219' ' ' VAL . 0.0 OUTLIER -115.93 124.43 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.364 -1.347 . . . . 73.430000000000007 107.364 163.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -94.32 118.59 31.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.171 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 219' ' ' VAL . 49.8 mt -105.21 116.3 48.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.484 0.659 . . . . 62.149999999999999 110.575 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.662 ' O ' ' HB ' ' A' ' 218' ' ' THR . 6.8 m -93.4 87.42 5.58 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.038 -0.983 . . . . 70.450000000000003 109.56 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -66.54 102.23 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.216 0.532 . . . . 53.350000000000001 110.503 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 216' ' ' ASN . 34.0 ttpt -70.51 111.17 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.331 -0.85 . . . . 75.430000000000007 109.968 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 267' ' ' THR . 1.1 m-85 -80.66 -151.9 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 53.210000000000001 111.192 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.474 ' H ' ' HB3' ' A' ' 262' ' ' TYR . . . -61.8 167.97 3.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.883 -0.599 . . . . 71.510000000000005 110.52 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 71.0 mtm -74.91 54.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.485 0.659 . . . . 63.509999999999998 110.245 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 69.8 m -152.31 -47.03 0.1 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.383 -0.826 . . . . 63.149999999999999 109.95 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -146.79 163.03 37.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 73.25 109.733 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 262' ' ' TYR . 41.3 p -134.53 160.11 39.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.689 0.28 . . . . 73.409999999999997 110.8 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 269' ' ' GLU . 24.1 tptp -122.89 162.55 22.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.747 -0.464 . . . . 60.0 109.747 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 268' ' ' LYS . 40.6 tt0 -144.56 141.96 29.85 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.485 -0.561 . . . . 65.200000000000003 109.485 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 258' ' ' ILE . 2.2 pp -136.66 167.13 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.146 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.5 p -112.71 123.82 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.554 . . . . 71.5 111.919 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 198' ' ' ILE . 31.4 mm -107.96 103.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.68 175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 188' ' ' SER . 46.6 ttt180 -119.93 122.7 41.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.0 0.429 . . . . 73.239999999999995 111.687 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -87.98 156.62 27.6 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.515 -0.766 . . . . 55.310000000000002 112.769 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 56.0 ttt180 -101.85 107.53 18.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.728 0.299 . . . . 74.530000000000001 110.49 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.568 -0.901 . . . . 64.310000000000002 108.568 173.737 . . . . . . . . 0 0 . 1 stop_ save_